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Abstract
Title: Equity in antiretroviral therapy access: An assessment of patients’ 
experiences in Lilongwe District, Malawi
Background: This thesis presents and discusses the findings of a study that assessed 
health care seeking pathways and experiences in accessing antiretroviral treatment and 
continuing with treatment. The thesis explores how patients’ experiences in health care were 
mediated by socioeconomic factors such as gender, poverty and rural/urban residence. The 
thesis aims to answer four main research questions:
• What is the health care seeking behaviour of patients leading to the time they are 
eligible for antiretroviral therapy (ART) and begin the antiretroviral drug initiation 
process?
• What are the associated direct and indirect costs of care seeking and are there 
inequalities in how the costs impact on different social economic groups?
• Are there patients who do not initiate treatment despite knowing that they are eligible 
for treatment and if so, why do these patients not start treatment?
• Among the patients who are lost to follow up or die whilst on ART, what are the 
factors that contribute to attrition?
Study Methods: The study employed a mixed quantitative and qualitative research design. 
A survey was conducted among males and females identified as eligible for ART in seven 
health facilities in urban and rural Lilongwe. Patients were then followed up to identify those 
who started treatment or did not and those who were continuing with treatment or dropped 
off. Follow up qualitative interviews were conducted with different groups of patients and 
health workers.
Findings: Patients make multiple visits to different health providers ranging from self­
treating, to visiting private clinics and public hospitals and health centres which result in a 
delay to HIV testing and ultimately delay in initiating ART. Inequities exist in how patients 
experience care seeking for HIV and ART services. The health care seeking pathway is 
influenced by socio-economic factors which in turn affect patient treatment outcomes. The 
type of health facility and the direct costs of care seeking in particular have an influence on 
whether patients start treatment or not. Patients’ perceived severity of illness plays a role in 
determining whether patients start or remain in HIV care. Male sex and poverty were
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associated with patients’ loss to follow up and deaths while on ART. From the qualitative 
interviews, long distance to health facilities, psychosocial problems and the challenges of 
disclosure interplayed with other factors to cause patients to interrupt treatment.
Discussion: The pathway to care seeking is influenced by the interactions at three levels - 
the community, the patients and their households and the health system. These interactions 
are mediated by gender, poverty, residence, illness meaning and stigma to determine a 
complex and long health care seeking behaviour, delays in HIV diagnosis, missed 
opportunities for HIV testing and pre-ART care, drop out from the health care seeking 
pathway, early mortality and survival or attrition from ART.
Conclusion and recommendations: To address existing inequities in ART access, there is 
a need to increase the availability of services to the rural poor and strengthen health 
systems. Supporting community based systems have the potential to bring services closer 
to poor communities. However, Malawi needs to consider revisiting the ART equity policy in 
a way that will create new financing opportunities for HIV treatment.
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Chapter 1: Introduction
1.0 Introduction
This chapter aims to briefly present the HIV and AIDS situation globally and in sub-Saharan 
Africa and the progress that has been made towards antiretroviral therapy universal 
coverage. It also presents the key questions that the thesis addresses and provides the 
general overview of the structure of the thesis.
1.1 The Global and sub-Saharan region HIV situation
Globally a total of 34 million people are estimated to be living with HIV and AIDS 
(UNAIDS/WHO, 2011). The greatest burden of HIV and AIDS is in the sub-Saharan region 
with 22.9 Million HIV infected people, representing 68% of the population infected with HIV 
and AIDS (ibid.). An estimated 1.9 million people became newly infected with HIV and an 
estimated 1.2 million people died of AIDS related deaths in the sub-Saharan Africa in 2010. 
Within the sub Saharan region, the Southern African region is worst affected with 11.3 
million people infected with HIV (UNAIDS, 2010).
HIV and AIDS have had a devastating impact on all sectors of the society resulting in a 
substantial loss of national productivity and a steep increase in the burdens of individuals, 
households and communities. AIDS has increased the percentage of people living in 
extreme poverty (UNDP 2005). AIDS has led to an increase in the number of orphans 
resulting in an increased number of dependents in households as well as child headed 
households. In Botswana, it was estimated, on average that every income earner is likely to 
acquire one additional dependent over the next 10 years (UNAIDS, 2006). In Malawi, 
treating of HIV and AIDS patients has placed an enormous pressure on the health sector, as 
of 1999, people with HIV and AIDS and related illnesses occupied 70% of the hospital beds 
(NACP, 1999).
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1.2 Global and regional scale up of antiretroviral therapy
In 2006, the United Nations General Assembly committed to universal access to treatment 
by the year 2010, following on lessons learnt from the World Health Organisation and 
UNAIDS 3 by 5 initiative (UN General Assembly 2006; WHO, 2003). The 3 by 5 strategy 
aimed to provide treatment to 3 million people by the year 2005.
HIV treatment has rapidly increased, from fewer than 8% of the people in need of treatment 
receiving it in 2003 to about 47% of people living with HIV receiving treatment in 2010 in low 
and middle income countries (WHO, 2003; UNAIDS, 2011). Despite rapid increase in ART 
coverage, with about 6.7 million of the 14.2 million people in need of antiretroviral treatment 
in middle and low income countries receiving it, 53% of people in need of treatment were not 
accessing the life-saving drugs (UNAIDS, 2011). Reaching the people still in need of 
treatment but not accessing it requires new commitments both financial and political by 
governments and donors.
Governments and international partners have reaffirmed their commitment to achieve 
universal access to antiretroviral therapy by reaching 15 million people by the year 2015 
(UN General Assembly, 2011). The goal of universal access is also a part of the MDG 6 
whose goal is to halt and begin to reverse the spread of HIV/AIDS by 2015. The impact of 
treatment on countries and communities is evidenced in studies that have monitored the 
benefits of the expanding treatment programme. ART has resulted in reduced morbidity and 
an opportunity for patients to return to performing their normal activities, earn a livelihood 
and be productive in their societies (Rosen et al., 2010). Due to the availability of 
antiretroviral drugs, annual HIV and AIDS related deaths decreased from 2.1 million deaths 
in 2004 to 1.8 million deaths in 2009 (UNAIDS, 2010). In sub-Saharan Africa, AIDS related 
deaths within the same period (2004 - 2009) decreased by 20% (ibid).
WHO in 2010 adopted new antiretroviral treatment guidelines which recommend patients 
starting treatment at earlier stages of HIV infection. This led to the number of people in need 
of treatment rising from 10 million to 14.6 million globally in 2009 (UNAIDS, 2010). Under 
the old guidelines coverage would have increased from 42% in 2008 to 52% in 2009 (ibid.). 
The sub-Saharan Africa ART coverage rapidly expanded between 2009 and 2010 with an 
increase of the number of people on ART from 3.9 million people in 2009 to over 5 million in 
2010 (UNAIDS, 2010; UNAIDS, 2011). In East and Southern Africa, ART coverage 
increased from 46% in 2009 to 56% in 2010 (UNAIDS, 2011).
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Achieving high levels of ART coverage is beneficial due to its potential to reduce further HIV 
transmission (WHO, 2011). To accelerate ART coverage, WHO and UNAIDS has 
introduced a comprehensive approach to HIV treatment Treatment 2.0’ to stimulate 
innovation and improve impact of HIV care and treatment programmes. Treatment 2.0 aims 
to simplify and optimize HIV diagnosis, treatment and care through: optimizing drug 
regimens; providing point of care and other simplified diagnostics and monitoring tools; 
reducing costs; adapting delivery systems to decentralize and appropriately integrate with 
other health services; and mobilizing communities (ibid).
1.3 The purpose of this thesis
Malawi since 2004 has shown great commitment to scaling up treatment through the WHO 
recommended public health approach. With support from the Global Fund against 
HIV/AIDS, Tuberculosis and Malaria (GFATM) treatment is provided free of charge at the 
point of delivery and is greatly subsidized in the private sector. ART expansion in Malawi is 
taking place amidst weak health systems with critical shortages of health workers, limited 
infrastructure, weak drug and supplies procurement systems.
Despite treatment being provided free of charge, Malawi is one of the poorest countries in 
the world. As such access to HIV services is influenced by poverty, gender, geography, 
stigma and discrimination and how individuals influenced by society interpret and 
understand . However there is limited evidence on how these factors interrelate to determine 
the patients care seeking journey, ART initiation and treatment retention. There are also 
gaps on systematically documenting where patients seek care, the cost of the care seeking 
pathway for ART and how this affects different population groups such as men/women, 
rural/urban and poor and non poor and the extent of delays before ART initiation. This thesis 
therefore aims to explore the experiences of poor men and women in accessing treatment 
and staying on treatment in Malawi.
In responding to this key question, the thesis focuses on addressing the following questions:
• What is the health care seeking behaviour of patients leading to the time they are 
eligible for ART and begin the antiretroviral drug initiation process?
• What are the associated direct and indirect costs of care seeking and are there 
inequities in how the costs impact on different social economic groups?
• Are there patients who do not initiate treatment despite knowing that they are eligible 
for treatment and if so, why do these patients not start treatment?
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• Among the patients who are lost to follow up or die whilst on ART, what are the 
factors that contribute to attrition?
Understanding these issues is key for Malawi in mapping the way forward for addressing 
equity issues in ART scale up and also to inform further ART scale up, particularly given that 
Malawi has adopted the revised WHO guidelines for ARV treatment. The new guidelines 
mean that more people are now in need of treatment. Taking that into account, Malawi in 
2009, had only reached 48% coverage on all the people in need of ART. With reducing HIV 
funding from donors, Malawi will need to consider actions that will accelerate access to 
treatment in a way that is more equitable among the poor.
To respond to the questions above, I have used applied social research and a multi-method 
approach drawing from a number of disciplines: economics, sociology, public health, 
anthropology and psychology.
1.4 Structure of the thesis
In order to address the objectives, the thesis has been divided into eight chapters and they 
are structured as follows:
Chapter 1: Introduction
This chapter introduces the theme of the thesis. It describes the global situation and 
commitments about HIV treatment and provides an introduction of the key questions that will 
be addressed in the thesis. It also outlines the structure of the thesis to the reader.
Chapter 2: Literature Review
The chapter explores the literature on what is known, the debates and discussion around 
antiretroviral therapy expansion focusing on sub-Saharan Africa. The literature explores this 
theme from the perspective of the health system and also from the patient and the 
community perspective. The chapter explores the concept of equity and how it relates to 
antiretroviral therapy. It discusses the role that health systems can play in advancing equity 
in HIV treatment programmes. The chapter also considers the influence of the patient and 
the community on health care seeking behaviour and access and adherence to ART; how
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gender and poverty affects people’s responses to illness and HIV diagnosis and treatment 
uptake and retention.
Chapter 3: The experience of Antiretroviral Therapy roll out in Malawi
This chapter focuses on both grey and published Malawi literature on the HIV situation, the 
ART expansion programme and the known experiences of patients and communities with 
respect to HIV treatment. The chapter is subdivided into three main sections. The first 
section presents the HIV trends, the policy framework around antiretroviral therapy 
programmes, and ART programme expansion. The second section synthesises my 
contribution to the Malawi grey and published literature over the period of about seven 
years. The section summarises case studies from a number of studies that I have been 
involved in as a researcher. This section also draws from other wider literature in Malawi, so 
that the case studies are situated within the broader experiences in the country.
The third section brings together issues learned from the literature review on sub-Saharan 
Africa in Chapter 2, and the specific issues learned from the Malawi specific literature and 
experiences in Chapter 3. These informed the development of a conceptual framework that 
underpins the research questions in this thesis.
Chapter 4: Research Methodology
This chapter presents the design and methodologies for collecting data from different 
respondent groups to address the questions and objectives of this study. The chapter 
presents the objectives of the study, the study area, design and methods that I used in my 
research study. The aim of the study is to advance understanding of the facilitators, barriers 
and challenges that patients face to access and adhere to antiretroviral therapy in Malawi.
The chapter explains the rationale for the study area and the health facilities included in the 
study and the reason why the study takes a mixed, quantitative and qualitative, approach
Chapter 5: Does patient socio economic status and health care seeking behaviour 
influence ART treatment outcomes
The chapter presents the findings from the quantitative component of the study. The 
chapter presents findings on the health care seeking behaviour of patients prior to initiating 
ARV treatment; it explores delay to HIV diagnosis and ART initiation; it presents findings 
from tracking patients (who after being identified eligible for treatment) initiate treatment and
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those who do not and presents the factors identified that contribute to patients initiating 
treatment or not. The chapter also explores retention in HIV treatment and the factors 
associated with attrition from ART through death or loss to follow up.
Chapter 6: ART initiation, adherence and loss to follow up from antiretroviral 
treatment: patients, health worker perspectives and experiences
The chapter mainly presents the qualitative findings which explore key questions that 
emerged from the quantitative findings that needed further interrogation. The chapter 
explores why patients are diagnosed at late stages of HIV infection; why some patients do 
not start treatment despite knowledge of their need to start treatment; the facilitators and 
hindrances to ART adherence and retention and the health system issues that affect 
effective and efficient provision of ART services. The findings are drawn from following up 
patients who had not started treatment during the period of the study; those who had started 
treatment but later were lost to follow up; patients who had started treatment and were alive 
and continuing with their treatment; and health workers.
Chapter 7: Discussion
This chapter discusses the findings of the quantitative and qualitative findings in relation to 
the literature reviewed in chapter 2 (sub-Saharan Africa) and chapter 3 (Malawi). The 
discussion is guided by the conceptual framework which was presented in chapter 3, section 
3 which shows how the interaction of factors at the community, the patients and their 
households and the health system mediated by gender, poverty, residence, illness meaning 
and stigma influence the experiences of patients in access and adherence to antiretroviral 
therapy leading to patients dropping out from the health care seeking and treatment 
pathway. I have used theTanahashi model of availability, accessibility, acceptability, contact 
and effective coverage as a framework for organising the discussion. At the end of the 
chapter, I have drawn recommendations for making ART more equitable and promoting 
access and adherence.
Chapter 8: Conclusion
The chapter draws out the main conclusions from the study results and the study processes. 
I also provide my assessment of the appropriateness and limitations of the conceptual 
framework and the methodological approach for the study.
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Chapter 2: Literature Review
2.0 Introduction
In this chapter I present a review of literature on evidence, debate and discussions around 
antiretroviral scale up from published and unpublished literature. The theme of HIV 
treatment is a very dynamic, broad, rapidly changing and the literature is very wide. I have 
therefore limited the review to debates and discussions around ART expansion, the 
challenges and opportunities currently faced in expanding equitable access to treatment and 
the approaches that have been used to overcome such challenges in the sub-Saharan 
Africa region. The literature explores this theme from the perspective of the health system 
and also from the patient and community perspective.
I have organized the review into different sections as follows:
• Section 2.1: In this section I present the strategy used to identify the literature that is 
discussed in this chapter.
• Section 2.2: This section discusses the concept of equity and how equity relates to 
antiretroviral therapy. It highlights the role of health systems in advancing equity of 
HIV treatment programmes and using the Tanahashi framework of health service 
coverage, situates the role of health systems and its impact on equitable coverage of 
ART.
• Section 2.3: This section draws attention to the patient and community influence on 
health care seeking behaviour, access and adherence to ART. It argues how patient 
and community beliefs may influence people’s responses to ill-health and treatment.
• Section 2.4: This section presents the impact of gender and poverty in people’s 
experiences and responses to HIV and ARV treatment.
• Section 2.5: In this section, I present the conclusions drawn from the literature 
review.
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2.1 Literature search strategy
An electronic database search strategy was carried using two main search engines Pubmed 
and Scopus. The search was limited to English articles published from the year 2000 when 
literature on ART in sub-Saharan Africa mostly began to be available. The following 
combination of words were used: ‘ART’, ‘antiretroviral therapy’, ‘access’, ‘adherence’, 
‘poverty’, ‘sub-Saharan Africa’, ‘cost’, ‘HIV’, ‘gender’, ‘retention’, ‘health’, ‘delay’, ‘health care 
seeking behaviour’, ‘equity’, ‘health systems’ ‘health workers’ ‘HIV testing’, ‘stigma’ and 
‘task shifting’. However literature reviewed about ‘equity’, ‘health’ and ‘poverty’ and health 
models used to situate the literature was dated before the year 2000. The search was 
extended to reference papers where they linked to issues closely related to the theme. In 
addition, grey literature was searched through relevant websites of organisations such as 
World Health Organisation, EQUINET, and UNAIDS.
2.2 Concept of equity in health
Equity means fairness or justice. However these terms are open to interpretation and as 
such one’s judgement is likely to be shaped by one’s background, experience and interests 
(Gwatkin, 2007). A common definition that has remained standard working guidance was 
provided by Whitehead in1992. She referred to ‘Health equity’ as addressing differences in 
health that are judged to be unnecessary, avoidable, unfair and unjust (Whitehead, 1992). 
While this has remained the standard working definition, many other authors have further 
elaborated on the meaning of health equity. Gwatkin (2007) however argues that the 
refinements have not departed much from the original definition by Whitehead (1992). For 
example WHO terms equity in health as minimizing avoidable disparities in health and its 
determinants including, but not limited to, health care between groups of people who have 
different levels of underlying social advantage (Braveman, 1998). The International Society 
for Equity in Health (ISEqH) introduced the concept that relevant differences to be tackled in 
inequity are systematic and they specify the importance of comparisons between socially 
defined groups to facilitate measurement and monitoring (Braveman, 2006; Starfield, 2006). 
Underlying social advantages are key to determining if there are inequities in health unlike in
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the measurement of health inequalities. Inequity does not refer to any inequalities between 
any population group but very specifically to disparities between groups of people 
categorised a priori according to some important features of their underlying social position 
(Braveman, 2003:182). In its definition of equity, the WHO considers the underlying causes 
of health disparities which are determined by social determinants of health (Braveman, 
1998).The underlying social position may relate to differences grouped by socio-economic 
status, gender, age, social groups, residence, geographical divisions, occupations, 
race/ethnicity or religious groups. These groups in different societies are associated with 
different levels of social advantage or privilege which have roots in unequal access to social 
determinants of health (Braveman, 2003). The materialist and structurist explanations of 
health explore the role of structural factors such as income, housing and unemployment 
which lead to deprivation and disadvantage in determining and influencing life chances of 
individuals (Clarke et al., 2010). For example people with greater economic resources are 
more able to live in and work in geographic areas with more favourable physical and social 
conditions than those with fewer economic resources. Poverty is one possibly social 
determinant of health which can be addressed, and has consistently shown to be strongly 
associated with inequalities in health outcomes. Studies show that disadvantaged groups 
like the poor experience greater health needs but utilize health services less due to various 
factors that hinder them from accessing and utilising health care (Zere et al.,2007; WHO, 
2008).
Since equity refers to justice and fairness and as such it is a normative or ethical concept, it 
is not possible to directly measure equity in health or health care but one can measure 
inequalities in health between more or less advantaged social groups (Braveman, 2003). 
The inequalities between these groups are likely to reflect inequities because they place 
already disadvantaged social groups at further disadvantage in health or health care (ibid). 
However it should be noted that not all health inequalities or disparities are unfair as there 
might be other health conditions that only affects certain population groups such as prostate 
cancer which only affects men and not women.Health equity focuses on the distribution of 
resources and other processes that drive a particular kind of health inequality, that is 
systematic between a more or less disadvantaged group and which is unfair or unjust 
(Braveman and Gruskin, 2003). These processes drive towards equalising the health 
outcomes of the disadvantaged social groups with those of the more advantaged social 
groups.
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Whitehead referred to equity in care as equal access to available care for equal need, equal 
utilization for equal need and equal quality of care for all (ibid). As such health equity does 
not imply that everyone should have the same level of health but in addressing such 
differences equitably, it would imply an approach which gives more to those who have 
greater need (McCoy, 2003). The proof of equity in health is that services are used 
according to the differential needs of different social groups (Solar et al., 2004). The 
inequitable distribution of health care by not delivering care to those who need it is a social 
determinant of health (CSDH, 2008).
2.2.1 Equity and antiretroviral therapy
Countries at the United Nation High General Assembly High Level Meeting on HIV and 
AIDS in 2006 committed to reach universal access to HIV prevention, treatment, care and 
support by 2010 (UN General Assembly, 2006). Two years after the commitment to 
universal access, assessments showed that there was an unprecedented increase in the 
number of people accessing ART, however the goal to reach universal access seemed 
unattainable for many countries as globally only 31% of the people in need of antiretroviral 
treatment were receiving the life saving drugs (UNAIDS, 2008; UNAIDS, 2010). By the end 
of 2009, only 39% had accessed the drugs and coverage extended to 47% in 2010 
(UNAIDS, 2010; UNAIDS, 2011). A number of challenges have been identified as limiting 
equitable and universal coverage of ART as scale up is taking place within a weak and 
overburdened health system which is faced with critical health worker shortages, centralized 
health programmes, fragmented delivery of health services, a lack of long term sustained 
funding, and weak procurement and supply systems (UNAIDS 2010). In 2011, countries 
reaffirmed the commitment to reaching the goal of universal access by 2015 (United 
Nations, 2011).
In 2010, WHO revised the ARV treatment guidelines which recommend starting treatment at 
earlier stages of disease progression (WHO, 2010). The guidelines have resulted in an 
increase of the number of people in need of treatment. Based on the previous WHO 
treatment guidelines, 52% of people would have accessed treatment; but with the new 
treatment guidelines ART coverage is estimated at 37% in the sub-Saharan region with an 
estimated 10.6 million people now in need of treatment (UNAIDS, 2010).
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Access to ARV treatment has raised equity and ethical issues concerning who should 
benefit from the life saving drugs given the limitations of funding and the limited capacity of 
health systems in limited resource settings (Bennett et al., 2005). It was recognized earlier 
on in the ART scale up that the financial, infrastructural and human resource constraints 
would not reach all in need of treatment requiring countries to make difficult choices on 
where and how ART would be provided (Rosen et al., 2005; Bennett and Chanfreau, 2005). 
The World Health Organisation proposed some clinical and social criteria in selecting 
patients to start treatment (WHO, 2004). According to WHO criteria for selection of patients 
those in advanced stages of illness and those deemed able to adhere to treatment should 
be prioritised. However, these criteria alone are not adequate for countries where HIV 
burden is high and supply greatly outstrips demand. Loewenson (2003) and Loewenson 
and McCoy (2004) argued that without clear, explicit strategies for rationing treatment, 
access to treatment will be biased reflecting underlying already present socio-economic 
inequities and social biases.
In recognition of the challenges in achieving equity in ART provision in a health system 
where resources are limited, EQUINET, a regional network for equity in east and southern 
Africa region conducted a consultative process within the region to identify indicators which 
would be important measures for equity in ART access in the SADC region (EQUINET,
2004; Kalanda et al., 2004; EQUINET, 2004). This process recognised that a major 
monitoring issue in equity in access to ART will be to analyse “Who” is accessing ART and 
what are the adherence and retention patterns among those on treatment. The aim of 
monitoring which population groups are accessing or adhering to ART is to ensure that 
vulnerable groups are adequately represented among those who access services. Under 
this framework the monitoring areas to assess equity were to monitor ART Clients by age, 
gender, poor/non poor, rural/urban and by other vulnerable populations such as sex workers 
and prisoners (Kalanda et al., 2004).
in this thesis, therefore equity in ART access shall refer to systematic, unnecessary and 
avoidable inequalities in access and treatment outcomes that are judged to be unfair and 
unjust. The thesis will focus on: age, gender, poor/non poor, rural/urban, type and level of 
health facilities. These factors have been identified as will be shown through the literature in 
this chapter, chapter 2 and also in chapter 3, they show to have impact on equity in ART 
access and retention in care.
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2.2.2 Health systems and equity in ART
A health system is defined as comprising all activities whose primary purpose is to promote 
and restore health (WHO, 2002). Achieving equity in HIV treatment programmes is a 
challenge considering that ART provision is being delivered in a health system which is, 
itself, inequitable (Kemp et al., 2003). For example, health care financing in many countries 
is usually inequitable. South Africa has a total national health expenditure of 8% which is 
similar to health expenditure in other developed nations, however seven times of the health 
expenditure is spent on the private sector which serves only 20% of the total population 
creating inequities even in the ART scale up which is favourable towards the more affluent 
provinces (Ojikutu et al., 2007). Health systems have the potential to mitigate against the 
effects of ill health impoverishment (WHO 2010). Health systems have the ability to redress 
existing health inequalities and prevent future inequalities by curtailing health expenditures 
on chronic illnesses such as HIV and AIDS (WHO, 2004). Health systems can facilitate 
effective coverage of ART or can present barriers. The past years have seen health sector 
reforms which have been motivated by cost recovery and economic efficiency other than the 
promotion of health equity resulting in increased private and out of pocket expenditures for 
health. In countries where user fees are charged for health services in the public sector, the 
direct costs for patients tend to be high as evidenced from data from Burkina Faso, Nigeria, 
Ghana, Kenya, Cameroon (Su et al., 2006; Russell, 2004; Onwujekwe and Uzochukwu 
2005; Chuma et al., 2007; Boyer et al., 2009). Where ARV treatment is provided at a cost, 
this cost presents a huge barrier limiting access and adherence (Boyer et al, 2009). User 
fees undermine access to ART and equity of HIV and AIDS programmes as it puts treatment 
beyond the reach of many poor and affected households (Souteyrand et al., 2008; Boyer et 
al., 2009). On the other hand, in countries where there is free care at the point of delivery 
the evidence is conflicting, with some countries experiencing lower direct medical costs and 
others not (Russell, 2005). It has become increasingly recognised that to achieve universal 
access and sustain patients on treatment, user fees for ARV will have to be abolished at the 
point of delivery while at the same time strengthening health systems (EQUINET, 2007; 
Brinkhof et al., 2008; Souteyrand et al., 2008).
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The challenges within health systems led to the recognition that ART scale up should 
happen within the framework of health system strengthening. ART programmes have 
attracted substantial new resources and these have shown substantial impact in 
strengthening health systems in a positive way and thus expanding ART access and 
supporting provision of other essential services, thereby promoting equity in ART access 
(WHO, 2011; Me Coy and Loewenson, 2004). The WHO strategy for 2011-2015 aims to 
provide universal access to high quality of care through a public health approach, in a 
manner that strengthens fragile public sector health services (WHO, 2011). The strategy 
recognises the importance of monitoring and analysing differences within and between 
countries to determine whether key social determinants to achieve equitable access are 
achieved (ibid). The monitoring of health systems and access to ART allows health 
programme managers to identify bottlenecks in the delivery system and the factors 
responsible for the constraints (WHO, 2010). Equity in access and the social determinants 
of health are linked as the factors that hinder access to ART services are usually socially 
determined (WHO, 2010).
2.2.3 Model for evaluating health service coverage for making health systems 
equitable
Service delivery or provision is the core function that is perfomed by health systems. Service 
delivery is defined as the way inputs are combined to allow delivery of health interventions 
or actions (WHO 2001b). For health systems to deliver services, there are some core inputs 
necessary for care delivery without which health systems will not have an impact. Such 
inputs include financial resources, competent health care staff, adequate physical facilities 
and equipment, essential medicines and supplies, clinical guidelines and operational 
policies (Islam, 2007).
Health service coverage is a concept which expresses the extent of interaction between a 
health service and the people to whom the service is intended. Coverage is usually 
expressed as the proportion of the target population who receive or have received the 
service. The basic issues of evaluating health service coverage is to determine resource 
allocation organisation of the service in order to reach as many people as possible; assess 
whether the service is reaching the people it should serve; and thirdly how effective the 
service is in meeting the needs of people. The Tanahashi (1978) model is a model that can
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be used to monitor and evaluate the extent to which health systems are meeting the needs 
of those who require the service. The Tanahashi model for health service coverage can be 
applied in making health systems equitable as it not only evaluates the service provision but 
the whole process from resource allocation to extent which service provision meets the 
desired objective (for example long term treatment adherence in ART programmes).
Figure 1 Model of health service coverage
According to the Tanahashi model of health service, there are five major domains of 
coverage as illustrated in Figure 1 showing the Tanahashi framework:
• Availability coverage - In order to deliver a service to the people who need it, there 
have to be resources available such as health workers, health facilities, drugs, etc. 
The availability of such resources will determine the extent to which a service can be 
provided i.e. the maximum capacity of the service which, due to limited resources, is 
oftentimes lower than the population in need.
• Accessibility coverage - Accessibility defines the population who can use or access 
the service. While a service might be available in order for it to be utilised, the
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service has to be allocated within reasonable reach of people who should benefit 
from it.
• Acceptability coverage - This domain defines the people who can access the service 
and are willing to use the service. When a resource is accessible, it has to be 
acceptable to the population for example in terms of costs, waiting time, beliefs.
• Contact coverage - These are people who have utilised the service. This level is the 
actual contact between the user of a service and the health provider.
• Effective coverage - Not all people who have contact with the health service receive 
an effective intervention; Tanahashi considers effective coverage to be the number 
of people who have received a satisfactory service. For example in relation to HIV 
treatment, this might represent those who have used ART and are continuing to 
make regular contact with the health system and are adherent to treatment.
Figure 1 demonstrates that at each step of the health service coverage, there are some 
people who are in need of a health intervention who drop off, resulting in some people not 
accessing the health intervention. In the next section, I will apply the Tanahashi Model to 
illustrate how health systems influence access and adherence to ART based on literature 
from sub-Saharan Africa. While the Tanahashi model has its roots in an economic model 
and uses proportions to express the different levels of access, in this thesis, I have mainly 
used the model to demonstrate the factors that contribute to the sub-optimal coverage at 
each level.
2.2.3.1 Availability of ART services
In order for ART to be available, the health system needs to invest in making available all 
the necessary resources including establishing adequate ART clinics, human resources, 
drugs and supplies amongst others. The number of ART sites providing ART is rapidly 
growing. Globally, the number of ART sites increased by 36% in 2009 (UNAIDS, 2010). In 
the same year, in sub-Saharan Africa, 37% of people eligible for ART were able to access 
treatment (ibid). This was an increase from 30% coverage in 2007 from only 21% ART 
coverage in 2006 (WHO, et al., 2008). By the end of 2011, coverage had increased to 47% 
in middle and low income countries (UNAIDS, 2011).
34
Critical health worker shortages are a major challenge to making treatment available 
particularly in sub-Saharan Africa which, despite harboring about two thirds of all the people 
living with HIV, has only 3% of the world’s health providers (WHO, 2006). Weak 
procurement and supply management systems, poor laboratory infrastructures and limited 
integration of services are among the key factors hindering availability of ART (ibid).
Health worker shortages
Critical health worker shortages have been identified as the major obstacle to rolling out 
ARV treatment in sub-Saharan Africa particularly in East and Southern Africa. Only five 
countries in the East and Southern Africa region meet the ‘Health for all’ threshold of a 
minimum of one doctor per 5,000 people; these are South Africa, Namibia, Madagascar, 
Mauritius and Botswana (EQUINET, 2007). No country in East and Southern Africa met the 
2.5 health care professionals (doctors, midwives and nurses) per 1000 population which is 
required for the minimum threshold of coverage at 80% (WHO 2006). The World Health 
Report 2006 defined ail countries that fail to attain 80% coverage level as having critical 
health worker shortages (ibid). Migration of health workers is one of the factors contributing 
to health worker shortages in Africa. Nurses are the backbone of health care provision in 
many African countries including for ART scale up (Ogilvie et al., 2007). However, more 
than 300 nurses, for example, leave South Africa every year in search of a better quality of 
life, better pay, professional development and personal safety (Roisin, 2004; Rowson, 2004; 
Kingma, 2001). Addressing health worker shortages requires investing in financial and non 
financial incentives for health workers to stay and addressing international and national 
factors fostering migration (EQUINET, 2007; Palmer, 2006; Rajamaran and Palmer, 2008). 
Governments and international development partners pledged in the 2008 Kampala meeting 
to mitigate the global crisis in human resources for health and to develop and implement 
specific plans to address the health worker crisis (GHWA, 2008).
The shortage of health workers has led to centralized ART services which favour urbanized 
areas and well resourced districts or provinces (Ojikutu et al. 2007; Bedelu et al., 2007).
The ART expansion has resulted in heavy workloads, over burdened and overworked health
35
workers (Kunihira et al., 2010; Heckman et al., 1998; Harden et al., 2007). Additionally, not 
all health workers are trained in management of ART which further limits capacity of health 
workers to manage patients on ART (Dong et al., 2007). These challenges have 
necessitated task shifting in order to create new capacity for ART expansion and 
decentralization. Task shifting involves devolving certain roles which were only being 
managed by more trained health workers to non-physician trained health workers, lower 
cadres of health care workers, community health workers and use of lay persons creating 
new capacity for the increasingly growing workload (Shumbusho et al., 2009; Bemelmans et 
al., 2010; Hermann et al., 2009).
Task shifting has enabled availability of ART services at the primary care level and in 
facilities closer to rural communities (Bedelu et al., 2007; Maddison and Schlech 2010). In 
Lusisiki, South Africa, the delivery of ART through community health clinics resulted in 
treating 60% of the people in need after 24 months (Bedelu et al., 2007). In countries where 
they have piloted nurse-centred ART provision, results have shown that the model is more 
effective for scaling up equitable HIV treatment with good treatment outcomes (Shumbusho 
et. al., 2009; Price and Binagwaho, 2010; Madison and Schlech, 2010). This is necessary in 
reducing inequities that come with hospital based provision of ART services which have the 
potential to exclude the poor, less educated, unemployed persons: Thereby requiring 
decentralisation of services to lower level of health facilities which are closer to communities 
(Tsai et al., 2009). Studies show that decentralisation of ART services to primary care clinics 
has increased access and retention of patients in ART programmes (Bedelu et al., 2007; 
Shumbusho et al., 2009). In South Africa, despite patients enrolling in primary health care 
facilities being in more advanced stages of illness at the time of initiating treatment, ART 
outcomes were better than those in a hospital setting (Fatti et al., 2010).
Human resources for supporting adherence
With more people accessing treatment, the health system is also under pressure to have 
adequate human resources to support adherence and retention. Health workers have a 
huge influence on supporting patient adherence through education and in some cases they 
have gone out of their way to provide resources to support transport or food expenses and 
accommodating patients who are late on their appointment dates (Ware et al., 2009). 
However, they are in short supply and cannot manage to adequately provide support
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beyond the health facility. In order to address the human resource constraints to supporting 
adherence, support workers, who may be lay persons or persons also living with HIV, have 
become an important resource both at the health facility level or through home based 
adherence support (Torpey et ai., 2008; Ware et al., 2009). Community health workers who 
are trained to provide adherence support to patients in their homes represent important links 
between the health facilities and communities (Ware et a!., 2009). The involvement of 
community health workers (CHW) in Uganda showed decreased virologic failure rates 
among long term ART patients and reduced rates of lost to follow up through increased 
engagement of patients and CHWs at the community level (Arem et al., 2011). In Zambia, 
an assessment of the quality of counselling provided by the support workers after training 
using a standardized training curriculum and adherence levels among patients counseled by 
HCW or by lay support workers showed that there was no significant difference in treatment 
outcome between people who were counseled by lay support workers and those counseled 
by nurses (Torpey et al., 2008). However, Tantchou and Gruenais (2009) argues that task- 
shifting needs to be conducted carefully and not haphazardly through clear redefinition of 
the roles and task-shifting procedures to avoid creation of tension, frustration and the 
questioning of the legitimacy of the new health actors.
Availability of drugs and supplies
At the advent of ART, high prices kept most sub-Saharan countries from providing treatment 
(Stewart et al. 2004). Under special terms international trade law, drug manufacturers in 
developing countries began to produce generic drugs and countries in sub-Saharan Africa 
began procuring generic drugs allowing the expansion of ART availability (ibid). Decreasing 
prices of ART have contributed to growing availability (WHO et al., 2009). First regimen ART 
prices in low and middle income countries decreased by 30-64% between 2004 and 2007 
(ibid). However, the global economic crisis has led to diminishing resource commitments to 
HIV and AIDS and is threatening the growth and sustainability of ART provision, the 
attainability of universal access to treatment and an undermining of the progress that 
treatment programmes have so far achieved (Geng et al., 2010; WHO, 2011). The AIDS aid 
from donors has remained flat between 2008-2009 when compared to consistent increases 
of previous years (Renaud-Thery et al., 2011; UNAIDS, 2009). The Global Fund also 
announced their inability to fund new grants that would allow expansion of health
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programmes due to the deteriorating economic situation that the donors to the Global Fund 
were facing leading to the cancellation of Round 11 in November 2011 (Global Fund, 2011).
The availability of drugs and other essential supplies are challenged by weak procurement 
and drug management systems, resulting in some countries experiencing drug stock-outs 
(UNAIDS 2010). In Uganda, shortage of ARV and Ol drugs was most frustrating to health 
workers when they were the ones telling patients about the importance of drug adherence. 
This resulted in providing drugs for shorter intervals to patients leading to patients making 
more frequent visits to the ART clinic than usual (Obua et al., 2011). A study in Abidjan, 
Cote d’Ivoire showed that frequent drug stock outs doubled the risk of treatment interruption 
and deaths (Pasquet et al., 2010).
Limited infrastructure and lack of adequate laboratory facilities has meant that ART 
programmes more often start in large hospitals than in smaller clinics (Ojikutu et al., 2007; 
Debrework et al., 2007). In a rural ART clinic in South Africa, delay of patients starting ART 
resulted from delay in collection and transportation of specimens, loss or inaccessibility of 
laboratory test results (Fredlund and Nash 2007).
2.2.3,2 Accessibility of HIV treatment services
Accessibility refers to ‘physical or geographical access’ which is also linked to ‘economic 
access’ of a health service. Clients will only use the service that they need if they can reach 
it (Tanahashi, 1978). Accessibility of ART services is important as patients are required to 
make on-going contact with health services to maintain treatment adherence.
Physical or geographical access
The distribution of supply of health services (health facilities providing a particular service) 
and the patient’s need for health care are used for measuring equity of health services 
provision and define ‘geographical accessibility’ (Ebener et al., 2008). Distance from home
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to the health facility is a common barrier to utilisation of health services in general including 
HIV treatment (Posse et al., 2008; Heckman et al., 1998). The effect of distance affects 
more rural populations in developing countries as there is a scarcity of health facilities in 
these areas and health facilities are further away from people (Buor, 2003; Noor et al., 2003; 
Wilson and Blower 2007). Factors closely related to distance include travel time, transport 
costs and the mode of transport available to patients. Patients have reported astronomical 
travel time to health facilities with median travel time of one (1) hour to more than five (5) 
hours for some patients (Dijk et al., 2009; Rosen et al., 2007).
Transport costs
Long distances to ARV clinics are exacerbated by financial resources for transport and other 
needs when going to the clinic (Kunihira et al., 2010). The need for repeated visits to the 
clinic for regular appointments to maintain adherence is a challenge (Mshana et al., 2006). A 
study in Uganda showed PLWHIV had to travel a median of 10 kilometres (km) and up to a 
maximum of 40km to reach an ART centre (Kunihira et al. 2010). In Zambia, the median 
distance travelled to the ART clinic for children and their caregivers was 28 km (van Dijk et 
al., 2009). Transportation to the medical service is a common barrier when people live far 
away from the health facilities with no access to public transportation and limited resources 
to pay for transport (Cooke et al., 2010; Chileshe and Bond, 2010; Wilson and Blower, 
2007). In rural areas lack of transportation, poor road conditions and financial resources 
means that people are sometimes forced to walk to health facilities (Harden et al., 2007). in 
rural areas of Zambia, patients had to walk long distances to first reach the main road where 
they could then board a public bus to the hospital (Chileshe and Bond, 2010). The cost of 
transport where ART is provided free of charge consumes a considerable amount of 
household health expenditure. In South Africa, transport costs accounted for 42% of health 
expenditure (Goudge et al., 2009), which is high considering that most people use minibus 
taxis or buses and may also use a rented private car depending on the situation of the 
patient’s condition for a trip to the clinic (Rosen et al., 2007). In Zambia, patients reported 
costs of between US$3 and US7.50 for each trip to a health facility, with the costs doubling if 
they travelled with a guardian (Chileshe and Bond, 2010).
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2.2.3.3 Acceptability of services
According to the Tanahashi framework, while services may be available and within access 
of the intended target population, clients may not utilize the services if the services offered 
are not acceptabie. According to Tanahashi, people are likely to seek alternative providers 
of care if they perceive a service to be unacceptable. Acceptability of services may be 
influenced by various factors such as cost of a service, perception of the service, stigma, 
attitudes of health workers, or waiting times amongst other factors.
Cost and impact of costs on acceptability of HIV treatment services
The cost of health care from the patient’s perspective consists of direct costs and indirect
costs. The direct costs refer to direct medical costs which are costs of drugs, consultation,
treatment including laboratory tests, and other procedures and other direct costs may
include transport and food costs. Indirect medical costs are based on the income and
productive working days lost due to illness or care seeking by the patient and their
caregivers.
Health care seeking often tends to be costly particularly for poor households which in some 
cases have lost their sources of income due to illness which is a larger cause of 
impoverishment than the out of pocket health expenditures (Wagstaff, 2002). In some 
countries, the direct costs over the treatment period were estimated to impose a cost burden 
of 8%-20% of annual income of already poor households (Russell, 2004). A study in Chad 
comparing health-related expenditures amongst households with a patient living with HIV 
and AIDS found a monthly expenditure of US$78.6 directly attributable to AIDS as 
compared with monthly costs of $4.3 in households without an AIDS patient (Wyss et al., 
2004). 56% of these costs were for purchase of drugs and remedies while 13% were for 
transportation costs (ibid). The study also showed that opportunistic infections such as 
tuberculosis caused the costs for AIDS patients and their households to be very high. In 
Cameroon, the median direct out of pocket expenditure of ART-treated patients was US$20 
(Interquartile Range (IQR: 13-38) with over a third of this cost being used for purchasing of 
ART drugs leading to 40.4% of the households facing catastrophic health expenditures 
(Boyer et al., 2009). Health expenditures are considered to be catastrophic if they are 
greater than 10% of the total household income. However, this is an arbitrary measure as it
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does not differentiate the impact for wealthier and poorer households. Other refined 
measures for catastrophic health expenditure are defined as more than 40%-50% of the 
household expenditure after basic consumption needs have been met (WHO, 2000; Xu et 
al., 2003; Wagstaff 2002). The costs of HIV increase with advancing stages of illness 
(Bachmann and Booysen, 2003).
The high costs of accessing treatment are one of the greatest barriers to accessing and 
adhering to treatment (Posse et al., 2008; Byakika-Tusiime et al., 2005). High costs are a 
huge problem resulting in some patients opting to postpone treatment or taking drug 
holidays despite advanced illness (Miller et al., 2010; Orrell et al., 2003). Relevant medical 
laboratory tests including viral loads and CD4 tests are in most cases unaffordable for 
patients. In Cameroon patients who faced financial difficulties in meeting the costs of 
antiretroviral treatment were young and those who spent a greater burden of their income on 
treatment (Boyer et al., 2009). In Burkina Faso, where treatment is provided at a fee with an 
exemption policy for the poor populations, only 20% of the people report actually paying for 
treatment; however an analysis of those who pay for the service showed that 16% of those 
without an income still pay for the service (Kouanda et al., 2010). High unacceptable costs 
and inequities in treatment access have been experienced where ART has been provided at 
a cost and user fees are charged (Souteyrand et al., 2008).
Economic and opportunity costs in health care seeking have been shown to hugely affect 
the care seeking pathway for patients as they influence the choice of health providers. The 
health care seeking choice itself amongst the poor is a strategy against incurring high health 
costs, which are unacceptable, such that the poor commonly seek care from shops and 
traditional providers (Falkingham, 2004; Onwukekwe and Uzochukwu, 2005). Trade offs in 
poor families with a member infected from HIV and AIDS are inevitable (Bollinger et al., 
2000). In poor households studies have shown reduced spending in other areas of necessity 
to increased expenditures in health care seeking (ibid). Financial outcomes of health care 
seeking may include loss of income, decreased household savings and increased debt or 
selling of household assets to supplement income; while the death of the AIDS patient (if 
he/she- was the bread winner as is frequently the case) may lead to permanent loss of
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income, high funeral costs and children dropping out from school (Bollinger and Stover, 
1999; Singh, 2005; Bachmann and Booysen, 2003).
Studies show that the greater burden of disease is among the poor, most of whom live in 
rural areas, yet there is skewed utilisation of health services which favours the better off 
(Hortsberg and Mwikisa, 2002; Su et al., 2006; Chuma et ai. 2007). Experience of loss of 
income and increased expenditure for HIV diagnosis negatively affects access to ART and 
treatment adherence which is important for ART programmes to be successful 
(Mannheimmer et al., 2005; Schackman et al., 2005).
Long waiting times
Long waiting times at the ART facility are a major challenge to access and adherence to 
antiretroviral treatment (Mshana et al., 2006). Long waiting times are usually a result of staff 
shortages and patient congestion (Obua et al., 2011). In Uganda, patients reported 
spending a minimum of seven hours and a maximum of 10 hours at the ART facility before 
they could receive care (Kunihira et al., 2010). In Tanzania, Uganda and Botswana, waiting 
times at the ART clinic ranged from four hours with the longest being 12 hours, with waiting 
times remarkably shorter in private facilities (Hardon et al. 2007). In cases where health 
facilities are only open during normal working hours, patients who are in paid jobs fear 
losing their jobs if they take time off from work to attend the ART clinic (Rosen and 
Ketlhapile, 2010).
Lack of privacy of HIV services
Lack of confidentiality due to the physical organisation of the HIV clinic can identify everyone 
found at those premises as HIV infected. Some patients feel vulnerable sitting in the waiting 
room of an HIV clinic picking prescriptions for fear of being seen at the HIV clinic (Alfonso et 
al., 2006; Kunihira et al., 2010).
Attitudes of health workers and patient- provider interaction
Poor patient-provider interaction in the health facilities, (for example where providers have 
not adequately explained a patient’s treatment or condition) could lead to more shopping for
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care at different providers in search of relief (Goudge et al., 2009). The experience and 
attitude of health workers is important for promoting continued HIV treatment and care 
utilisation. In Kisesa, Tanzania, rural people reported feeling intimidated by poor staff 
attitudes which were often viewed as impersonal, difficult to negotiate with and at times 
involved in seeking of bribes (Mshana et al., 2006). Poor communication by the health 
workers on the meaning of the test results could lead to patients not understanding their 
results and might cause patients not to realise the importance of ART (Muchedzi et al., 
2010).
Stigma from health workers and the community
HIV related Stigma is an effect of a judgemental discourse that distinguishes HIV infection 
through immorality and therefore implies that a person deserves to be infected and has no 
consideration for the ‘innocent’ such as those infected by unfaithful partners (Skinner and 
Mfecane, 2004). Persons who practice same sex relationships may be refused health care 
services and have more fear of utilising health services because of health workers’ 
stigmatising attitudes (Fay et al., 2011; Rispel et al., 2011). Stigma may cause people to 
prefer to remain unaware of their own HIV status: it reduces pressure for behaviour change 
and it delays access to HIV testing and ARV treatment and compromises ART adherence 
(Skinner and Mfecane, 2004; Gilbert and Walker, 2010; Sambisa et al., 2010). Studies show 
that people who have stigmatising attitudes are less likely to access or accept an HIV test 
themselves (Ayenew et al., 2010; Weiser et al., 2006; Njozing et al., 2010). A study in Rakai, 
Uganda showed that fear of being seen at the ART clinic caused people to seek alternative 
care (Kunihira et al., 2010). Distressing emotions from stigma such as anger, depression, 
shame guilt and embarrassment around being HIV positive discourage some persons from 
starting ART (Alfonso et al., 2006). Stigma is also often not directed at the individual but to 
the whole family and caregivers (Aga et al., 2009).
Health systems have the potential to promote ART access through provision of ART in a 
confidential manner, thereby minimising stigma. Therefore programmes that aim to provide 
confidential HIV services have been shown to increase acceptability of HIV services 
including among HCWs themselves (Uebel, 2007). In Zambia, a model of integrating HIV
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care with other health services was seen by PLWHIV to be less stigmatising even though it 
increased the waiting period for patients (Topp et al., 2010).
2.2.S.4 Contact coverage of HIV treatment
Tanahashi refers to this coverage domain as the number of people who actually make 
contact with the health service. People who make contact are those who have made it into 
the health system and utilize a health service. Due to the challenges discussed above which 
hinder accessibility and acceptability of HIV services, delay in contact with ART services are 
common. First is the delay in making contact with health services; second is the delay 
between knowing HIV status and initiating medical care; and third is the delay in starting 
ART, often leading to pre-ART deaths.
Three stage delays in HIV care and treatment
Delay to HIV treatment can occur at three stages. First delay is between the time of 
acquiring HIV infection and getting an HIV test. A study in Uganda found that about half of 
patients offered provider initiated HIV testing had advanced HIV infection (Wanyenze et al., 
2011). The study showed that patients with delayed diagnosis had not made prior contact 
with health facilities and had sought care from non-medical facilities (ibid). A high number of 
patients in need of ART has also been identified through HIV screening in a medical 
emergency unit (Nakanjako et al., 2007).
Second delay takes place from the time a person receives an HIV positive test to when 
he/she initiates medical care. In a study in Cameroon, about 15% of the patients reported a 
delay of at least six months between their HIV diagnosis and their first medical consultation 
and just over half of the patients had sought medical care within a month of HIV diagnosis 
(Marceliin et al., 2009).
Third delay is from the period after initially establishing care to starting ART. The delay from 
the time of acquiring infection to identifying HIV sero positive status is usually the significant 
barrier to early ART initiation (de Cock et al., 2006). In Uganda, among patients who had 
been identified to start ART just over half of the patients, started within three months of 
being recommended for ART, 24.5% started within three to six months and about 10% took 
longer than six months (Parkes-Ratanshi et al., 2010). Among a cohort of TB patients in
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Capetown South Africa, an average median delay of 95 days was observed (Lawn et al., 
2011). Delays in initiating ART at this stage have been linked to long waiting lists, delays in 
patient referral and the time taken to prepare patients for ART (Lawn et al., 2008).
Limited integration of services
Limited integration of services is a contributing factor to delay in HIV diagnosis and 
treatment. In HIV treatment, the continuum of care among those tested for HIV through 
antenatal care or sexually transmitted infections (STl) services into pre-ART care (including 
cotrimoxazole and isoniazid preventive therapy) is weak, with most persons not staying in 
HIV care (Kranzer et al., 2010). This is due to limited integration and coordination of care of 
ART services with other health services, resulting in duplication and the creation of parallel 
systems (including for monitoring and evaluation) which is recognised as unsustainable 
(Ojikutu et al., 2007; WHO 2010). Co-infection of TB and HIV is common requiring 
integrated management of the diseases and requires that health providers are conversant 
with management guidelines for both diseases which is sometimes not the case (Dong et 
al., 2007). Lack of coordination among services, some of which are part of ART programs is 
a threat to good patient management (Bartlert et al. 2009). Lack of integration and 
coordination across services minimises the opportunities for offering HIV testing (Posse et 
al., 2008).
Provider Initiated Testing and counselling as a way of increasing contact with HIV 
services
Client initiated HIV testing approaches commonly referred to as Voluntary Testing and 
Counselling (VCT) have been the primary model for providing HIV testing and counselling 
services. However, despite high HIV prevalence in sub Saharan Africa, few people know 
their HIV status. In response to evidence that Provider Initiated Testing and Counselling 
(PITC) can increase patient uptake of HIV testing and support referral, WHO/UNAIDS in 
2007 recommended PITC as a standard part of medical care in settings with generalised 
HIV epidemics. This means making HIV testing more routine for all adults and adolescents 
seen in health facilities (WHO/UNAIDS, 2007).
Routine HIV testing and counselling identifies previously undiagnosed HIV infection, 
provides the opportunity for CT without having to seek permission from male partners and 
refers clients to early HIV prevention, treatment and care services (Matovu et al., 2007; 
Weiser et al., 2006; Creek 2007; Manzi et al., 2005; Silvestri et al,, 2011; Pope et al., 2008).
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A study in Zimbabwe to assess the impact of routine antenatal HIV testing for prevention of 
Mother to Child transmission of HIV (PMTCT) showed that 99.9% of over 4500 patients 
were tested for HIV in the first 6 months of routine HIV testing as compared to 65% of 4700 
clients during the last 6 months of voluntary HIV testing. The number of HIV infected women 
identified through ANC increased and more women collected their test results during the 
routine HIV testing (Chandisarewa et al., 2007).
A study in Durban, South Africa in an out-patient department (OPD) compared a physician 
referral to a VCT site within the hospital complex (about 300 yards from the OPD) with a free 
routine HIV testing intervention offered in the OPD for all adult patients. The study found that 
within the 14 weeks VCT referral period, only 32% of the patients underwent testing within 4 
weeks after the referral. However during the 12 week routine testing more than 2000 
individuals were offered testing and 49% of these persons agreed. The study revealed that 
routine HIV testing at the point of care in an OPD identified nearly five times as many new 
cases per week as HIV tesing by physician referral to an adjacent hospital affiliated VCT 
(Bassett et al., 2007).
PITC was shown to also be successful in increasing the proportion of patients tested for HIV 
and those offered HIV in a cluster controlled trial to assess the impact of PITC on 
proportion of patients tested for HIV among STI patients in Cape (Leon et al., 2010).
Routine testing for clients presenting in health facilities has raised a number of ethical, 
human rights concerns and the ability of its effective implementation in resource constrained 
settings. The PITC guidance by WHO/UNAIDS emphasise that PITC should be voluntary 
and that the “Three CV informed consent, counselling and confidentiality must be observed. 
There are concerns that routine HIV testing can be coercive and that counselling will no 
longer be practiced and this could potentially dissuade people from accessing health 
services (Csete et al., 2004; ICRW, 2005). A cross sectional survey in Botwana 11 months 
after the introduction of routine HIV testing among adults revealed that 81% were in favour 
of PITC because it reduces barriers to testing (89%), HIV related stigma (60%) and violence 
towards women (55%) and would increase access to ART (93%) (Weiser et al., 2006). On 
the other hand the study also found that 68% were unable to refuse the test suggesting that 
the voluntary nature of routine testing is not understood and 43% believed routine testing 
could lead to avoidance of medical care (ibid).
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Although the WHO/UNAIDS is strong on the need for informed consent and the right to 
refuse; there are concerns that some providers interpret the policy as an “opt out” policy - 
that is if a person does not expressly say no they can be tested for HIV (Bell et al., 2007). 
However for people to be able to say no, they need to be aware, have confidence and 
power to say decline a test. The voluntary aspect of routine testing is likely to be 
compromised given the organisational cultural factors that give high social status to health 
workers and the tendency not to question authority or advice of a health professional 
(Cassell, 2005; Gruskin et al., 2008). Therefore without strategies to ensure informed 
consent, the opportunity to decline HIV testing may not be feasible for many.
Counselling is not only a human right imperative but also a medical intervention (Bradley et 
al., 2011). Pre-test counselling increases the opportunity for informed consent and creates a 
conducive environment for receiving a positive test result. In PITC, it is feared that pretest 
counselling has been replaced with simplified pretest-information (Gruskin et al., 2008).
PITC has to be in the best interest of the individual patients and therefore raises some 
ethical challenges as to when test results should be communicated. For example in the case 
of a pregnant woman tested while in labour as well as the quality and quantity of counselling 
to be provided (Delva et al., 2006; Gruskin et al., 2008).
In a follow up survey of women who had participated in routine testing in ANC in Zimbabwe, 
most were satisfied with the quality of counselling, 98% stated that the pretest information 
had adequately prepared them for the test result and 89% felt that routine HIV testing 
during pregnancy was helpful because it is an empowering tool for women to exercise their 
rights and responsibilities (Chandisarewa et al., 2007).
Maintaning privacy and confidentiality is critical for long term management of HIV illness. 
While the need for disclosure is important clients, especially pregnant women, risk stigma or 
gender based violence from disclosure (Csete et al., 2004). Pressuring a woman to disclose 
to her partner or to test with a partner might make sexual and reproductive rights violations 
for men and women (Bell et al., 2007). Health workers experience ethical challenges and 
dilemmas with respect to advice and action on disclosure (Gruskin et al., 2008; Evan et al., 
2009).
While health workers are positive about PITC, they are sceptical about the increased 
workload, limited health workers, lack of space to provide private and confidential HIV 
services and lack of time to provide adequate counselling (Evan et al., 2009; Gruskin et al.,
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2008; Kapolongwe et al., 2011). A cross sectional study conducted among health workers in 
Mbeya region in Tanzania in government health facilities revealed that 35% of the health 
workers had negative attitudes about PITC as they felt it was too time consuming. In the 
absence of test kits as such they proposed PITC should only be limited to symptomatic 
patients (Kapolongwe et al., 2011). In the same study, 61% of the health workers felt 
discussing PITC with a client is difficult especially if the patient is not symptomatic or has a 
compliant not related to HIV and AIDS (ibid).
Finally to make PITC more effective, it should be accompanied by the provision of a 
minimum package of HIV services ranging from condoms to antiretroviral therapy (Gruskin 
et al., 2008; Dalai et al., 2011). However the challenge is retention in care of newly 
diagnosed HIV positive patients. For example while women testing through ANC was high, 
loss to follow up was also very high, 55% by the 36 week ANC visit, 68% by delivery and 
70% by the first postnatal visit (Manzi et al., 2005). Similarly a study in Durban of patients 
enrolled before HIV testing in the medical outpatient department revealed that only 39% of 
those who underwent CD4 cell count testing within 90 days after HIV testing and were 
deemed to be eligible for ART were known to have initiated ART in 1 year (Bassett et al., 
2010).
While PITC is effective in identifying HIV infection and has shown to be acceptable in 
different settings, the missing link in effective integration of different health services. PITC 
must balance individual rights with public health and questions about how best to implement 
routine testing including ensuring confidentiality, dignity and availability of care and 
treatment services if it is to be effective (Bassett et al., 2010).
Impact of delay in health care seeking and making contact with ART services 
Late initiation of HIV care reduces the clinical benefits from antiretroviral therapy, 
prophylaxis for opportunity infections and also reduces the potential public benefit achieved 
by reducing further infection (Samet et al; 2001; Anglemyer et al., 2011). Starting ART early 
has shown to have benefits of longer survival (Johansson et al., 2010). The experience of 
most ART programmes in sub-Saharan countries has shown substantial risk of mortality in 
the first few months of treatment (Lawn et al., 2010; Braitsten et al. 2006; Lawn et al. 2006; 
Birbeck et al., 2009). In a community based ART program in South Africa, the mortality rate 
was estimated at 19.1 deaths per 100 person years in the first months of treatment,
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substantially decreasing to 2.9 deaths per 100 person years beyond 4 months of treatment 
(Lawn et al., 2006). A comparison of mortality of patients on ART to a non-infected 
population in a combined cohort of five treatment programmes in sub-Saharan countries 
showed that mortality risk was 18 times higher in the first year of ART than in the general 
population (Brinkhof et al., 2009). The risk of death is much greater in patients presenting at 
advanced stage of illness and with low CD4 cell count (Lawn et al., 2010; Braitstein et al 
2006; Lawn et al. 2008; Brinkhof et al. 2009).
The high risk of mortality is to a greater extent attributable to delayed treatment initiation 
(Lawn et al. 2006; Harries et al., 2010; Lawn et al. 2008). It is common for most patients in 
sub-Saharan Africa to have their diagnosis made following presentation to health services 
and mostly at an already advanced stage of illness (Lawn et a!., 2008). Delay to HIV care 
and antiretroviral therapy is a result of delay at different steps of the HIV care pathway. The 
pathway to HIV treatment is often complex for many patients and because of the nature of 
the infection which has slow disease progression and an asymptomatic nature during the 
earlier stages of infection, it is likely that a certain extent of delay is unavoidable (Samet et 
al., 2001).
Pre-ART deaths
Delay to contact with health services for HIV care leads to early and pre-ART deaths. The 
high rates of mortality during the first months of treatment are seen to be indicative of high 
deaths among patients who are eligible for treatment but have not yet started treatment 
either because they are waiting for treatment to be initiated or are undergoing necessary 
treatment preparations. Two studies in South Africa have reported deaths among patients 
undergoing ART preparation for initiation of treatment and showed that these deaths 
accounted for approximately 67% and 87% of all deaths occurring during the first three 
months of treatment (Lawn et al., 2006; Bassett et al., 2009). A study in Durban, South 
Africa, showed that a significant number of patients were lost to follow up during the pre- 
ART preparation. Out of the number of patients who were lost to follow up more than a third 
of the patients had actually died (Bassett et al., 2009). In Kenya, 11% of patients thought to 
have not accessed treatment had actually died (Karcher et al., 2007). Another study in 
South Africa in a care facility where pre-ART services were offered for patients not yet 
eligible for ART, about 70% of patients failed to return for their first medical visit within a
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year of enrolment (Larson et al., 2010). The pre-ART care link is important to address the 
challenge of late presentation.
2.2.3.5 Effective coverage of HIV treatment
This domain refers to the number of people who have received a satisfactory service. The 
success of an ART programme is defined by the number of people who are adherent to 
treatment. Adherence rates exceeding 95% are necessary to maximise benefits of ART 
(WHO, 2006). Different ART regimens require different levels of adherence, but initially a 
minimum adherence threshold of 95% on prescribed doses was necessary to ensure viral 
suppression (Chaiyachati et al., 2011). Suboptimal early ART adherence increases the risk 
of early adverse outcomes (Steele et al., 2011). Adherence is an important determining 
factor to avoid failure in immunological and virological response and delay disease 
progression (WHO, 2006). In poor resource settings, maintaining high levels of adherence is 
important in order to sustain first line regimen effectiveness (El-Khatib et al., 2011). The 
weak health infrastructure, a general lack of resources and shortage of staff poses a 
challenge for monitoring adherence in resource poor countries (Obua et al., 2011). Despite 
the many challenges faced by ART programmes in resource poor countries, adherence is 
often higher in sub-Saharan Africa, exceeding adherence levels shown in some North 
American studies (Mills et al., 2006; Byakika-Tusiime et al., 2009). Patients have used 
mobile phone alarms, relying on their own memory and pill boxes (El-Khatib et al., 2011).
Retention of patients on ARV treatment
An important element in effective coverage is retention of patients on ARV treatment and 
this is becoming a challenge as treatment programmes increase in size (Miller et al., 2010; 
Rosen et al., 2007; Ekouevi et al 2010). The true status of patients who are lost to follow up 
is difficult to know but it is an important area to understand. Patients who are lost to follow 
up may either have died, transferred to a new ART site or opted to discontinue treatment out 
of their own choice or because of financial, social or psychological problems (Rosen and 
Ketlhapite, 2010; Geng et al., 2010; Yu et al., 2010; Miller et al., 2010). A review of patients 
initiating ART in sub-Saharan Africa showed that 22% of patients were no longer in care one 
year after treatment initiation, 25% at 24 months and at 36 months there was 30% attrition 
from treatment (Fox and Rosen, 2010). In Zambia, 60% of losses to follow up occurred in
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the first month of initiating ARV drugs as patients never returned for their follow up visit 
(Birbeck et al., 2009).
In a bid to improve retention and effective ART coverage, innovative approaches are being 
used such as patient tracers who follow up patients if they have missed treatment 
appointments (Rosen and Ketlhapile, 2010). The availability of a tracing method for patients 
who miss appointments through home visits or phone calls is associated with better 
retention of patients (Ekouevi et al., 2010). Use of cellular phones is showing to be 
acceptable and is effective for adherence support, though issues around confidentiality need 
to be carefully considered (Crankshaw et al., 2010). In South Africa, where patients who 
were lost to follow up were traced to their homes or by phone, the tracer was able to 
determine the status of 260 (53%) patients out of 493 lost patients. Out of those that were 
traced, 21% had died, 21% were still on ART at the same site, 30% had transferred to 
another ART site, while 27% had discontinued treatment (Rosen and Ketlhapile, 2010). The 
study showed that among those who had discontinued treatment, common factors were 
relocation to another area, turning to traditional medicine and religious belief, belief in being 
cured of HIV and fear of disclosure of HIV status. There are also challenges in finding 
patients lost to follow up because of cost and because patients might provide incorrect 
contact information for fear of being identified as HIV-infected (Ekouevi et al., 2010; Dalai et 
al., 2008).
Among patients, factors that have been associated with good treatment adherence have 
included having a treatment partner, social support and disclosure of HIV status. Treatment 
partners are chosen by the patient themselves, such as a close friend/relative or a partner, 
to support adherence and to assist the patient in not missing ARV doses (Ware et al., 2009; 
El- Khatib et al., 2011). Spouses are important sources of adherence support (Byakika- 
Tusiime, et al., 2009). The concept of ‘social capital’ through social networks, social 
responsibility and determination has shown to play a very positive role in adherence support 
in sub-Saharan African countries (Binagwaho and Ratnayake, 2009; Skovdal et al., 2011).
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In rural Zambia, adherence was associated with disclosure of HIV status to one’s spouse, 
knowing the HIV status of one’s partner and having a ‘treatment buddy’ (Birbeck et al., 
2009). Treatment buddies have a positive effect on adherence and patients without a 
treatment buddy are at greater risk of dropping out from treatment (Unge et al., 2010).
2.3 Factors affecting access and loss to follow up in HIV treatment: From 
the patient and community perspective
2.3.1 Theoretical perspective of illness and health care seeking from a social 
perspective
People’s experiences of health and disease are seen as being influenced by the society in 
which they live. Social constructionists perceive illness as not only a physical experience but 
also a social experience (Morgan et al., 1985). Explanatory models are explanations of 
illness and treatment framed within a given society which are important in understanding an 
individual’s perspective on illness (Kleinman 1980). Culture provides guidelines about 
ideals, values, social roles and preferred social behaviour. Cultural models provide 
explanations about the cause of distress or illness, how wellness is achieved and allows 
groups to develop shared and meaningful patterns of health promotion, help seeking which 
are natural and predictable within the larger cultural model. According to Kleinman (1980), 
the type and severity of symptoms, the course of illness and the labels of etiologies attached 
to the illness play a critical role in determining health care seeking behaviour and are 
influenced by socio-cultural factors and the availability of services.
In sub Saharan Africa it is common to attribute illness, including sexually transmitted 
infections, to witchcraft, taboos or violation of sexual taboos (Ashforth, 2002; Liddell et al., 
2005; Shuster et al., 2009). As such while there has been increasing knowledge of HIV and 
AIDS and its causes there are still some people who believe HIV is also caused by 
witchcraft, spirits or the violation of sexual taboos (Mshana et al., 2006; Kalichman and 
Simbaya, 2004).
As such individual health care seeking takes place in the context of a broader social 
network, which include relationships of power that shape resources including division of
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labour, care and support (Arnault, 2009). Arnault (2009) argues that while people may be 
guided by wider cultural societal models, there are conscious and unconscious processes 
that create a coherent cognitive map that is shared by small groups such as family. As such 
the culture of health care seeking is understood and operationalied at the small group and 
individual levels. Therefore illness behaviour focuses on how individuals, perceive, evaluate 
and react to symptoms (Clarke, 2010).
Limitation of health care resources affect how, where and when individuals seek care. 
Perceived beliefs of the causes of illness influence decisions where to seek care whether 
from traditional providers or from allopathic therapy (Golooba-Mutebi and Tollman, 2007). In 
a rural area in South Africa, an anthropological study of illnesses whose symptoms could be 
attributed to advanced HIV/AIDS disease found that villagers believed their illness could be 
best treated by traditional therapy (Golooba-Mutebi and Tollman, 2007). This resulted in 
patients only resorting to medical health facilities when the traditional healing was judged to 
have failed (ibid). The same study showed that older people, in consultation with others 
such as neighbours, relatives and friends, had influence over the type of treatment that 
younger members of the household sought. In most instances, they chose the type of 
therapy for them (ibid).
Studies however show that persons may not necessarily start with traditional medicine then 
proceed to modern medicine but that they might sequentially or concurrently use both 
modern and traditional forms of medicine (Reniers and Tesfai, 2009; Langlois-Klassen et al., 
2007; Eastwood and Hill 2004). In Ethiopia, using verbal autopsies, individuals perceived to 
have died from TB and HIV/AIDS were more likely to visit a medical facility primarily but also 
used holy water and traditional healers more often (Reniers and Tesfai, 2009). In Uganda, 
traditional herbal medicine was commonly used by patients before and after HIV diagnosis 
and while on ART (Langlois-Klassen et al, 2007). However, a study in rural Zimbabwe 
showed that as the realisation of the effect of ART is growing, use of traditional medicine is 
declining (Skovdal et al., 2011).
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Similariy religious beliefs also frame the health care seeking behaviour and beliefs of HIV 
and AIDS treatment (Zou et al.t 2009; Roura et al., 2010; Peltzer et al., 2008). In a study 
among Christian believers in Tanzania, 80.8% of the respondents believed HIV could be 
cured through prayer and some people from Pentecostal churches reported that they would 
not take antiretroviral drugs if they became HIV positive (Zou et al., 2009). However, the 
study showed that belief in healing power was not associated with a person’s willingness to 
begin ART (ibid).
The health belief model is based on the belief that people will be motivated to take action on 
their health in response to a perceived threat to their health (Quine et al., 1998; Rosenstock, 
1974). An individual’s health care seeking behaviour is influenced by a desire to avoid 
illness and that a particular action will prevent or relieve illness. The model predicts that 
preventive health action is influenced by the belief that one is susceptible to illness and that 
the consequences of the illness are severe and that the health action has perceived benefits 
of reducing the severity of the disease (Rosenthal et al., 1992). Wringe et al., (2009) applied 
the model to explore factors influencing attendance at HIV clinic appointments among 
patients in a rural area in north-west Tanzania. The findings from the study in relation to the 
Health Belief Model are presented in Table 1.
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Table 1 Dimensions of the health belief model in relation to health facility attendance 
for HIV care
Concept Definition Expressions of the concept
Perceived
susceptibility
Assessments made by an HIV­
positive patient of the likelihood
of succumbing to HIV-related
illnesses, including death
Denial of HIV status;
understanding of disease 
progression; Beliefs around HIV
causation, including beliefs in a
cure for HIV
Perceived severity HIV-positive patient’s opinion of
how serious HIV infection and its
consequences are.
Influence of poor physical health
on initiating clinic attendance;
consequences of improvements
in health on clinic attendance
Perceived benefits Anticipated or experienced
positive outcomes of attendance
at HIV treatment clinics
Improvements in health; ability
to return to work; ability to care 
for children; social acceptance
when well
Perceived barriers An individual’s assessment of
the tangible and psychological
costs of attending HIV treatment
clinics
Inability to overcome health
systems barriers (queues, travel
to clinic etc); psychological costs
including impact of
discrimination or segregation by
family or community
Self-efficacy An individual’s confidence in
their ability to regularly attend
the HIV clinic
Often determined by ability to
live independently; ability to 
overcome family influences on 
treatment-seeking decisions
Source: Wring© et al., 2009
According to a study by Wring© et al. (2009) in rural Tanzania, people’s perceived 
susceptibility to HIV illness was shaped by their perceptions of HIV aetiology, such as 
beliefs that HIV was caused by witchcraft and could be cured. Perceived low susceptibility of 
HIV might cause some people not to access HIV testing and treatment (Kigozi et al., 2011;
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Bignami-Van Assche et al., 2007). The presence of physical symptoms was usually 
associated with perceived severity and therefore seeking care from a health facility (Wringe 
et al. 2009). A patient’s desire to stay alive in order to care and support one’s children and 
other family members has been reported as a perceived benefit of ART access and 
adherence (Byakika-Tusiime, et al., 2009). Improvement in health leading to weight gain, 
renewed energy and ability to participate in normal activities is a motivator for adherence 
(Ware et al., 2009). Consequently, a lack of improvement could lead to non-adherence 
(Cooper et al., 2009).
2.3.2 Stigma and discrimation and disclosure in the era of ART
Stigma and discrimination have been associated with HIV and AIDS since it first started and 
often referred to as the ‘third epidemic’ after the HIV epidemic and the AIDS epidemic 
(Mann, 1987; Foreman and Taylor, 1990). Stigma has been recognised as a highly complex 
phenomenon which interplys between social and economic factors and manifests in all 
spheres of life (Ogden and Nyblade, 2005). Goffman (1963) while foucing on the individual 
aspects, described stigma as ‘an attribute that is deeply discrediting within a particular social 
interaction’. Stigma is seen as a mark of disgrace or discredit while discrimation is the 
negative action following form this belief (ibid). Parker and Aggelton (2003) offer a 
framework that explores stigma as a social process that produces and reproduces relations 
of power and control. They observe that stigma is used by dominant groups to exert social 
control through the exclusion of stigmatised groups (ibid). Parker and Aggelton argue that 
stigmatisation is so much linked with the workings of social inequality by its capacity to 
cause some groups to be devalued and others to feel they are superior (Parker and 
Aggelton., 2003; Mahajan et al., 2008). Stigma and discrimination are therefore seen as 
social consequences of the fear generated about the disease in individuals and societies 
(Foreman and Taylor, 1990). Stigma related to medical conditions is worsened when the 
illness is associated with deviant behaviour, particularly when linked with religious beliefs 
and thought to be contracted through morally sanctioned behaviour such as in the case of 
HIV which is associated with improper sexual contact, drug use (Ogden and Nybalde, 2005). 
According to the UNAIDS definition, HIV and AIDS related stigma and discrimination is the 
process of devaluation of people either living with or associated with HIV and AIDS 
(UNAIDS, 2003).
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People living with HIV often experience stigmatisation and lack of social support and 
patients have to overcome these barriers in order to benefit from treatment. PLWHIV have 
reported loss of jobs, isolation, divorce, being badly treated by family or partners after 
disclosing their HIV status, blame, gossip and verbal and physical abuse (Harden et al.,
2007; Maman, 2009; Gilbert and Walker, 2010).
People might be more fearful of stigma itself more than the disease (Skinner and Mfecane, 
2004). Factors that contribute to the HIV stigma and discrimination among PLHIV include 
fear of transmission, suffering and death (Maman et al., 2009). Fear of anticipated stigma, if 
HIV status was revealed was associated with having depression among men in Botswana 
(Gupta et al., 2010). Fear of stigma goes beyond the individual infected person to reach 
broadly into the society, disrupting functioning of communities and complicating prevention 
and HIV treatment service utilisation (Skinner and Mfecane, 2004; Mahajan et al., 2008). 
Stigma is a barrier for uptake of HIV and AIDS prevention, treatment and care services 
(Obermeyer et al., 2007; Bond et al., 2002; Kalichman and Simbayi, 2003). A study in 
Ethiopia on the uptake of HIV testing among TB patients revealed that patients with low 
stigmatising attitudes were more likely to accept HIV testing (Ayenew et al., 2010).
Evidence of impact of ART on stigma and discrimination is conflicting with some studies 
reporting reduced stigma among patients utilising ART, while some argue stigma is still high 
or that there is some reduction in stigma but still it remains at high levels. A study in 
Mozambique among patients interviewed at the time of initiating ART and one year later 
reported no change in stigma (Pearson et al., 2009). A study in five countries in Africa found 
decreases of HIV stigma over time among people on ART and those not on ART over time; 
however patients on ARV reported significantly higher stigma than those not on ART 
(Makoae et al., 2009). In Kwazulu-Natal, perceived stigma decreased over a period of one 
year among patients on ART but levels of stigma still remained high (Peltzer et al., 2011). A 
study among those who had discontinued ART in a public clinic in South Africa found that 
fear of disclosure (often associated with stigma) was a factor that contributed to drop out 
from treatment (Rosen and Ketlhapile, 2010). Another qualitative study in Zambia among 
women in urban Zambia, showed stigma was a significant challenge to ART acceptance and 
adherence due to fear of being laughed at, fear of being embarrassed, fear of being chased 
from their homes or losing their economic livelihood due to the changing interpersonal 
relationships especially between husbands and wives (Murray et al., 2009).
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However, a study also in South Africa found that among patients lost to follow up, there was 
less influence of stigma as a factor contributing to lost to follow up (Miller et al., 2010). 
Another study in Zambia also found no significant associations between stigma and self 
reported adherence (Pearson et al., 2009). While increasing access to treatment may lead 
to lower HIV stigma, providing services is not enough to address stigma, there is need to 
increase services alongside implementing strategies that particularly aim at addressing 
stigma and discrimination (Maman et al., 2009). This is important as stigma goes beyond 
the individual patient to the family and society. A study on experiences of HIV patients in 
South Africa revealed that mostly family members, neighours and employees did not share 
the view that HIV is a chronic manageable condition and continued to hold stigmatising 
attitudes (Gilbert and Walker, 2010).
To cope up with stigma and discrimination, PLWHIV have used strategies such as changing 
their behaviour, turning to God, networking with other people with the same problem or 
people who make them feel protected and supported (Makoae et al., 2008; Green et al., 
2011; Medley et al., 2009). .
Disclosure of HIV status
Lack of disclosure is associated with not starting treatment and with poor adherence 
(Bajunirwe et al., 2009; Birbeck et al., 2009). Disclosure to one’s spouse and knowledge of 
the status of a spouse has been shown to be associated with good adherence (Makoae et 
al., 2009). In an ART program in South Africa, lack of disclosure was one of the factors 
contributing to loss to follow up (Rosen and Ketlhapile, 2010). In South Africa being on ART 
was associated with disclosure (Vu et al., 2010). In Tanzania, lack of disclosure, even to 
partners, was a challenge to accessing treatment with patients not wanting to be followed up 
to their homes or work places (Mshana et al., 2006). Similarly in Cameroon, less frequent 
disclosure of HIV status was associated with not receiving ART (Marcellin et al., 2010). A 
study among TB patients to assess the acceptability of integrating TB and HIV care found 
that while patients found it easy to combine the therapy, patients experienced challenges in 
disclosure of their HIV status (Gebrekristos et al., 2009). HIV infection impacts on 
interpersonal relationships, particularly for husbands and wives due to fear of divorce and 
rejection (Murray et a!., 2009). Disclosure is challenging among unmarried men and women 
as they realise they might never be able to marry or have their own children (Smith et al.,
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2007). Pearson et al. (2009) found that low levels of stigma were associated with disclosing 
to more people. In their study, disclosing to workmates and friends was less associated with 
stigma but there was no difference in overall stigma when disclosing to a spouse or a 
partner. A study in Uganda showed that factors predicting non-disclosure included not 
initiating ART, testing for HIV in an antenatal clinic and fear of negative outcomes (Kadowa 
and Nuwaha, 2009). However in the study disclosure was favoured by having 
communication skills to disclose, ongoing counselling and seeing a PLWHIV disclosing her 
status (ibid). Women face particular challenges to disclosure, often due to fear of abuse and 
divorce (Birbeck et al., 2009; Turan et al., 2011).
2.3.3 Treatment literacy and community beliefs
Beliefs about ART may be influenced by understanding and perceptions about ART as a 
result of social networks and also diffusion of information about ART. ART is a relatively new 
intervention and in most countries, wide availability only started after the WHO 3 by 5 
initiative Rogers’ (1971) theory of diffusion explains how the process by which a new 
innovation, in this instance ART, spreads to members in a social system and may result in a 
functional or dysfunctional consequence, depending on whether the effects of the innovation 
are desirable or undesirable. Diffusion of innovation theory studies the level of adoption of 
an innovation and identifies the characteristics of the individual decision maker and the 
social system to impact on the decision making process (Mitchell et al., 2007). The social 
system and its norms act to hinder or facilitate the rate of diffusion and adoption of new 
ideas or rejection of the innovation. Rogers (1971) describes that an innovation is that which 
is communicated through certain channels over time among members of a social system. 
Based on Rogers’ theory, members of the social system’s rate of adoption of antiretroviral 
therapy will be based on how communities perceive ART to be of relative advantage; how 
consistent it is with their existing values, experiences and needs; its complexity in use; trial- 
ability of the treatment and the observability of the results. This usually results in community 
early adopters of treatment and as the communities observe the experience of those on 
treatment, late adopters will start to access treatment.
The rate of adoption (ART) will therefore be influenced by the perceptual barriers of ART. 
Patients’ negative beliefs about antiretroviral medication keep persons who are aware of 
their HIV positive serostatus from starting antiretroviral treatment (Fox et al., 2010; 
Agnarson et al 2010). A study in South Africa found that nurses were the only group who 
had firm beliefs in the efficacy of ART treatment whereas other community members
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considered it an unproven experiment (Mitchell et al., 2009). In Rakai district in Uganda, 
people believed ARVs were a poison and discouraged community members from taking 
them (Kunihira et al. 2010). Life style changes and the fear of developing a new cultural 
framework around illness is a barrier to considering taking ART for life, as medicine has 
usually been thought to be curative and therefore temporary (Murray et al., 2009). A study in 
Tanzania also showed that community members perceived that ARVs needed to be taken 
with good food such as meat or fish as the drugs could be dangerous for undernourished 
people (Mshana et al. 2006). Fear of restrictions to be followed when taking ARVs such as 
stopping taking alcohol, smoking and never having sex without a condom are considered 
profound changes to patients’ lives (Kunihira, et al. 2010; Murray et al., 2009). In Uganda, 
those who had witnessed illness and side effects after initiation of ART in relatives or friends 
delayed starting ART (Parkes-Ratenshi et al., 2010). In Tanzania, there were anxieties that 
after a certain period of time the drugs would become ineffective and cause sudden death 
(Roura et al., 2010). In Kenya, it was shown that pregnancy was associated with not starting 
treatment, as women may have been worried about the risk of drugs on their unborn 
children (Karcher et al., 2007). A study in an urban slum in Kenya, showed that conflicting 
information of ART from religious leaders and their communities created challenges for 
communities with high illiteracy levels to understand ART (Unge et al., 2008).
It is therefore important for ART programmes to strengthen HIV treatment literacy in the 
communities before and after introducing ART in the communities (Bharath-Kumar, 2009). 
Poor communication by health workers may also present challenges to ART access and 
adherence. Some studies have shown that health workers were not able to provide 
adequate information about ART to patients, for example about the importance of 
adherence, opportunistic infections, or side effects of ARV drugs and that these disappear 
overtime (Harden et al. 2007; Obua et al., 2011). In a study in urban South Africa, it was 
found that insufficient information about ARV drugs side effects led to temporary treatment 
discontinuation (Aspeling et al., 2008). In Botswana, where side effects were extensively 
discussed by health workers, very few cited them as reasons for missing their medication 
(Harden et al., 2007). Inability to retain staff is a challenge to providing adequate information 
about treatment to patients due to lack of dedicated staff in the ART clinic (Obua et al., 
2011).
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2.4 Influence of gender and poverty on HIV treatment 
2.4.1 The relationship between poverty and health
Poverty and poor health are interrelated. Poor people tend to experience poor health more, 
and at the same time, poor health makes poor people remain poor (Wagstaff, 2002; Bloom 
and Canning, 2003). Poverty increases the risk of exposure to disease. Inequalities exist 
between and within countries and from the eyes of the poor, the gap between the rich and 
the poor keeps widening (Narayan and Petesch, 2002). The poor have higher rates of 
morbidity and mortality, but access health care less (Bloom and Canning, 2003; Zere et al., 
2007). Poor people lack material assets, face hunger, live in poor housing and unsanitary 
conditions, are unemployed and have poor education resulting in inequalities in health and 
health service utilisation (Dhai, 2008; Onwujekwe et al., 2005). The poor are less likely to 
access HIV testing and consequently HIV treatment (Helleringer et al., 2009). AIDS has 
greater economic impacts on the poor, plunging households into more poverty and 
increasing income inequalities (Piot et al., 2007; Obrist et al., 2007; Collins and Liebbrandt, 
2007). Ill-health contributes to economic hardship and increases risk of households’ 
impoverishment. The direct and indirect costs of health care seeking demands a substantial 
proportion of household income leading in some cases to catastrophic health expenditures 
(Whitehead et al., 2001). Catastrophic spending has been found not to be triggered by one 
single devastating event, but rather, a series of events to every day illness which is common 
in chronic or long term illness such as tuberculosis and HIV and AIDS (Su et al., 2006).
Poverty and food insecurity have also been associated with poor treatment acceptance and 
adherence, especially where there are competing demands between costs of food and 
medical expenses (Ware et al. 2009; Unge et al., 2010; Weiser et al., 2010; Unge et al., 
2008; Nabyonga et al., 2005). Patients are continually faced with difficult choices due to 
poverty over whether to continue to adhere to treatment at the expense of other important 
needs. In order to raise money to meet treatment appointments, patients resort to begging, 
borrowing or getting loans from friends with some resulting in indebtedness (Russell et al., 
2005). Being on TB and ART treatment has more often been associated with the need for a 
good diet and special food to be taken with medication, and adds an additional stress on 
health expenses (Rosen et al., 2007). TB patients in Zambia co-infected with HIV had
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changed their diets from vegetables and maize meals to include more fish, eggs, meat, soft 
drinks and fruit (Chileshe and Bond 2010).
Coping with costs of health care among the poor
The strategies used by households to cope with illness include the use of savings, 
borrowing, sale of assets and sacrifice of future investments (such as children dropping out 
of school) and reduction in essential consumption which have long and shortterm negative 
impacts on the welfare of the household (Chuma et a!., 2007). In most cases, household 
savings are small amounts of money reserved for basic food needs in the household. 
Studies also show a shift in household consumption patterns. Households experiencing ill- 
health were more likely to have curtailed education for children, and reduced expenditure on 
critical households needs, such as food, clothing and accommodation (Parker et al., 2009; 
Russell., 2004; Hosegood et al., 2007). Though the costs of health care are incurred by both 
men and women, literature shows that the impact of care seeking is greater for women than 
for men. Women tend to have few options for economic independence (Ojanuga and 
Gilbert, 1992).
The impact of poverty on ill health is evident across regions and within countries. The sub- 
Saharan Africa region while it harbours about 10% of the world’s population, has almost 
twice the levels of communicable diseases than those in other country regions 
(WHO/UNAIDS, 2005). This region has been heavily affected by malaria, HIV and AIDS and 
tuberculosis; Africa has 25% of the global burden of disease, and 60% of people living with 
HIV and AIDS are in this region (EQUINET, 2007). While the relationship between poverty 
and HIV is greatly contested, there is agreement that poverty has the potential to put the 
poor at more risk of infection (Fox, 2010; Matrass, 2009; Parkhurst, 2010). Studies have 
documented that HIV has been concentrated among the better off, wealthier population in 
sub-Saharan Africa, however there seems to be shift of increasing transmission among the 
poor due to their social position which gives them less empowerment to change their sexual 
behaviour (Lopman et al., 2007; Piot et al., 2007; Parkhurst, 2010).
2.4.2 Gender, health and HIV and AIDS
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“Gender” refers not only to the physiological differences of the sexes but also to the variety 
of behaviors, expectations and roles that exist within a social, economic and cultural context. 
Gender refers to the social expectations, roles, status and power accorded to women and 
men because of their sex (Gender and Health, 1999). Gender equality implies the absence 
of discrimination on the basis of a person’s sex in opportunities, in the allocation of 
resources and benefits, or in access to services. ‘Gender equity’ refers to eliminating 
unnecessary and avoidable health iniequities which exist as a result of of the social 
construction of gender. Gender equity in health refers to fairness and justice; it recognises 
that women and men have different health needs, power and have differential access to 
health related resources (Doyal, 2000). Women and men have different exposures to health 
risks due to differences in the male and female biology; women are more likely than men to 
be financially insecure, and have a lower social status, while men are more often employed 
in occupations with specific threats to health (Bingenheimer, 2010; Asiki et al., 2011). 
Therefore these differences should be identified and addressed in a manner that rectifies 
the imbalance between the sexes through an equitable distribution of health related 
resources (Doyal, 2000).
The social constructionist theory conceptualises gender as a system of social classification 
that influences access to power, status and material resources (Connell, 1987). The norms 
and roles for masculinity and femininity allocated to men and women vary across 
communities and are influenced by social, political and cultural dynamics. These dynamics 
in turn are shaped by gendered social practice (Tersbel, 2006). In many African societies, 
traditional gender roles involve women staying at home to raise the family with men going 
out to work to provide for the family. According to Connell’s theory of gender and power, 
gender inequalities have their roots in the sexual division of labour, the structure of power 
and the structure of sexuality (Connell, 1987). In this thinking, the gendered division of 
labour which stems from capitalist systems is run by, and mainly to the advantage of men. 
Since men have more control over the division of labour, their interests help them to keep 
predominant power, and a gendered access and control over resources, power and 
structure of identities and norms (ibid). The gendered differences in men’s and women’s 
roles and responsibilities and gender inequities in access to resources, information and 
power affect their health status, access to preventive and curative measures and quality of 
care (Gender and Health group, 1999; Krishnaan et al., 2008).
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The inequalities in health can be traced to traditional medical practices, which discriminate 
against women and prevent them from getting prompt treatment. This is propagated by the 
patriarchal structure of societies that prescribe an inferior status to women in the society so 
that women are expected to adhere to rigid gender norms and the sexual division of labour 
in return for security and protection (Seeley et al., 2004). The gendered differences in 
financial inequality, authority relations and social identities of men and women influence how 
families, communities and health care systems react towards HIV infection among men and 
women (Mbonu et al., 2010). Gendered differences have also been seen in factors that 
affect adherence. In Uganda, men were likely to use items of monetary value to enhance 
adherence such as wrist watches or mobile phone alarms, where as women used non­
monetary items and tended to schedule their pills around their routine activities (Nyanzi- 
Wakholi et al., 2011).
2.4.2.1 Women, HIV and health care seeking
Women are physiologically more vulnerable to HIV infection and this may be compounded 
by hormonal changes arising from hormonal contraceptives and a higher prevalence of 
sexually transmitted diseases, pregnancy and the early post partum period (Quinn and 
Overbaugh, 2005). Gender inequalities put younger women at more risk of HIV infection; in 
southern African countries women between the ages of 15 to 24 are three to six times more 
likely to be infected than young men due to behavioural high risk activities and physiological 
factors of an immature genital tract (Quinn and Overbaugh, 2005). Gendered norms in many 
contexts means that men are expected to have younger sexual partners (Shisana and 
Davids, 2004).
The existence of gender inequalities and asymmetrical sexual relations increases the risk of 
women being infected more than men (Ghosh and Kalipeni, 2005; Lindren et al., 2005). 
Women’s vulnerability to HIV infection increases through gender based violence and male 
dominated partnerships (Ghosh and Kalipeni, 2005). Gender based violence is an effect of 
strained gender relations (Seeley et al., 2004; Strebel et al., 2006). Views of blame and 
accusations have in some societies been directed towards female PLWHIV more than male 
PLWHIV (Mbonu et al., 2010).
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Gender inequalities are aggravated by mobility constraints that often affect women’s access 
to HIV treatment and care. At the same time, limited access to resources such as land 
ownership and financial assets unequally affect women and reduces their capability to 
mitigate the impact of HIV and AIDS (Seeley et al., 2004; Shisana and Davids, 2004). 
Women are faced with many socio-cultural factors which tend to have a negative impact on 
their physical well being and accessibility to appropriate health care services (Ojanuga and 
Gilbert, 1992). The woman’s status affects her exposure to illness, progression to disease 
and access to health services by directly affecting the decision to seek health care. Men 
often hold power in decision making about health care seeking especially where costs are 
involved; where services are provided at a cost, these are more likely to be accessed by 
men who often have greater sources of income than women (Muko et al., 2004). The 
Commission of the Social Determinants of Health proposes that action should be taken by 
countries to tackle inequitable distribution of power, money and resources (CSDH, 2008).
2.4.2.2 Masculinities and its regressive effect on HIV treatment and care
At the same time, a number of masculinity norms have shown to be regressive in relation to 
HIV and AIDS putting men at a possible disadvantage in seeking treatment and care. Men 
with beliefs of dominance, prowess and who interpret health care seeking as a sign of 
weakness are likely to seek HIV testing, treatment and care at a late stage. The emphasis 
on the ‘vulnerability’ paradigm of women and interventions to address these vulnerabilities 
have sometimes left out heterosexual men and fail to address how norms of masculinity 
can be harmful to men’s and women’s health (Higgins et al., 2010). Increasing evidence 
from sub-Saharan Africa shows that more women access HIV treatment services than men 
and that men seek HIV care at more advanced stages of illness and tend to have poor 
treatment outcomes (Carael et al., 2009; Braitstein et al., 2008; Cornell et al., 2009). Women 
access health systems through under-five child services, prenatal services and in turn are 
tested for HIV as part of Prevention of Mother to Child Transmission (PMTCT) (Peacock et 
al., 2009; Ujiji et al., 2011; Byamugisha, 2010).
2.4.2.3 Gender and disclosure of HIV status
Studies have suggested that the experience of stigma also reflects local gender roles and in 
turn shapes reasons for disclosure or non disclosure for men and women (Somma et al., 
2008). In Ethiopia, men did not disclose their HIV status to their partners because they were
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concerned about causing worry to their partners and also exposing their own unfaithfulness, 
whereas women feared physical violence and social and economic pressure in raising their 
children (Deribe et al., 2010). The fear of divorce, abandonment and mistreatment and other 
marriage related problems where women are economically dependent on their partners may 
force women not to access care (Murray et al., 2009; Skovdal et al., 2011). As such, 
women have been found to be more likely to withhold disclosure of their HIV status from 
their spouses than men (Birbeck et al., 2009; Anglewicz and Chitsanya, 2011). Men are 
however more concerned with connotations of weakness and the financial impact of illness 
resulting from their inability to work due to illness (Somma et al., 2008).
2.4.3.4 Impact of gender on mortality
In sub-Saharan male sex is a risk factor for early mortality as well as for pre-ART loss to 
follow up (Braitstein et al. 2008; Bassett et al., 2009; Brinkhof et al., 2009; Ekouevi et al., 
2010). Women have reduced risk as they tend to start ART earlier and at a less advanced 
stage of illness (Brinkhof et al., 2009; Parkes-Ratenshi et al. 2010). However, Geng et al. 
(2010), in a study in south western Uganda, where patients initiating ART were followed up 
for up to 3.75 years, found that male sex was only associated with high risk of death where 
deaths only known passively to the clinic were considered, but when deaths known through 
patient tracking were included to represent a sample in all lost outcomes, male sex was no 
longer a significant predictor of death.
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2.5 Conclusion
This chapter has discussed the importance of equity in health and health care systems so 
that service delivery meets the needs of those whom it is intended to meet. It has explored 
the influence of gender and poverty on health and on HIV and AIDS.
Poverty is interlinked with health as poor people have more risk of illness but access health 
care services less than those who are better off. The literature showed that there are still 
debates about whether HIV is a disease of the poor, nonetheless there is consensus that 
HIV has exacerbated poverty and poor people face the brunt of the impact of HIV.
The literature has shown the influence of gender on HIV risk and also how gender impacts 
access to health care for both men and women. The risk of HIV and AIDS has a gendered 
face: women have more risk of being infected by HIV and AIDS, while the influence of 
masculinity, where men are believed to be strong, hinder them from adopting HIV preventive 
services and also accessing timely health care services when ill.
In the chapter, I used the Tanahashi framework to demonstrate how it can be used to 
evaluate the health service coverage of ART provision from a health system perspective. 
The framework showed how the different levels of coverage need to be assessed to 
determine effective health coverage of an intervention. The chapter also demonstrates the 
importance of the influence of the community or society on determining how people interpret 
their illness and seek care. As such, it is the interplay between the health system and patient 
factors that influence care seeking and treatment adherence and retention in care.
The chapter illustrates how the provision of ART services is taking place in fragile health 
systems and the urgent need to strengthen health systems in order for ART services to be 
more equitable. Due to social and health system factors, delay to HIV diagnosis results in 
high mortality rates before ART initiation and in the first months of treatment. Delay is 
influenced by the patients’ illness behaviour which is influenced by health care seeking 
pathways, the high costs of accessing care and health system related barriers.
67
Treatment adherence is key to the success of ART and ART treatment programmes. The 
literature provides evidence for factors that lead to attrition from ART and treatment 
compliance factors that facilitate ART adherence.
In the next chapter, I will explore more about how the factors identified in chapter 2, play out 
in the context of Malawi to influence access and adherence to ART.
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CHAPTER 3: The experience of Antiretroviral Therapy roll out in 
Malawi
3.0 Introduction
This chapter aims to present the HIV and AIDS situation and the expansion of antiretroviral 
therapy in Malawi. The chapter is divided into three main sections.
The first section, Section 3.1, will outline the HIV trends, the policy framework around 
antiretroviral therapy programmes, and how the ART programme is expanding in Malawi 
including the challenges being faced and existing gaps.
The second section, Section 3.2 focuses more on the analysis of the studies around HIV 
programmes and treatment that I have been involved in. It presents a picture of how 
different people experience HIV and AIDS treatment, care and support programmes in 
Malawi. The section also draws on other published and unpublished literature within Malawi.
In the third section, Section 3.3, based on the literature from Chapter 2 on sub-Saharan 
Africa and the experiences from Section 3.1 and 3.2 in Chapter 3,1 present a conceptual 
framework that has guided this study.
3.1 The HIV situation and the antiretroviral therapy programme in Malawi
3.1.1 HIV trends in Malawi
Malawi is one of the countries facing a severe HIV epidemic. Since the identification of the 
first HIV case in 1985, the epidemic has rapidly expanded. Malawi, like most countries in the 
east and southern African region, has a generalized epidemic (UNAIDS/WHO, 2006). 
it is estimated that close to one million people are living with HIV and AIDS (MOH and MAC, 
2005). About 86,000 deaths annually are attributable to HIV and AIDS related illnesses 
(MoH, 2005). In 2005, it was estimated that there were 185,000 people in need of treatment 
(ibid). In the same year, an estimated 110,000 new infections occurred (Bello et al., 2006). 
Amongst women attending antenatal care in 2003, 19.8% were HIV positive, with higher 
rates of 21.2% in urban areas and 14.5% in rural areas (MOH 2003). Over 70% of people 
living with HIV and AIDS reside in rural areas of Malawi (MoH, 2005).
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There has been a declining trend of HIV prevalence over the last few years in Malawi (Bello 
et al., 2006; MOH, 2008). Comparison over the years has been made using the median 
prevalence which is commonly used in comparing prevalence over a period of time as it is 
not affected by changes in site sample size, and is less affected by extreme site results 
(MoH, 2008). According to the HIV Sentinel Surveillance Surveys between 1998 and 2007, 
the median prevalence increased from 18.5% in 1998 to 22.5% in 1999. There has been a 
declining trend from 1999 from 22.5% to 13.5% in 2007 among women attending antenatal 
clinics as shown in Figure 2 (MOH, 2008). The national HIV prevalence estimates based on 
the Antenatal Sentinel Surveillance was at 14% in 2005 and declined to 12% in 2007 (MoH, 
2008). The decrease in the prevalence in 2007 is attributed partly to an improved 
methodology of prevalence estimation and the 2007 prevalence estimates were adjusted by 
the 2004 MDHS results. The decline in prevalence is more visible in the urban and semi 
urban areas although prevalence in these areas is still higher than the national average 
(ibid). According to recently released data from the MDHS 2010, prevalence is estimated at 
10.6% (8.1% among men and 12.9% among women) (NSO, 2011).
Figure 2: Malawi median HIV prevalence trend
Source: MoH, 2008 (Sentinel surveillance survey)
HIV and AIDS is the main cause of death in the economically productive age group. 
Mortality trends increased between the 1987 and 1998 census, crude death rate (CDR)
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increased from 14.1 per 1000 in 1987 to 21.1 per 1000 in 1998 ( Bello et al. 2006). 15% of 
under-5 deaths are directly attributable to HIV infection (MoH, 2008). The 2008 census 
showed that there has been a marked decline in the CDR and is currently estimated at 10.4 
deaths per 1000 (NSO, 2010). Life expectancy among males has increased from 39 years in 
1998 to 48.3 years in 2008: among females, it has increased from 45 years to 51.4 years 
over the same time period (NSO, 2010) possibly reflecting the impact of the availability of 
ART among other factors.
Distribution of HIV prevalence by socio-economic characteristics 
The MDHS 2010 provides insight on the distribution of HIV and AIDS by socioeconomic 
characteristics. The MDHS 2010 showed that 10.6 percent of the population aged 15-49 
was living with HIV and AIDS. There are spatial, gender, age, and regional disparities in HIV 
prevalence. Prevalence is higher among women (12.9%) than among men (8.1%); 
prevalence is twice as high in the urban areas than in rural areas. However, because most 
of Malawi’s population (85%) resides in rural areas, more people living with HIV and AIDS 
are in rural areas. There is a higher prevalence among those who are wealthier, more 
educated and in employment. Figure 3 shows the variation in HIV prevalence by gender. 
Among the 15-19 age group, women are three times more likely to have HIV than men 
showing that women get HIV infection at younger age than men. HIV prevalence remains 
higher among women in all age groups, except in the 40-44 age group, where it is slightly 
higher among men than women.
Figure 3: Percentage HIV positive among women and men among 15-49 age-group
Women
15-19 20-24 25-29 30-34 35-39 40-44 45-49
Source: MDHS 2010
Table 2: HIV prevalence by socioeconomic characteristics
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Background Characteristics Women (%) Men (%) Total
Population
(%)
Residence
Urban 22.7 12.0 17.4
Rural 10.5 7.1 8.9
Region
Northern 8.2 4.8 6.6
Central 9.0 6.2 7.6
Southern 17.6 11.0 14.5
Education
No education 14.1 10.9 13.2
Primary 11.6 7.7 9.8
Secondary 16.1 8.1 11.4
More than secondary 16.3 11.9 13.6
Wealth Quintile
Lowest 8.9 5.6 7.5
Second 9.3 6.5 8.0
Middle 10.6 8.0 9.4
Fourth 13.7 8.2 11.0
Highest 19.7 10.8 15.3
Employment
Not employed 9.6 2.4 7.7
Employed 14.2 8.9 11.3
Source: 2004, Malawi Demographic and Health Survey
According to the MDHS 2010, while there has been a decline in most of the population 
groups, there is an increase amongst urban women from 18% in 2004 to 22.7% in 2010 
(NSO, 2011).
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3.1.2 The HIV and AIDS Policy landscape
The Malawi government in 1988 established the National AIDS Control Programme (NACP) 
in order to implement a national response to the HIV epidemic. The review of NACP led to 
the development of the National HIV and AIDS Strategic Framework (2000-2004) whose 
aim was to emphasize the need for an expanded and multi-sectoral response to HIV and 
AIDS and sexually transmitted infections (STIs). In 2001, NACP was replaced by the 
National AIDS Commission under the Office of the President and Cabinet (OPC) whose role 
is to coordinate the multi-sectoral National HIV and AIDS response. In 2003, The National 
HIV and AIDS policy was formulated with two goals, first to prevent the further spread of HIV 
and secondly, to mitigate the impact of HIV and AIDS on the socio-economic status of 
individuals, families, communities and the nation (NAC, 2003). In the policy, the government 
commits to bringing progress to the HIV and AIDS response through a public health 
approach that integrates principles of prevention, treatment, care and support and to 
‘progressively provide access to affordable, high quality ART and prophylaxis to prevent 
opportunistic infections (Ols), (but only to individuals who have tested HIV-positive and are 
medically deemed to be in need of this drug therapy)’ (NAC, 2003:20). The government also 
commits to promoting access to HIV treatment information, quality Community Home Based 
Care (CHBC), training of health workers in the use and management of ART, treatment of 
opportunistic infections, and that treatment of HIV and AIDS and related infections is 
incorporated and provided according to the Essential Health Package (EHP).
At the end of the National HIV and AIDS Strategic Framework (2000-2004), the National HIV 
and AIDS Framework (NAF) (2005-2009) was formulated and it brought to the forefront the 
emergence of HIV treatment (COM, 2005). The framework also incorporated the ‘three 
ones’ approach: one coordinating authority, one national action framework and one 
monitoring and evaluation framework”. Among the objectives of the NAF was to enhance 
equitable access to HIV testing and counselling services, expand quality services for 
prevention of mother to child transmission (PMTCT) and to improve the capacity of the 
health delivery system to provide equitable access to ARVs and drugs for management of 
HIV related infections and increase access to high quality community home based care 
(CHBC). The HIV and AIDS response is also situated within the Malawi Growth and 
Development Strategy (MODS) (2006 - 2011) to improve status and extend life of HIV 
infected people through increased uptake of ARVs (GOM, 2006) and the National Health 
Policy. The National Health Policy and strategy provides the general operation guidance on 
issues of HIV and AIDS prevention, treatment, care and support and impact mitigation.
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3.1.3 Promoting equity in access to ART
The need for equity in access to ART was realised very early in the ART expansion plan to 
avoid marginalisation of certain population groups such as the poor, rural or women (Kemp 
et al., 2003). Women contribute the largest number of vulnerable groups and they are at 
more risk of HIV infection (MDHS, 2004).
As such, the government through the National AIDS Commission initiated a wide 
consultative process on issues of equity in access to ART. This involved accessing views 
from the grassroots to the national level through radio and television programmes, a special 
commissioned study in seven districts of the country and consultative meetings held with 
different groups of people including people living with HIV, youth, different public institutions, 
Civil Society organizations and the private sector (Makwiza et al. 2005). The findings from 
the consultations were interpreted in the light of the National HIV/AIDS Policy and policy 
principles to promote equity in access to ART were drawn. Amongst the policy principles 
(see Appendix 1), government pledged to provide ART free at the point of delivery in the 
public sector on a ‘first come first served’ basis but targeted gender sensitive health 
education provided to groups of people considered to be in vulnerable situations (e.g. 
pregnant women) and in strategic positions such as health workers, teachers and civil 
protection amongst others (NAC, 2005). The principles also promote equity monitoring 
disaggregated by age and sex to be part of the ART expansion programme (ibid). Promoting 
equity in access is also recognized in the HIV and AIDS National Action Framework 2005- 
2009 (NAF) (COM, 2005).
3.1.4 Antiretroviral therapy provision
Malawi through the Ministry of Health first started to provide antiretroviral therapy in 2001 in 
the two major tertiary facilities in Blantyre and Lilongwe. ART was provided at a heavily 
government subsidised cost of $30 per month (Hosseinipour et al. 2006). By the end of 
2002, about 1400 patients had been started on ART in three government and mission health 
facilities (Chimzizi et al., 2003).
The experience of providing ART free of charge started with Medecins Sans Frontieres 
(MSF) working closely with the Ministry of Health in 2001 in Chiradzulu district and also in 
Thyolo district in 2003 (Fenradini et al 2006; Zachariah et al., 2007). At the beginning of
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2004, over 4000 patients had ever started ART in both the public and private sector 
(Chimzizi et al., 2004; Harries et al.t 2006).
In 2003, the World Health Organisation initiated the “3 by 5” initiative with the aim of 
ensuring treatment for three million people by the year 2005 in low and middle income 
countries (WHO, 2003). In June 2005, an interim report showed that globally only 1 million 
of the 6 million people in need of ART were actually receiving it, with most of the 
beneficiaries being from middle-income countries. The report concluded that the 3 by 5 
programme would not achieve its goal (WHO, 2005).
Malawi, following the 3 by 5 initiative, embarked on an ambitious plan to rapidly expand 
treatment with support from the Global Fund against Tuberculosis, HIV/AIDS and Malaria 
(MoH 2004). This led to the development of “The two year plan to scale up ART" with the 
goal of providing free ART at the point of delivery to 80, 000 patients by the end of the year 
2005 using a public health approach as advocated by WHO in resource poor countries 
(MoH, 2004; WHO, 2006; Harries et al., 2004). The goal of the ART scale up plan was 
reducing mortality and morbidity of HIV in adults and children by providing long term ARV 
therapy to eligible patients with individual drug adherence levels of 95% for the patients. The 
ART scale up was based on the lessons and experiences from managing the tuberculosis 
“directly observed treatment, short course" (DOTS) strategy (Harries et al., 2002; Harries et 
al., 2004; Libamba et al., 2005). These include standard eligibility criteria for starting 
treatment and a reliable consistent system for registering cases and monitoring and 
evaluation of treatment outcomes. Malawi adopted a generic fixed dose combination 
therapy of stavudine, lamivudine and nevirapine as the first line ARV regimen. Alternative 
regimens are available in case of side effects and a second line regimen in the occurrence 
of failure of the first line regimen (MoH, 2008).
The Malawi ART programme using the public health approach with intention to minimise the 
threat of drug resistance and realise more benefits for people in need of treatment was 
additionally informed by early experiences and lessons of ART provision in Thyolo and 
Chiradzulu district by MSF (Harries et al., 2002).
Following on the progress of the two year plan to scale up treatment, a new five-year plan 
was developed to guide scale up from 2006 - 2010 (MoH, 2005) in line with the global 
“Universal Access” goal. However, realising that Malawi would not have the capacity nor the 
resources to achieve “universal access”, Malawi aimed to place at least 45,000 patients
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every year from the year 2008, which translated into reaching 50% universal access with the 
aim of reaching a total of 245,000 patients by the end of 2010 (ibid).
3.1.5 Description of the Malawi ART programme
The minimum staff requirement when running an ART clinic is one clinician, one nurse and 
one clerk (MoH, 2006). ARV initiation, prescription and follow up can be provided by medical 
officers, clinical officers, medical assistants and nurses provided they fulfill the necessary 
training and certification for provision of medical care and ART.
According to the ART guidelines, for a person to be eligible for ART, he/she must be HIV 
sero-positive, understand the implications of ART, and be assessed as WHO clinical 
stage 3 or 4 or have a CD4-lymphocyte count of less than 200 per pL (MoH, 2006).
Figure 4 presents the pathway for identifying ART eligibility and pathway to initiating ART. 
The CD4 count test is not mandatory as it is not available in most sites initiating patients 
on ART; therefore assessment for ART eligibility is mainly dependent on clinical 
diagnosis. As of September 2009, 76% of patients ever started on ART were initiated 
because of clinical stage 3 and 4 (MoH, 2009). There has been an increasing number of 
people initiating ART due to low CD4 count, from 10% in 2005 to 22% in 2009, as more 
clinics are having CD4 machines (54 sites in 2010) (MoH, 2009; MOH, 2010; Harries et 
al., 2006). Patients are encouraged to select a guardian, who will support them with 
treatment adherence.
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Figure 4: Steps in the referral to and screening at the ART clinic
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Source: Adapted from MoH 2008 treatment guidelines
Once a person is eligible for treatment, he/she is given a two week starter pack of the ART 
drug formula to allow a formal nevirapine lead-in phase (van Oosterhout et al. 2007). Adult 
patients on treatment are given a dose of one tablet twice a day of a fixed combination of 
stavudine, lamivudine and nevirapine. The choice of the first line ARV regimen was because 
of availability of fixed dose combinations, cost of drugs and no or minimal requirement for 
laboratory monitoring (Beadles et al., 2009; Harries et al., 2006; Harries et al., 2004). 
Alternative ARV drugs are available for patients with side effects. Efavirenz for patients with 
clinical hepatitis and severe rash caused by nevirapine; zidovudine for patients with 
peripheral neuropathy (PN), lactic acidosis or pancreatitis caused by stavudine.
The World Health Organisation has revised the treatment guidelines (WHO, 2009). The new 
guidelines advocatefor safer regimens with less side effects and have increased the 
threshold for initiation of therapy from 200 per pL to 350 per pL. Malawi recently adopted the 
new guidelines and is in the process of phasing out stavudine from the first line regimen,
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however, availability of resources is delaying this switch (UNAIDS /WHO, 2011). Apart from 
increasing the threshold for ART initiation, the revised guidelines in Malawi are promoting 
universal ART to pregnant women and children under 24 months (MoH, 2011).
The ART facilities are classified into several categories depending on their capacity with 
respect to the number of patients they can manage to enrol. Health facilities are classified 
as low-burden, medium-burden or high-burden sites. The low burden sites recruit 25 new 
patients to start ART per month, the medium - burden sites initiate 50 new patients per 
month and the high-burden and very high-burden sites start 150 new patients and 250 new 
patients respectively per month. The classification allows the development of a simplified 
process for procurement and distribution of ART as it enables estimations of the drugs 
required and ensure that ARV drugs stock outs are minimised (Harries et al., 2006; Harries 
et al. 2007). Health facilities performance is assessed and those performing well are offered 
the chance to increase their ceiling.
To monitor the progress of the ART programme, ARV cohort analysis and cumulative ARV 
analysis are performed on a quarterly basis using the routine data from the patient treatment 
master cards and ART registers (Libamba et al. 2006; MoH, 2003). Patients are monitored 
according to standard primary outcomes (alive, dead, lost to follow up, stopped treatment 
and transferred out); secondary outcomes are also monitored including the ability to walk at 
home unaided, to work, side effects and drug adherence by pill count). This information is 
collected through the patient master cards and the ART registers. The information is then 
used for quarterly cohort analysis and cumulative ARV analysis. Quarterly supervisory, 
mentorship and monitoring visits are conducted by Ministry of Health in conjunction with key 
partners. During such visits, data from the master cards and the patient treatment registers 
are systematically collected and used for national quarterly cohort and cumulative analysis 
of ART access (Libamba et al. 2006; Lowrance et al. 2007; Makombe et al. 2006).
3.1.6 Access to Antiretroviral Therapy
The number of people who have ever started treatment since the beginning of the ART 
roll out has rapidly increased: from only 4,000 patients to have ever accessed ART in 
early 2004, to close to over 345,000 patients by the end of 2010 (Chimzizi et al., 2005;
MoH, 2010). The national target was to reach 80,000 people ever started on ART by the 
end of 2005 in line with the WHO 3 by 5 campaigns (MoH, 2004). However by the end of 
2005, only 37,840 were on treatment: by far short of the goal that had been set (Libamba 
et al. 2007). In 2006, Malawi set a universal access target to reach 200,000 patients by
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the end of 2010. By the end of 2009, the number of patients ever started on ART 
surpassed the national universal coverage goal by 36% (MoH, 2005; MoH, 2009). Figure 
5 shows the trend in increase in number of patients ever started on ART by gender.
Figure 5: Showing the progress of number of people ever registered on ART by 
gender.
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According to the HIV global report, Malawi achieved coverage of 72% using the CD4 less 
than 200 eligibility criteria, but with the revised WHO eligibility criteria of CD4 350, 
coverage was estimated at 48% in 2009 (UNAIDS, 2010). By the end of December 2010, 
the number of patients ever initiated on ART increased to 345,598 patients (MoH,
2010).
3.1.7 Who is accessing ART?
From the time when ART began to be provided free in the public sites, consistently more 
women have accessed treatment than men with an approximate ratio of 4:6 (Libamba et 
al. 2006; Lowrance et al. 2007; Makombe et al. 2006). This is in contrast with ART 
access by gender during the fee paying period, where slightly more males were 
accessing treatment than females. An analysis of ART access by age and gender in 5
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districts in Malawi in 2006 showed that in the young age group (0-12 years), access is 
similar between male, and females. However from the age 13, more females than males 
access ART, and the difference is more marked amongst those aged 25-34, which is 
reflective of higher female positivity in this age-group (WHO, 2010).
The number of children accessing ART has remained low due to particular challenges in 
ART delivery in this group which include health workers with specialized training in 
paediatric ART delivery and challenges in early infant diagnosis.
3.1.7.1 ART access by occupation
The ART data from 2005 and 2006 shows that farmers and housewives were the most 
common occupations of patients accessing ART as illustrated in Figure 6 (MOH, 2006).
Figure 6: Showing Access to ART by occupation
Year 2006
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Source: MOH, 2006
The Ministry of Health, in keeping in line with the principles of promoting equity in access 
to ART, has analysed access groups deemed ‘essential human resources in key front­
line services’ which includes the police, defence force, health workers, teachers.
Defence force: By the end of December 2006, 0.7% (546 army personnel) of the total 82, 
297 patients ever started on ART (for whom information on occupation was available in 
the public and private sector) were from the defence force. The army personnel differed 
from the general population as more males started on ART than females and more
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patients were also started in WHO clinical stage 1 and 2 with a low CD4 count as they 
have good access to laboratories (Banda et al., 2008).
Teachers: Among 72,328 patients ever started on ART in the public and the private 
sector by the end of September 2006, (for whom information on occupation was 
available) 3.7% (2643 patients) were teachers (Makombe et al. 2007). Of these, 57.9% 
were female. Makombe et al. observed that the number of teachers on ART increased 
rapidly with the free ART national scale up programme.
Health workers: The analysis of health workers’ access to ART two years after Malawi 
started ART scale up showed that among the 59, 581 patients accessing treatment, health 
workers represented 2% of all patients (Makombe et al., 2007). Health workers were more 
likely to start treatment at earlier stages of HIV infection. The assessment estimated that 
250 health-care workers’ lives were saved 12 months after ART initiation. Their combined 
work-time of more than 1000 staff-days per week was equivalent to the human resources 
required to provide ART at the national level at the time of the assessment (ibid.).
3.1.8 Outcomes of patients on ART
The success and quality of a health programme are measured through its outcomes 
(Cowing et al 2009; Corrigan et al., 2001). In districts pioneering ART in Malawi, 
immunological and virologicai treatment outcomes were similar to those in other developing 
and developed countries and showed the clear benefits and effectiveness of a simplified 
approach and a fixed-dose combination drug (Ferradini et al. 2006; Harries et al. 2004).
Standardized treatment outcomes are used for monitoring and evaluating the outcomes of 
patients on ART (MoH, 2006). The treatment outcomes are recorded on the master cards 
and the ART registers. A cohort analysis is then performed every three months on the most 
recent 3-month cohort of patients registered on ART and on the cumulative patients ever 
started on ARV treatment (ibid). Table 3 shows the definitions of the treatment outcomes.
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Table 3: Standardised treatment outcome
Outcome Definition
Alive and on ART A patient who is alive and on ART at the facility where he/she
registered
Dead Patient who dies for any reason while on ART
Defaulted Patient who has not attended the ART clinic for 3 months or longer for
no known reason
Stopped Patient who stops treatment for any reason during the course of the
treatment
Transferred out Patient who has been permanently transferred out to another treatment
facility
Source; Makombe et al. 2007; MoH ART guidelines 2008
The cumulative analysis of all patients ever started on ART showed that by the end of 2009, 
73% of all the patients who had ever started ART were alive and continuing on ART, 10% 
had died, 13% were lost to follow up and less than 1% had their treatment stopped by their 
clinicians. Most of the patients reported to be lost to follow up have actually died. A study in 
the northern region of the country showed that about 50% of the patients who were 
registered as lost to follow up had actually died (Yu et al., 2007). The national trend of 
patients lost to follow up has remained within 8-10% from 2004 - 2007, but the rates in 
specific districts varied from between 5% to 19% (Macro International Inc. 2009).
A major concern for ART programmes has been high early mortality of patients initiating 
treatment. MoH reports that in 2005, about 15% of new patients died within the first 3 
months of ART initiation. A study in Thyolo district among patients initiating treatment in 
primary health centres also showed high early mortality, as more than 7 of every 10 deaths 
reported occurred within the first three months of treatment (Zachariah et al., 2009). As ART 
services are becoming more available, early deaths on ART are minimizing. Among all 
patients who initiated ART in the fourth quarter of 2009, only 5% died within the first three 
months of initiating treatment (MoH, 2010). Quarterly rates of ART deaths have decreased 
from 3.7% in 2005 to around 1% in 2009 (MoH 2010).
A twelve months’ survival analysis conducted amongst patients who had initiated treatment 
in the last quarter of 2004, showed 63% of the patients were alive and on ART (MoH, 2006).
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A comparison with a 12-month survival analysis of patients recruited in the fourth quarter of 
2008 showed an improved survival rate of 79% of patients who were alive and retained on 
ART (MoH, 2009). A 48 month survival analysis of a cohort recruited in 2004 showed that 
55% of the patients are still alive and on ART (MoH, 2009). This demonstrates improvement 
in long term treatment outcomes overtime of patients on ART (ibid.).
Retention of patients may vary dependent on the level of the health facilities. Analysis of 
treatment retention in Thyolo, a rural district in Malawi implementing ART scale out with 
support from MSF, from June 2006 to June 2007, found that patients initiating treatment in 
peripheral health centres had a higher retention rate than those at the district level 
(Massaquoi et al., 2009). The loss to follow up rate was significantly higher at the hospital 
level (9.9%) than at the health centre level (1.5%) which might be related to better 
geographical access at the primary level (Massaquoi et al. 2009).
Treatment outcomes also vary by socio-economic status. A long term follow up (30 months) 
of patients registered for ART at one of the central hospitals in Malawi found females had 
higher survival rates than males (Chen et al., 2008). Males initiated ART at a more 
advanced stage of ART and therefore suffered from a higher mortality. Similarly, women 
also showed better treatment compliance than men.
Studies have reported ART benefits which show population level effect on reduced mortality 
attributable to HIV and AIDS (Floyd et al., 2010; Jahn et al., 2008). A study in a rural 
northern district of Malawi measured the impact of ART on adult mortality. The study used a 
demographic surveillance system over a number years from 2002 to August 2006, 8 months 
after the opening of an ART site in the study area. The results showed a 10% reduction in 
the mortality rate of adults between 15-59 year age group and in populations near the main 
road (with higher HIV related mortality) mortality was reduced by 35% (Jahn et al. 2008). 
While, there is reduction in mortality and ART access is increasing, clinical needs of 
PLWHIV still require availability of of home based care as a lot of patients who need ART 
have not yet accessed it (Bowie et al., 2010). The study found that the number of new 
patients seeking HBC services had only decreased by 8% over a six year period from 2003 
to 2008, and about half of the eligible patients for ART did not have access to ART. This 
signals that despite ART being available, there are still overwhelming challenges that 
patients face.
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3.1.9 Challenges facing the Malawi ART programme
3.1.9.1 Shortage of skilled health workers
Malawi is one of the countries in Africa with critical human resource shortages. In 2004,
15 out of 26 districts had less than 1.5 nurses per facility and about 38% of the health 
worker posts in MoH and CHAM facilities were vacant (Me coy et al., 2008; Muula et al., 
2007). The reasons for health worker attrition include low salaries, poor working 
conditions, lack of incentives, migration to the NGO sector within Malawi and international 
migration. Apart from migration, death mainly due to HIV and AIDS is a contributor 
towards the health worker shortage in the high prevalence countries including Malawi.
(WHO 2006; Muula and Maseko, 2005; Feeley, 2006). In Malawi, a study in 1999 found 
an annual death rate amongst health workers of 2%, with AIDS and tuberculosis being 
the common causes of death (Harries et al, 2002).
The Emergency Human Resource Programme (EHRP) planned to address the health 
worker shortage crisis by (amongst its strategies) expanding local training of health workers, 
incentivising health workers through recruitment and retention through a salary top up and 
using international doctor volunteers as a stop gap (Palmer, 2006). This has increased the 
ratio of health workers per population which is estimated now at 1.44 health workers per 
1000 population. According to the Ministry of Health, the number of nurses increased from 
3,456 in 2004 to 4,812, representing a 39% increase and a ratio of 36.8 per 100,000 
population, while the physician population increased from just 45 in 2004 to 265 in 2009, 
representing a 516% increase and a physician population ratio of 2.03 per 100,000 
population (MoH, 2010). While the health worker indicators have improved as more and 
more people are accessing ART, the demand on human resources is also increasing. By the 
end of 2009 there were 35 sites with patients between 2,001-5,000 and 11 sites with over 
5,000 patients registered. On average, a total of 2.7 working days per facility in a week were 
being spent on ART, an equivalent of 151 clinicians working full-time in ART delivery each 
week (MoH, 2010). To expand and sustain the HIV programmes, there is still demand to 
continue to substantially increase the number of health workers.
As has been promoted by the World Health Organisation, Malawi has depended on task 
shifting as a strategy for decentralisation of ART services (WHO, 2008; MoH, 2006). The
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Ministry of Health guidelines allow non-physician clinicians and nurses to initiate ART. HIV 
testing and counselling was shifted from trained nurses to Health Surveillance Assistants 
who follow a 10-week basic training. The HSAs further receive a three week training to be 
certified by the MoH to conduct HTC. Shifting of HIV testing to community health workers 
saw a five-fold increase in uptake of HIV testing in one district in Malawi (Bemelmans et al., 
2010). The experience in Thyolo district has shown that with task shifting, it is feasible to 
reach universal access. In the district, in addition to two hospitals, ART initiation has been 
decentralized to seven peripheral health centres and a total of 21 sites (two hospitals, 14 
Health Centres, five Improved Health Posts) provide follow-up ART care after the initiation 
period. In the district, ART initiation is conducted by the clinical officer, medical assistant or 
a nurse; ART follow up and management of opportunistic infections is by the nurse or the 
medical assistant; dispensing of ART is by the nurse or HSA; defaulter tracing and support 
group activities of PLWHIV is by the nurse and PLWHIV. This model of service provision 
has enabled Thyolo district to achieve universal ART coverage (Bemelmans et al., 2010).
3.1.9.2 Limited infrastructure
While there have been concerns both from within and outside the country of the need to use 
advanced laboratory technology for immunological and virological monitoring of patients, the 
DART trial showed that ART monitoring for the first regimen can be managed without 
laboratory monitoring (DART trial team, 2010). In Malawi, most health facilities lack basic 
laboratory services and there are limited laboratory personnel. As such, it was argued that 
advanced laboratory technology would weaken the general laboratory service delivery 
(Ferradini et al.2006; Harries et al.,2006). Therefore ART expansion in Malawi has 
depended on clinical monitoring as per WHO guidelines which emphasise the importance of 
virological monitoring and the need for its wider use but that in the absence of its availability, 
ART programmes expansion should not be hindered (WHO). However, ART facilities which 
serve as ‘centres of excellence’ perform laboratory monitoring and record additional data on 
viral loads and CD4 counts (Harries et al., 2008).
Lack of laboratory monitoring has its own disadvantages. First, it means that using clinical 
assessment, patients in WHO stage 1 and 2 (though they might be severely immune 
compromised) would not receive treatment. Secondly, viral resistance and toxicities might 
not or be recognised at a late stage (Harries et al. 2008). Virological failure rates are 
estimated at 25% in the first year of ART therapy, however, due to the mechanisms used for
85
monitoring patients in resource poor settings, programmes are unable to recognise them 
(Braitsten et al. 2006). Assessment conducted at the Lighthouse Trust, ‘a WHO centre of 
excellence’, showed that one third of the patients on ART showed signs suggestive of 
peripheral neuropathy (PN); but this was challenging to ascertain as there has been no 
validation of the clinical diagnosis of PN and there is no proper grading system to direct 
clinicians on the best time to switch to an alternative therapy (Beadles et al., 2009).
It is therefore evident that while the ART programme has expanded with minimal reliance on 
laboratory diagnosis and monitoring, the need to strengthen the laboratory infrastructure has 
to be emphasised to improve quality of ART services and early identification of treatment 
failures.
3.2 Case study analysis of the Malawi HIV situation
The following section will present an analysis of different studies conducted in Malawi on 
HIV and AIDS prevention, treatment, care and support in order to present a review of 
studies of the HIV and ART situation in which to situate the discussion of the current study 
(PhD findings). The analysis will draw mainly from studies where I have played a significant 
role as the lead researcher or a member of the study team and was involved in the analysis 
of the data. However, in order to present a more holistic picture, I will also draw from the 
wider literature on HIV treatment in Malawi. These studies have been presented in Table 4 
below. The studies have been conducted over a number of years starting from 2003 to 
2010, in different districts in Malawi and have used different methodological approaches 
both qualitative and quantitative. The methods have ranged from in-depth qualitative 
interviews, key informant interviews, critical incidence narratives, focus group discussions, 
observations, mapping using Geographical Information Systems (GIS), structured interviews 
and analysis and review of routine information such as clinic patient registers. The 
participants in the studies have also varied from HIV positive patients, general community 
members (men, women, girls and boys), health workers, patients on ART who interrupt 
treatment, caregivers/patient guardians, and health providers.
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3.2.1 Aim of case study analysis
The aim of this case study analysis is to:
1. Synthesise findings from diverse studies on HIV in Malawi in order to situate 
and discuss the PhD findings.
2. Critically discuss key issues identified in the literature review which influence 
health care access and explore how these play out in the Malawian context.
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3.2.2 Method for identifying key themes within the case study
The studies selected in this case study derive from research aimed at understanding and
promoting equitable access of HIV and AIDS services, focusing on ART delivery from the 
community, patient and health system perspective. Most of the studies were operational 
research studies. Operational research tends to be holistic in nature as it aims to identify 
how health systems are functioning with the aim of improving performance (Theobald et al., 
2009). I developed a framework for mapping the key issues in the different studies which 
was then used to identify the common themes emerging across time, geographical areas, 
and respondent groups. The case study therefore includes experiences reported by local 
community members and leaders, patients, health workers and also draw from policy 
makers.
From the review and mapping process, I identified five major themes that seem to be 
recurring in most of the studies and that seem to influence who, when, where and how 
utilization of HIV services impact on people’s livelihoods, relationships and social networks. 
The themes include poverty, gender, geography, stigma and discrimination and 
interpretation of illness. These issues are cross cutting and continuously manifest 
themselves in the community and patient’s interaction and experiences with the health 
system as was also shown in Chapter 1 of this thesis (Posse et al., 2008; Buor, 2003; 
Kunihira 2010; Chileshe et a!., 2010; Harden et al 2007). In addition, the studies also show 
how these factors interplay within a health system which is crippled by inadequate 
resources, congestion and health workers who themselves are infected or affected by HIV 
(Hardon et al., 2007; Obua et al., 2011; Fredlund and Nash 2007; Dieleman et al., 2007, 
WHO 2006). These factors interrelate to influence how, where and why health care is 
sought and may either facilitate or hinder timely care seeking and diagnosis of HIV, and in 
determining whether patients will adhere or interrupt their treatment. The factors also 
determine how the health system responds or is non-responsive to patient needs. The 
findings for each theme and its impact is presented in detail below.
3.2.3 Poverty
In a country where about two thirds of the population is poor, the impact of poverty on health 
care access is a critical component to consider. The time range of the studies under review
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allows a temporal analysis on the impact of poverty in accessing and adhering to ART 
through the different payment systems: Firstly through the partial government subsidy where 
patients were supposed to contribute financially towards treatment, and secondly, through 
free treatment provision at point of delivery. The key insights from the patient contribution 
are from studies 1-2 which clearly showed that paying for ART was a huge barrier to 
accessing and adhering to ART (Makwiza et al. 2003; Makwiza et al. 2005; Weigel 2009). 
During study 1, the direct and indirect costs of accessing and adhering to ART were high 
which enabled mostly only those who were non poor to be able to access treatment. The 
direct costs of treatment included the cost of ARV drugs and laboratory tests for CD4 count 
tests. In-direct costs such as travel costs which were also high as there were very few ART 
sites nationally. As such, most patients travelled from far away places and districts to access 
ART which meant that some patients also had to pay for accommodation costs. Patients 
reported that the costs of treatment had impacted on their households as they also had to 
pay for house rents, provide for their families, pay school fees and take care of other 
dependants and extended family, as is common in Malawian culture. Study 2 highlighted 
that high costs of ART was a demotivator for most families to access HIV testing services 
even when parents knew their likelihood of testing HIV positive were high because their 
children had been diagnosed to be living with HIV/AIDS (Makwiza et al. 2005). It became 
clear that many children and adults living with HIV were unable to access ART due to cost 
prior to the policy change to make ART free of charge. Other studies during this period have 
shown that despite government heavily subsidizing the cost, there was a high defaulter rate 
amongst those who had started treatment with a loss to follow up rate of up to 59% as 
patients could no longer afford treatment (van Oosterhout et al., 2005; van Oosterhout 2007; 
Hosseinipour et al., 2006).
Despite government policy change to make ART free of charge at the point of delivery, 
poverty has continued to negatively affect patient’s ART access and adherence. The 
repeated need for transport money to adhere to treatment and the need for a healthy diet 
were shown to be major concerns and challenges in studies 3, 4, 7,10, 12, 14. 
(Chikaphupha et al., 2008; Nyirenda et al., 2007; Chilipaine-Banda et al., 2010; WHO 2010; 
Namakhoma et al., 2010; Chibambo et al., Chikaphupha et al., 2010 ). Rural populations 
face greater challenges as the further away from the health facilities they live, the more 
money they might need for ART relative to their wealth. The findings of study 8 conducted in
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two districts in Malawi showed there were great inequities among the poor and non poor in 
accessing treatment with ART services favouring the richest groups. People in the poorest 
20% wealth quintile were found to incur higher transport costs (mean cost=MK3521 for a 
single visit to the ART clinic) in comparison to the richest 20% (mean cost= MK301) 
(Chilipaine-Banda 2010). HIV and AIDS causes an economic shock on the household 
(Masanjala et .al. 2007); anxiety about adherence for patients starts very early even though 
they know the treatment will benefit them as presented in the following quotation:
Imagine this is just my first month but I'm already tired. I’m supposed to foot 
transport costs for two people whenever we come here [one being his guardian].
Now I wonder that if things will continue to be like this in future am I going to adhere 
to the drugs” (C\M with man on ART in Thyolo district) (Nyirenda et al. 2007).
Amongst those who default or interrupt treatment, poverty played a significant contributing 
factor (Chibambo et al., 2010; Chikaphupha 2008; Nyirenda et al. 2007).
“/ would say that problems of means of transportation from my home to Lighthouse 
were what prompted me to stop taking the drugs as due to lack of money / could not 
make it to the hospital. But I it was a tough decision to make because I still had the 
wish to continue taking these drugs until I got better” (CIN with a male patient who 
had stopped treatment, Lighthouse Clinic)
“We always have problems to find transport to come to the hospital, we come from 
long distances for example I have spent K400 for me to get to this place, which is 
K800 to and from; so most people have problems to find money for transport as 
patients ... we have sold many things like blankets for us to get money to support 
ourselves” (CIN with a male patient who had missed treatment doses - Lighthouse 
Clinic)
Health workers are considered to be better off because of their stable employment and 
better access to good nutrition and have an advantage because they work within the health 
system. However, transport problems and limited ability to afford proper nutrition, particularly 
in times of sickness, were common challenges amongst those on ART. Most health workers 
who were working in rural areas had to travel long distances to get their treatment 
(Namakhoma et al., 2010). The challenges faced by health workers and other civil servants
J MK 149=$1
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living with HIV forced the government to introduce an allowance for all civil servants living 
with HIV which later was revised to provision of nutrition supplements.
Due to long episodes of illness before accessing ART, patients lost their means of earning 
an income (loss of jobs and failure to run their small businesses if self employed). This was 
commonly reported, particularly among patients who were in informal employment or ran 
small scale businesses, which plunged poor households into deeper poverty (Chikaphupha 
et al. 2008). Prolonged sickness meant that patients were unable to cultivate and as such 
experienced food shortages leading to treatment interruption as some believed they could 
not take their medication on an empty stomach (Chibambo et al. 2010; Nyirenda 2007). 
Opportunity costs are high if a patient is admitted to hospital, as they require a guardian to 
be resident at the facility, who might have left children at home; are unable to work in their 
gardens or are unable to do business, amongst others. This was particularly challenging for 
caregivers with children in the Nutrition Rehabilitation Units (NRU) where patients are 
admitted for relatively long periods of time (Fergusson et al. 2010; Chikaphupha et al., 
2006). Poverty among the NRU clients in study 11 resulted in a lack of financial and material 
support to enable them to stay comfortably at the NRU and, in some cases led to caregivers 
abandoning treatment. Despite the fact that ARVs and some of the essential health services 
are provided free, in mission health facilities, there are still other services which patients can 
only access at a fee. In study 11, treatment costs were a challenge where carers had to pay 
for other drugs not included in the free services if a child caught an illness while at the NRU. 
In the same way, in CHAM facilities some treatments for opportunistic infections are 
provided at a fee for PLWHIV.
Poverty coupled with a lack of social support, or perceptions of better health after stabilizing 
on ART (and the desire to escape health seeking financial burdens) caused patients to 
interrupt treatment. In some instances, patients reported missing some doses to make the 
ARV drugs last longer (Makwiza 2003). Studies 3 and 4 showed that free ART and the start 
of the decentralisation of ART services had addressed some of the challenges but not all, 
and that transport and opportunity costs were still high for patients (Nyirenda et al., 2007; 
Chikaphupha et al. 2008; Chibambo et al., 2010; Zachariah et al. 2009; Zachariah et al., 
2006).
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However, the positive effect of ART was experienced by many patients with more patients 
returning to their normal productive work including paid work and business.
3.2.4 Geography
Geography strongly interrelates with poverty to determine who has access to ART. Studies 
4, 5, 6 and 7 showed that access was higher in more urbanised areas and in areas closer to 
ART sites, A sentinel analysis conducted in Thyolo district, which was the first district to 
decentralize ART to the primary care level showed that the highest numbers of ART clients 
came from the more urbanized TAs - Chimaiiro (on the road to Blantyre - Malawi’s biggest 
city); Nchilamwera (the site of the district hospital and the two main trading centres - Thyolo 
and Luchenza and Bvumbwe) Makwiza et al. 2005. This was indicative of more people from 
semi-urban areas accessing ART (ibid.). Health facilities providing ART tend to be located in 
more urbanised areas as such rural populations have a distance barrier to access HIV 
treatment and information (Ntata et al., 2007). ART roll out was based on the readiness of 
the site and therefore the major health facilities were more likely to meet this readiness 
criteria. According to study 5, by the end of 2004 only 12 out of 28 districts had at least one 
ART site, however, Lilongwe which is the capital city of Malawi had five sites during that 
same period. Study 5 also demonstrated that the availability of ART was not according to 
need i.e. the HIV prevalence. For example while Lilongwe district has a lower prevalence 
rate, it had more ART sites than Blantyre which had a higher HIV prevalence but had only 
one ART site. Rapid decentralisation of the ART services addressed some of the distance 
related challenges, but not all (Makwiza et al., 2005). By 2006, all the districts had at least 
one ART site. Despite coverage of the districts, there was minimal decentralisation of 
services to primary health care centres which are closer to people. Over 65% of ail patients 
ever started ART had accessed from secondary level health facilities, 25% had accessed 
from tertiary level facilities and only 8.5% were accessing ART through primary level health 
facilities (Chilipaine-Banda et al. 2010; WHO 2010). Considering the fact that most 
government health facilities at secondary level of care are mainly located at district centers 
or town assemblies, this meant high cost implications for the majority of ART patients 
accessing treatment at this level of care.
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The spatial distribution of the HIV prevalence population compared to the ART site network 
in 2006 showed that there is a geographic inequity in terms of prevalence population 
coverage capacity in the country. The use of spatial mapping using geographical information 
system (GIS) demonstrated that the scaling up should mainly take place in the Southern and 
Central part of the country rather than the Northern region of Malawi due to high prevalence, 
despite the fact that Southern and Central are the regions where the higher density of ART 
sites is already observed (Ebener et al., 2009). Patients on ART are not equally distributed 
among the prevalence population with more patients coming from areas surrounding the 
ART sites. This finding concurs with the population level effect of ART in Karonga district, 
where the greatest reduction in mortality was more evident near the main road where 
access is easier (Jahn et al., 2008). The GIS mapping also showed that 98% of the 
coverage capacity of the ART care delivery system observed in 2006 would be reached with 
up to 4 hours of travel time (taking into account the different modes of transport commonly 
used by patients in Malawi - walking, own or borrowed bicycle, hired bicycle, own car, public 
transport and matola) if all the patients were to go to the nearest ART site (Ebener et al., 
2008; WHO 2010). The poor were most disadvantaged in distance and travel time to access 
ART as shown by an analysis into districts. The poorest 20% from the rural areas travel 
longer distances to get to the ART facility as compared with the poorest 20% from the urban 
areas (mean distance of 23.3 Km and 7.7 Km respectively) (Chilipaine et al. 2010; WHO 
2010). This translates into the poorest rural patients incurring higher costs and travelling 
longer distances to an ART site than the poorest 20% from the urban set up (mean transport 
cost of MK372 and MK160 respectively) and an average travel time of 111 minutes and 63.4 
minutes respectively. Poorer groups were more likely to walk to a facility, possibly because 
they do not have the money to spend while richer groups are more likely to use the public 
bus.
Long travel distances and high transport costs are a major contributor to patients defaulting 
treatment (Zachariah et al., 2006; Nyirenda et al., 2006; Chikaphupha et al., 2010; 
Zachariah et al., 2008).
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3.2.5 Gender
Access and adherence to ART and the multiple barriers faced by patients are influenced by 
gender roles, cultural values, norms and expectations, multiple responsibilities which are 
also shaped by gender and its interrelationship with poverty and stigma. There has been a 
transition in gender differences in ART access between the period ARVs were being 
provided at a cost, and when they became free in the public sector. Makwiza et al. (2005) 
found that patients enrolled in centres where ART was provided at a cost were more likely to 
enroll male patients or equal numbers of both sexes (Hosseinipour et al. 2006; Van 
Oosterhout et al. 2005, Muula et al. 2007, Makombe et al., 2006; Makwiza et al., 2009). With 
the introduction of free ART, there was a shift to more female patients, younger patients and 
also presentation at earlier stages of immune-suppression (Makwiza et al. 2005).
In terms of gender and age, the younger age groups (less than 40 years of age) tended to 
have more women in treatment than men, the 40-44 age group is where the percentage of 
men on ART was almost equal to that of women (Chilipaine-Banda et al., 2010; WHO 2010). 
Above 45 years, more men start to access ART than women. An overall comparison 
between access to ART and the population in need of ART by gender clearly showed 
relatively more women had ever started ART than men.
Gender influenced patient treatment outcomes in Malawi. Women show better treatment 
outcomes than men. An analysis of treatment outcomes for all patients who started ART in 
2006 showed that men were more at risk of dying and defaulting treatment as shown in 
Table 5 (Chilipaine-Banda et al. 2010).
Table 5: Overall differences in treatment outcomes by gender
Characteristic Male Female Odds Ratio Chi-square P-Value
Death rate (%) 10.4 8.5 1.25 9.12 0.003
Default rate (%) 6.5 5.7 1.15 3.09 0.078
Transfer rate (%) 6.7 10.8 1.27 12.64 <0.001
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Results in the table above show that the death rate was higher for men than for women 
(10.4% against 8.5%). An odds ratio of 1.25 indicates that men on ART are at 25% greater 
risk of dying compared to women (p-value^O.OOS). A comparison of the default rate between 
men and women on ART shows a slightly higher default rate for men as compared to 
women (6.5% against 5.7%). With an odds ratio of 1.15, men on ART are 1.15 times more 
likely to default as compared to women (p-vaiue= 0.078). Other studies have also shown 
poorer outcomes amongst men. The assessment of treatment outcomes amongst 2180 
teachers who had accessed ART by 2006 showed male teachers had a 73% increased 
probability of drop-out, and two-fold increase in mortality compared to female teachers 
(Makombe et al., 2006).
While higher access to treatment might be explained by the higher rates of HIV infection 
amongst women, study 4 found better knowledge of HIV/AIDS and ART amongst women 
than men. This is attributed to diverse avenues for getting information among women than 
men (Nyirenda et al., 2007). The gendered roles of women provided women with better 
access to knowledge and information about HIV and AIDS and ART. The role of women as 
carers for children and younger siblings was obvious in study 2 and 10, which resulted with 
women having more interaction and opportunities for HIV testing and ART information 
(Makwiza et al., 2005; Fergusson et al. 2010; Chikaphupha et al., 2006). Women have 
responsibility for taking children to the health facilities where in turn they are more exposed 
to health information and also become aware because of prevention of mother to child 
transmission programmes (PMTCT). Men, however, do not have as much contact with the 
health system and may result in limited opportunities to HIV testing.
Gender roles place more burden and responsibility on women. In most instances, the 
mother has the responsibility for deciding to take a child for HIV testing and treatment and to 
ensure that a child is adhering to treatment appointments and doses according to study 2 
(Makwiza et al., 2005). In study 10, some women felt that their husbands were not taking 
part in nursing their children (even when admitted in hospital) and were not providing moral 
support to the wives as shown in the illustrative quotes below by mothers admitted in the 
NRU with their children (Chikaphupha et al., 2006).
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“It is only my parents and my brother who agreed that I can come but on the part of 
my husband he is showing no interest to come and visit me; he just sends 
messages that he is very busy; that he cannot find time to come here and see me 
and the cMcL.” (In-depth interview with female carer)
"/ came to know that it was him who passed on the virus to me due to the fact that 
whenever I asked him to escort me to the hospital he was refusing. And when at last 
we managed to come together to the hospital, he actually ran away and left me 
alone." (In-depth interview with female carer).
Gender plays a pivotal role in determining risk of HIV infection and the likelihood of 
accessing an HIV test in study 6. Older men and women have low risk perception of HIV as 
they interpret HIV as a disease of the younger generation, and the women perceive their 
husbands not likely to be involved in multiple concurrent relationships and as such, do not 
prioritise the importance of an HIV test (Chilipaine-Banda et al., 2010). Female health 
workers mostly reported accessing an HIV test because of their partner's behaviour, illness 
death, or plans to have a child, whereas men were more likely to report having tested 
because of their own sexual behavior (Namakhoma et al., 2010).
Health workers attitudes seem to vary by gender. Male health workers were perceived by 
clients to be more respectful and helpful than female health workers particularly nurses 
(Chikaphupha et al., 2006). Women more commonly report poor health workers attitudes 
than men. According to study 11, among a total of 22 male and female patients who had 
been interviewed at the Lighthouse Clinic using in-depth interviews to understand why they 
had interrupted treatment, five females and no male patients mentioned health worker 
attitudes as one of the contributing factors (Chibambo et al. 2010).
3.2.6 Stigma and discrimination
Stigma and discrimination is a cross cutting issue and emanates from both the community 
and health system and presents a huge barrier to HIV services utilisation. Stigma and 
discrimination leads to non-disclosure of HIV status and affects patients’ adherence to 
treatment (Makwiza et al. 2003; Makwiza et al., 2005; Chikaphupha et al., 2008; Nyirenda et 
ai., 2007; Chilipaine- Banda 2010; WHO 2010; Namakhoma et al., 2010; Fergusson et al.,
101
2010; Chikaphupha et al., 2010; Chikaphupha et al., 2009). Name calling, backbiting, 
gossip, divorce/separation were commonly reported in most of the studies. While others had 
experienced actual stigma, for some patients on ART and those who had not had an HIV 
test, fear of stigma was common.
Study 3 showed that sometimes stigma can arise from guardians tiring of caring for a sick 
person with HIV and AIDS and end up ignoring or sometimes even locking them away so 
that they are kept away from people, as reported by Home Based Care (HBC) volunteers 
(Chikaphupha et al., 2008). Quarrels and misunderstandings between patients and 
guardians or spouses caused some patients to interrupt treatment feeling that death could 
save them from their hopeless situations, as summarized in the typical quotes below 
(Chikaphupha et al.,2007; Chibambo et al., 2010).
7 really wish I could be taking these drugs but my husband has made me an angry 
person; he is so temperamental about this HIV issue and I just can't take the drugs 
as things are right now because he is even not interested to take whatever I say if I 
say anything he storms on me and he brushes aside any thing I say... / have failed 
to do anything. What I have discovered is that he want to see me dying and I have 
actually lost my wish to take the drugs so that his wish should be fulfilled and he can 
be happy whether I will be the first one to die or it will be him I think his soul will be 
happy to see that I have also died”. (CIN with female patient who stopped treatment, 
Lilongwe)
7 used to have quarrels with my relatives that whenever I use water, they threw it 
away, so I decided to stop treatment because even though I was coming to get 
drugs, I wasn't taking them as they did not want me to use their cups and drinking 
water because I have HIV and AIDS...I wanted to die to prevent such situations” (In- 
depth interview with female patient who stopped on treatment)
It is not only the general population and ART patients who reported fear of stigma: amongst 
health workers, findings suggested that health workers found it difficult to access testing and 
counselling at their own facility (Namakhoma et al., 2010). Lack of confidentiality and fear of 
stigma were the most commonly cited responses as barriers that health workers face in 
general. In some cases, health workers resorted to self-testing or not testing at all. The 
study also showed that health workers feared providing care to people living with HIV and
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AIDS due to fear of occupational exposure and, in some instances, health workers were 
observed by their fellow workers as giving less care or attention to patients with HIV or those 
suspected of having HIV and AIDS. These sentiments were also reported among some 
carers of children in the NRUs who failed to disclose their HIV status to health workers for 
fear that the health workers will not maintain confidentiality (Chikaphupha et al., 2006). Fear 
of stigma keeps people even those who suspect themselves to be living with HIV in fear of 
accessing HIV testing services. Among home based care clients, half of the clients did not 
access ART due to barriers, refusal of an HIV test being the second most common factor for 
the refusal (Bowie et al., 2010).
3.2.6 Interpretation and meaning of illness
In Malawi, there are different belief systems on the causes of illness which also influences 
beliefs about appropriate treatment for illness. Most of the traditional causes of illness are 
believed to be a result of breaking taboos, disobedience to ancestors, or through witchcraft 
(Munthali, 2005; Bowa et al., 2005; Munthali 2006). A lot of diseases are attributed to sex 
and sexuality taboos. A study in Rumphi found that community members believed that a 
woman who is breastfeeding is not supposed to engage in sexual intercourse (Munthali 
2005). In the case that they do, it was believed semen moves around the body and 
ultimately contaminates the breastmilk which causes diarrhea in underfive children (ibid). 
Another study among caregivers in the southern region of Malawi revealed that reproductive 
tract illnesses locally known as ‘mauka’ (vaginal itching) were believed to cause fever in 
underfive children (Chibwana et al., 2009). A study in Kasungu district found that diseases 
such as coughing, diarrhoea, weight loss were associated with ‘mdulo’. ‘Mdulo’ is caused 
factors relating with non compliance of sexual restrictions or violations of certain traditions or 
taboos (Bowa et al. 2005). According to Bowa et al., these factors include for example
• If a husband has sexual contact with other women and comes and sleeps with his 
pregnant wife;
• If a girl has reached puberty, the parents are supposed to abstain from sex, but if 
one of the parents has sex outside the family then the initiate will have ‘mdulo’.
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• If a girl who has reached puberty, an initiate, pours salt in relish while menstruating, 
mdulo can affect those who have the relish.
• If one of the partners has sex outside the family before the process of ‘kuponya 
mwana kumphasa’ (a traditional ritual marking the resumption of sexual relationship 
after childbirth in a family).
In the study HIV and AIDS were perceived as ‘new kanyera’ (a part of the mdulo family) 
which occurs to a man who has sex with a woman who had aborted or is menstruating. 
Symptoms of ‘kanyera’ are similar those of HIV/AIDS (ibid). Diseases caused by ‘mdulo’ can 
only be cured using traditional medicine.
For illnesses caused by ancestors, it is believed that there is no cure, apart from the 
concerned people coming together and talking to the ancestors to appease them (Munthali,
2006) . Often these afflictions are seen to be as a result of the ancestors desire to see their 
descendants living peacefully as such fightings and quarrels do not please the ancestors 
who might react by afflicting the descendants with certain afflictions (ibid). The ancestors 
might also cause afflictions if their obligations or customs are not followed.
HIV and AIDS is also believed to be caused by witchcraft. Belief that HIV could be cured 
through medication provided by traditional healers, or through religious beliefs and prayers, 
improvement in health, or opportunistic infections such as those that patients were not 
familiar with led to ARV treatment interruption (Chikaphupha et al., 2008; Nyirenda et al.,
2007) . Beliefs around traditional medicine were stronger in some patients before they were 
diagnosed with HIV and they believed they had been bewitched, but attitudes changed after 
a hospital diagnosis of HIV. But for other patients, such beliefs persist, particularly if they 
see no improvement to their health or when they get an opportunistic infection they might 
not be familiar with e.g. Karposi Sarcoma. See the illustrative quote below:
"... the traditional healer explained every problem that I had and he told them that 
you should be giving this child these drugs from today onwards, you shouldn’t give 
her the drugs from the hospital. So when I stopped taking the drugs for 16 days I 
regained my strength and that’s what has made me to come back to Lighthouse, I 
did not want to stop the traditional medicine unless on instruction from the healer 
himself because I was feeling better just like any other person” (In-depth interview 
with a patient who had stopped treatment, Lighthouse clinic) (Chibambo et al., 2010).
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While different beliefs about causation of illness including HIV are evident, the bio- medical 
belief is wide in the communities that HIV is caused by a virus ‘kachirombo’ (Bowa et alM 
2005; Makwiza et al., 2003; Chikaphupha et aL, 2008). How patients and communities 
interpreted or understood the HIV/AIDS related conditions emerged as a key theme in many 
qualitative studies. Patients’ understanding of their illness, their perception, beliefs and 
interpretation determines how, where and when they should seek care. In turn, how patients 
interpret their illness is shaped by poverty, geography, stigma, gender cultural beliefs, 
education etc.
In the same way, treatment adherence is influenced by the level of understanding of the 
consequences of treatment interruption. In the early days of ART scale up it was evident 
that there was limited knowledge amongst general community members of ART, how it 
works and who needs it (Nyirenda et al. 2007; Makwiza et al., 2005). The general 
community members could not differentiate between HIV and AIDS and discordance 
amongst couples was a challenge for people to comprehend. Only those who are on ART or 
have a friend or a relative on ART seemed to have better knowledge of ART (Makwiza et al., 
2003; Makwiza et al., 2005; Nyirenda et al., 2007). Communities question why some people 
are started on ART and others not after testing positive for HIV, and some people continue 
to relate HIV with witchcraft (Ntata et al., 2006).
In the NRU, the level of education of carers was seen as a determinant for understanding 
health concepts and how HIV and malnutrition interlink (Chikaphupha et al., 2006). Those 
with no or limited education were seen to have difficulties in understanding the guidance and 
information provided by health workers. Some carers believed that non response to feeding 
at the NRU was equated to a child having HIV. Cultural beliefs such as that some symptoms 
related to malnutrition and HIV and AIDS are a result of the sexual immorality of the child’s 
father hampered appropriate health care seeking.
3.2.7 Gaps in knowledge about access to ART and adherence in Malawi
While the evidence discussed above clearly identifies the poverty, geography, gender, 
stigma and interpretation of illness as influencing patients’ experiences and equity in access
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to ART, there are stilt a number of gaps within these themes that need to be explored to 
provide a holistic understanding of equity in ART access and adherence. Most of the studies 
that have explored poverty as a barrier to access have been qualitative, only one study has 
quantified the cost of a return visit to refill ARV drugs from the health facility. Therefore, first 
it is not known whether patients who access ART are generally better off economically or 
not. Secondly the health care seeking behaviour and barriers to access and adherence have 
leaned more on qualitative approaches and no study has investigated the average number 
of visits that patients make from then they start seeking health care to the time that they 
access an HIV test and initiate ART. Thirdly, there is a gap in the direct and indirect costs 
that are incurred by patients in their health care seeking pathway. Fourthly, while the 
literature from the sub-Saharan African region in section 2.2.3.4, shows that pre-ART loss is 
a challenge, there is limited evidence in Malawi on the rate of loss to follow among patients 
deemed eligible for ART but who do not start treatment. Finally, it is not clear how socio­
economic factors, such as poverty, sex, areas of residence, costs affect attrition from care.
3.3 Implications of the themes identified for ART programmes
The studies above have illustrated the barriers and facilitators that different population 
groups including men, women, children, and health workers face in accessing HIV services. 
Gender, poverty, geography, stigma, discrimination and understanding of illness play a 
pivotal role for whether HIV programmes are successful or not. These factors also inter­
relate and are cross cutting: it might be possible for an individual to be affected by one or all 
of the challenges. The greater the barriers faced the more likely some people might be 
excluded from HIV treatment programmes. The factors identified contribute to patients’ late 
presentation for HTC and ART and for those on ART treatment, poor adherence and default, 
thereby raising fears of drug resistance development. Most people access HTC because of 
illness, with the majority of these being referred by the health workers, community home 
based care groups, relatives and at times, self referred. Patients and sometimes health 
system delays contribute to late referral and presentation for HIV testing and ART leading to 
high death rates within the first few months of starting treatment (Zachariah et al.2009; 
Zachariah et al., 2006; Brinkhof et al., 2009; MoH, 2006). Those who find the barriers 
insurmountable are excluded from ART access (WHO 2010).
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The fears surrounding HIV testing cause delay to access testing, the fear of a positive HIV 
test, the stigma attached to being positive and the possible loss of status that might follow a 
positive result are important reasons why testing is difficult for many people.
From the health system view, a number of factors pose challenges for access to HTC and 
ART. Inability to train and retain adequate health workers has led to huge health worker 
shortages. This is recognised as the main challenge to expanding treatment (Makwiza et al., 
2009; Chilipaine-Banda et al., 2010; WHO 2010; Palmer 2006; EQUINET SC, 2007). Long 
waiting periods for patients due to staff shortages at the health facility were common 
resulting in increased indirect and opportunity costs for clients (Nyirenda et al. 2007; 
Chikaphupha 2008). While overburdening staff impacts on the time that patients spend to 
get the services they require, Chikaphupha et al (2006) found that health workers are 
sometimes ‘lazy’ or do not plan their time properly. Clients claimed that while the health 
workers sometimes claimed to be busy, they could be seen sitting idly.
Health worker attitudes are also critical, with some clients feeling they are ill-treated and not 
treated with dignity by health workers. Favouritism and discrimination is evident among 
health workers (Makwiza et ai. 2003; Chikaphupha et al., 2006), where some clients get 
special treatment over others such as not queuing. However, there are also clear examples 
of good staff attitudes which motivate patients to access services and adhere to treatment 
(Makwiza et al 2003; Chikaphupha et al., 2008; Chikaphupha et al., 2006; Nyirenda et al., 
2007). Good staff attitudes were reinforced by a conducive work environment with 
availability of adequate resources for delivering quality health services.
In conclusion, the studies presented above illustrate that there is an inter-relationship 
between poverty, geography, gender, stigma, discrimination and interpretation of illness 
which influences the experience of HIV care seeking and treatment adherence in Malawi. It 
is apparent that people face multiple barriers and follow different pathways to access HIV 
and AIDS services. These barriers are evident both within the community and the health 
system, resulting in delayed access to treatment and treatment interruption.
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The studies are useful as they have employed multiple methods from qualitative to 
quantitative, collation and analysis of routine health information data and geographical 
information system data to present a wide variety of views of the key themes identified. They 
present analysis of issues: from the time when ARVs were being provided at a cost to when 
they became free of charge; and from when ART was very much centralised to ART 
becoming more decentralised and the changes that have taken place. Their analysis has 
taken into consideration different population groups and taken into perspective the views of 
multiple players from the community, patients on ARV, patients who have interrupted 
treatment, caregivers of children with malnutrition and HIV. Also important is the analysis 
through space, rural and urban areas, and different districts in Malawi. The key role and 
considerable involvement that I have played throughout these multiple studies enables me 
to critically re-analyse the issues, situate the conceptual framework for the research 
question under study in this thesis according to the experiences in Malawi and to frame the 
discussions in a holistic picture.
3.4 Deriving a conceptual framework for the study
The literature review in chapter 2 shows that the experience of patients’ HIV treatment is 
modelled on influence from three levels: the community, the individual and the health 
system. According to social constructionism, the nature of experiences of illness depends on 
how ideas about health and illness are shaped and are socially constructed and influenced 
by factors such as cultural beliefs, religious beliefs, gender and social class (Clarke, 2010). 
These factors play a role and influence the understanding of the explanatory concepts of the 
origin, condition, treatment and the possible outcome (Kleinman; 1980). Chapter 3, also 
showed how patients perceive their illness, its perceived seriousness and the symptoms that 
they experience determine the type of health care that will be sought from. As such, 
people’s experiences of illness and their illness behavior are influenced by the society in 
which they live. Therefore, the individual’s illness behavior in determining care seeking is the 
result of how the individual perceives the type and severity of symptoms, and the labels of 
etiologies by which his community defines the illness (Kleinman, 1980).
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Chapter 2 and 3 then demonstrate that the decisions to seek care for HIV and the provider 
to visit are influenced by gender, poverty, geography, the meaning of illness, stigma and 
discrimination. These factors interact with one another and affect the experience of care 
seeking at the individual, community and health system level.
Gender determines how the illness is interpreted and the urgency to seek care; decision 
making at the household level and authority over household resources for care seeking. 
Chapters 2 and 3 have shown that women are more likely to make contact with health 
services and therefore are more exposed to HIV treatment services, while men have high 
early mortality risk because they seek care at more advanced stages of illness. At the health 
system, the literature shows that there are more HIV services that target women than men.
Poverty - In situations where resources are scarce decisions have to be made over other 
equally urgent priorities such as meeting basic necessities. The choice of provider will be 
dependent on how affordable the health provider is. The literature shows that the health 
system in Malawi is heavily under-resourced. The health system is faced by constraints 
regarding a lack of critical resources such as health workers and inadequate resources to 
provide ART to all who might be in need of it resulting in insufficient provision of ART. This 
has led to an inaccessibility of ART for many people especially those in rural areas where 
health facilities are unable to provide HIV treatment. At the household level, choice of health 
care provider is based on how affordable the services are perceived. As most people in 
Malawi are poor, poverty affects timely health care seeking from formal health providers.
Geography - Distance is a common determinant of health care utilization. Rural residents 
often face the challenge of accessing health care, as usually, the location of health facilities 
is more favourable towards urban populations. Therefore, for the majority, availability and 
accessibility of health services is limited due to lack of good road networks and high 
transport costs resulting in high unaffordable transport costs. Geography is particularly 
important in ART services as decentralization of services is still limited.
Illness meaning - How people might understand and interpret their illness is influenced by 
society, and in terms of HIV and AIDS, also the level of health promotion on HIV treatment 
too. According to the diffusion model of innovation, health promotion might have a negative 
or positive effect depending on the level of acceptance or rejection of the innovation. In 
cases where acceptance of ART is low, perceptual barriers of treatment might be high.
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Stigma and discrimination have an impact on accessing health care services in the 
communities. Due to fear of stigma, people might delay accessing and HIV tests and this 
may also lead to the denial of test results. The health system might also perpetuate stigma 
among people living with HIV and AIDS through lack of privacy in providing services and 
also stigmatizing attitudes among health workers.
At the community level, these factors are mediated by cultural, religious and traditional 
beliefs, the norms of the society and the social capital available. At the individual or 
household level, these factors will be influenced by the community norms and beliefs as well 
as by factors affecting the household including economic resources, opportunity costs of 
care seeking, their illness behavior and the decision making to care seeking. The individual 
or household’s decision to seek care and from whom are affected by the availability of care 
providers, their accessibility, acceptability or affordability.
It should be recognized that for HIV treatment, there is a need to move beyond models of 
health care access which focus on a single one off encounter with the health system. 
Treatment requires multiple visits through time, and this requires an interrogation of the 
multiplicity of factors shaping access through time. Depending upon how the factors 
interplay at different stages, people drop off from the care seeking pathway resulting in 
fewer patients who access and adhere to treatment. The effectiveness of a treatment 
programme is through adherence and continued contact with the health system over time. 
The conceptual model derived is presented in Figure 7 below.
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Figure 7: Conceptual model for the study
Poverty Gender Stigma Geography Illness
meaning
Culture
Social
Traditional beliefs 
Religion beliefs 
Identities/norms 
Social capital
...
Urban/rural residence 
social status 
Economic resources 
Opportunity costs 
Social Costs 
Illness behaviour
Decision making
Availability of services 
Accessibility of services 
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|i 1 I
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Conclusion
The first section 3.1 of the chapter frames an understanding of HIV in Malawi, the structure 
of the ART programmes, its reach and challenges and successes. It explores the 
environment under which health facilities and health workers have to provide life saving 
drugs in a country which has experienced a massive HIV epidemic.
The second section has drawn from an analysis of multiple studies supported by other 
literature in Malawi and how patients have experienced access and adherence to HIV 
treatment programmes. This section pulled out five key themes which seem to play a 
crucial role in experiences of patients which included gender, poverty, geography, illness 
meaning and stigma and discrimination.
The third section has taken into consideration the literature review from the sub-Saharan 
Africa discussed in Chapter 2, the structure and performance of the Malawi ART programme 
from Section 3.1 and the patients’ experiences from studies reviewed in Section 3.2, to 
derive a conceptual framework to guide this study.
The next chapter, Chapter 4 will present the key questions that this study will address, the 
study design which combines a quantitative and qualitative approach.
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Chapter 4: Research Methodology 
4.0 Introduction
In this chapter, I present the objectives, study area, design and methods that I used in my 
research study. The aim of the study is to advance understanding of the facilitators, barriers 
and challenges that patients face in accessing and adhering to antiretroviral therapy in 
Malawi. As highlighted in Chapter 3, where I have presented an overview of the ART 
programme in Malawi and a summary of studies that I have been involved in, it is clear that 
there has been progress in expanding the ART treatment programme. However, patients’ 
experiences have drawn attention to the multiple barriers that they face in accessing and 
adhering to treatment. From the health system perspective, studies have shown that 
patients present themselves at advanced stages of illness, and that the health system itself 
is faced with a myriad of challenges which hinder effective delivery of health services.
According to the literature discussed in chapter 2 and 3, there is limited evidence that has 
systematically identified or explored the pathway for health care seeking for HIV and AIDS 
care and access to ART in Malawi and in the sub-Saharan African region. The high cost of 
care seeking, long travel distances, long waiting times at health providers, stigma and 
discrimination, poor communication among health providers and health clients, lack of food 
and poverty are commonly perceived as the major challenges to accessing and adhering to 
ART (Kunihira et al. 2010; Harden et al., 2007; Rosen et al., 2007; Chileshe et al., 2010; 
Boyer 2009). However, little information is known about where the patients shop for care, 
why they choose the providers they visit and the related direct and indirect costs of care 
seeking for their sickness. Studies have also shown that there is early mortality among 
patients during the early months of ART and in the pre-ART period (Lawn et al., 2010; 
Brinkhof et al., 2009; Braitstein et al., 2006). In Malawi, there is little documentation of the 
number of patients who are identified as being eligible for ART (according to the National 
ART guidelines) but who drop out from care before initiating treatment. While there are a 
few studies that have assessed attrition from ART due to death or loss to follow up, there 
has been limited exploration of whether the patient’s socio-economic status and health care 
seeking experiences interact with ART attrition (Bassett et al., 2009; Yu et al., 2007; 
Massaquoi et al., 2009; Chen et al., 2008).
The aim of the study is to assess if the socio-economic status of patients and their 
experiences of health care seeking influence access and adherence to ART.
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The objectives of my study therefore are:
1. To understand the health care seeking behaviour of patients from the time that they 
perceive themselves to be ill and in need of health attention to the time they are 
identified as eligible for ART treatment;
2. To understand the associated direct and indirect costs of care seeking and how 
these impact on different social economic groups such as the rural vs. the urban 
population, the poor and non poor, and also by gender;
3. To identify factors that contribute to why patients do not start treatment;
4. To identify factors that contribute to attrition from ART.
In Figure 8 I have presented an analytical framework for the study questions and process. 
The framework presents an overview of the key research questions and sub questions that I 
have explored in this study, the methods used in answering the research questions and the 
respondents who participated in answering the different research questions.
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4.1 Study area
Lilongwe is the capital city of Malawi and is located in the central region of Malawi (Figure 
9). It has a total population of 1,897,167 representing 14.6% of the Malawi population. About 
35% of the Lilongwe population resides in the city. There is a huge difference in the 
population density in the rural and city areas; while Lilongwe city has a population density of 
1,497 persons per square kilometre, the rural area has a density of 216 persons per square 
Kilometre. The city also has a higher number of females than males with a sex ratio of 104.7 
and the sex ratio in the rural Lilongwe area is 95.2.
Nationally, it is estimated that 52.4% of Malawians live below the poverty line. Poverty is 
more marked in the rural population where 55.9% of the population is poor compared to 
25.4% of the urban population. In Lilongwe district, 24.6% of the urban population is poor 
compared to the 37.5% of the rural population (IMS, NSO 2006). The Crude Birth Rate 
(CBR) is estimated at 39.4 per 1000 persons. Lilongwe city has better socio-economic and 
health indicators than the rural areas as shown in Table 6. Life expectancy in the city is 57 
years and in the rural areas it is estimated to be 43.8 years. Similarly, poverty and literacy 
levels are better amongst the urban (84%) population than in the rural areas (57%). The 
population based HIV prevalence is estimated at 10.3%, with prevalence higher amongst 
females (11.5%) than males (9.2%).
Table 6: Socio- economic indicators for Lilongwe City and rural areas______________
Indicator Lilongwe city Lilongwe rural Total
Sex ratio (percentage of females per
100 male)* 104.70% 95.20%
Crude birth rate (Per 1000 persons)* - - 39.4 per 1000
Total fertility rate * 4.9 6.6 5.8
Life expectancy (years)* 56.9 43.8 50.4
Crude death rate (Per 1000 persons)* 7.6 8.5 8.1
Poverty levels (%) ** 24.6% 37.5%
Literacy levels (%)* 84% 57%
HIV prevalence (%) *** 10.4%
Source: ‘Population census 2008, NSO, 2008; **IHS 2004-2005, NSO, 2006; ***MDHS 
2004, NSO 2005
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There are a total of 43 health facilities in Lilongwe district comprising 4 mission hospitals, 2 
community hospitals, 37 health centres and 68 health posts (Lilongwe District Assembly, 
2006). There is one tertiary facility, which acts as a referral facility for the central region of 
Malawi including Lilongwe district as Lilongwe does not have a district hospital as most of 
the other districts in Malawi. For administration purposes, Lilongwe district is divided into 6 
health zones with each zone comprising 6-10 health facilities (ibid.).
Provision of ART in Lilongwe
Lilongwe was among one of the first districts that pioneered the provision of ART treatment. 
At the end of 2004, there were 3,445 patients who had ever started treatment in five ART 
sites. By the end of the second quarter in 2011, the number of ART sites had increased to 
43 (including sites in the public and private sector) and the number of patients alive and on 
ART was 40,139 (MoH, Central West Zonal 2011).
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Figure 9: Showing map of Malawi and Lilongwe district
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Source: Lilongwe District Assembly, 2006
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Why Lilongwe was chosen for the study
I chose to undertake the study in Lilongwe district for a number of reasons. Lilongwe district 
was selected to generate data that may have a broader generalisability to other districts as it 
has both rural and urban areas. It has a combination of public, private, and faith based 
health providers (which include Christian Health Association of Malawi (CHAM) facilities). 
CHAM facilities provide about 37% of health care services in Malawi. The HIV prevalence 
rate is relatively higher in urban areas. Since the aim of the research is to document the 
health care seeking behavior of patients as influenced by different socio-economic and 
health system factors, I felt Lilongwe would provide a relevant example as it has 
longstanding experience of ART provision with relatively more centres providing ART and is 
in the process of decentralising ART to the health centre level.
I also purposively chose Lilongwe because of convenience. The longitudinal nature of the 
study required continuous interaction with the study health facilities to follow up patient 
treatment outcomes on a monthly basis. Since the study also involved tracing and following 
up of some patients to their homes for additional interviews, being resident in Lilongwe and 
knowing the study area had an advantage.
4.2 Study design
The study applied a longitudinal cohort study design and combined use of quantitative and 
qualitative research methods (Bryman, 2004). The baseline data for the cohort was 
collected using quantitative research methods. Baseline data was collected from the 
sampled patients using a structured questionnaire. The ART treatment records of all the 
patients who were recruited into the cohort were prospectively followed up for a minimum 
period of one year. During the follow up period, a selected number of patients were traced to 
their homes for in-depth qualitative interviews. Key informant interviews were also 
conducted with health care workers (a detailed description of the different research methods 
are presented below in section 4.3, 4.4 and 4.5).
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4.2.1 Rationale for combining quantitative and qualitative methods 
The combination of quantitative and qualitative methods have over the years been 
increasingly recognised as useful by health researchers because of the complexity of health 
issues and the recognition that a mixed methods approach will produce a better 
understanding of the phenomena understudy (Morgan, 1998; Ostlund et al., 2011; Risjord 
et al., 2002). The increased demand for practical research that informs policy necessitates a 
mixed methods approach for more holistic understanding of ways to understand the 
performance of HIV and AIDS programmes (Brannen, 2005; WHO, 2011). Combining the 
approaches comes from the realisation that qualitative and quantitative methods have 
different strengths and weaknesses and mixing the approaches will minimise the 
weaknesses and capitalise on the strengths of each approach (Morgan, 1998). In this study, 
the motivation behind employing mixed methods is for triangulation, elaboration and 
complementarity in order to gain a more insightful picture of health care seeking patterns 
among PLWHIV and factors that might cause patients to drop out from ART (O’Cathain et 
al., 2010; Morgan, 1998). I used the strength of the qualitative methods in order to enhance 
the performance of the quantitative methods. Therefore, the combination of both qualitative 
and quantitative research methods allows for triangulation of data sources and respondent 
groups and allows for the interpretation of data that cannot be obtained from the quantitative 
methods alone. This approach which complements the survey results with qualitative 
exploration is also useful in generating policy-relevant insights that can be easily lost in 
conventional quantitative studies (Russell, 2005).
Quantitative research is deductive and based on a positivist paradigm which assumes that 
'reality is fixed and objectivity is achievable’ (Broom and Willis in Saks and Allsop; 2007 pg. 
18). The process involves the formulation of theory and hypotheses and testing and 
verifying them empirically on a set of data. Quantitative research provides numerical 
summaries that allow understanding of the magnitude of a phenomenon, establishing causal 
effects and the testing of hypotheses using statistical methods (Matveev 2002, Bryman 
2004). Quantitative methods are advantageous because of their objectivity; as the 
researcher’s views are detached from the subjects, information can be quantified and data 
can be generalized to a wider population. It should be noted however, a scientific approach 
cannot be totally objective as subjectivity applies even in the very choice of the problem to 
be investigated and in the interpretation of results (Brannen, 2005). Quantitative methods in
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social research have been criticized for failing to distinguish people and the social world 
from the science of the natural world: the analysis of the relationship between different 
variables do not take into account the social dynamics and the definition that is present in 
human groups (Bryman, 2004). Quantitative methods may therefore fail to provide the 
context in which the phenomenon being studied took place.
On the other hand, qualitative research methods are grounded in interpretivist or 
constructivist paradigms which are embedded in a view that reality is not static but 
constructed (Bryman, 2004; Ritchie and Lewis, 2003). It attempts to figure out how research 
subjects view what is around them or affecting them with a focus on subjective meanings 
and interpretations of the researcher, in order to have depth of analysis. Qualitative methods 
are useful for understanding meaning, explanations and exploring reasons and associations 
in phenomena from the respondents own perspective though they are not sufficient in 
testing validity in any differences or similarities in data (Ritchie 2003, Casebeer and Verhoef 
1997). The inquiry can divert from the original objectives in response to the changing nature 
of the context and necessitates a high level of experience from the researcher to get the 
required information from the respondents (Matveev 2002; Bryman 2004; Johnson and 
Onwuegbuzie 2004). While some feel that qualitative research is subject to its reliance on 
the researchers’ views (making it subjective and thus difficult to replicate or generalize the 
findings over a wider population), others argue that qualitative findings may be generalized 
to other settings or contexts or they may involve theoretical generalization, where findings 
are extrapolated in relation to their theoretical application (Ritchie & Lewis, 2003; Brannen 
2005).
In this study, I have used a quantitative approach as the principal research method. I have 
however drawn the quantitative research questions from the research findings which I 
presented in Chapter 3.2. The quantitative analysis then informed my generation of research 
questions and areas that needed to be explored using qualitative research methods: it also 
identified the study respondents to be included in the qualitative research (Bryman 2004; 
Ritchie in Ritchie and Lewis, 2003). As a researcher myself, most of the work that I have 
done has been rooted in qualitative research and I have confidence in the implementation 
and analysis of qualitative research. Therefore using quantitative methods as the principal
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method in this study provided an opportunity to learn and gain knowledge in implementing 
quantitative research. In Figure 8 and Figure 10, I have shown an illustration of how I have 
applied the mixed study methods in this study. This translates to what Morgan (1998) has 
described as a complementary follow up qualitative study in a quantitative study.
Figure 10: Design of the research methods
4.3 Phase 1: Understanding and documenting the health care seeking 
behaviour of patients initiating ART and the associated socio and 
economic costs
In this component of the study using quantitative approaches, my aim was to assess the 
health care seeking pathway of PLWHIV initiating antiretroviral therapy and understand the 
social and economic costs of health care seeking on different socio-economic groups. I 
selected the sites providing ART after stratification by rural and urban, CHAM and 
government facilities and secondary facilities (hospitals) and primary facilities (health 
centres). Although the private sector provides ART in Lilongwe, I did not include them in the 
study as they serve a smaller population. Nationally, only 4% of the patients access ART 
through the private sector (MoH, 2010).
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Three of the facilities were in rural areas while four were in urban areas. Five of the health 
facilities were government owned facilities while two facilities belonged to CHAM as shown 
in Table 7.
Table 7: Facilities recruited in the study by type and location
Type of facility Rural Urban
CHAM Facilities Nkhoma Mission Hospital Likuni Mission Hospital
Government Facilities Kabudula Community
Hospital
Bwaila Hospital (Martin
Preuss Centre)
Mitundu Community Hospital Kawale Health Centre
Area 18 Health Centre
4.3.1 The sample size
The determination of sample size was determined based on the primary objective of the 
study which aimed to establish the number of health care visits from the time patients start 
seeking care to the time that they initiate ART in Lilongwe district. To calculate the sample 
size, I used the following formula for a single proportion to derive a representative sample of 
all patients accessing ART:
(n = k x ((p (1-p) x z2))/d2 (Cochran 1963:75)
Where:
n is the desired sample size
• k is the design effect in this equals 1
• p is proportion of the population having a particular characteristic of interest: here the 
proportion of patients in need of ART accessing it, estimated at 50% or 0.5 in order 
to obtain the maximum sample size
• d is the precision (error margin), set at 5% (0.05)
• z is standard normal deviate normally set at 1.96 for the 95% confidence interval
Using this approach, the survey required a sample size of 384 respondents, however taking 
into consideration refusals and losses, I increased the sample by 10% bringing the required 
sample size to 422 participants.
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It was important that this sample size also provided adequate statistical power for the 
secondary objective of identifying risk factors for failing to initiate or adhere to treatment. 
Assuming that 10% of patients fail to start treatment, a sample size of 400 individuals will 
detect factors that increase the risk of failing to initiate treatment by a factor of 3 with a 
power of 85-90% (depending on the prevalence level of the risk factor). Assuming a 
treatment drop-out rate per unit period of time of 20%, the proposed sample size will provide 
approximately 85% power to detect risk factors that increase the risk of drop-out by a factor 
of 2.
In order to ensure that the study would have adequate power to detect risk factors that 
increase drop out, I recruited a total of 452 respondents into the study from seven (7) health 
facilities (Table 8) in Lilongwe district.
Patients were eligible to participate in the study if they fulfilled the following criteria:
(a) Must have been resident in Lilongwe for a period of about three months;
(b) identified as eligible for ART by the health facility clinicians or patients on 
ARV treatment for two weeks or less;
(c) Aged 16 years or above;
(d) Consented to participate in the study.
My aim was to recruit and collect data from patients as early as possible from the period 
when they were identified as eligible for treatment. Patients were recruited on the clinic days 
when patients chosen to start ART came for their group counselling sessions, or when they 
came for their drug refill after the initial two week phase in (when patients are given the ARV 
starter pack). According to the ART programme, all persons aged 15 years and above are 
considered adults. For purposes of this study, a person was considered an adult and eligible 
to participate if they were 16 years and above as according to the Malawi Government, 
persons are considered adults from the age of 16 (Constitution of the Republic of Malawi, 
Section 23 sub-section 5). Including persons under 16 would have required consent from 
their guardian.
Informed consent was sought from the patients after explaining the purpose of the study. 
Additional consent was also sought to visit the participant at their home. Those who 
consented to be followed up at home were asked to provide a physical map to their homes 
or to provide a phone number through which they could be reached.
124
Consecutive patients eligible for ART (those waiting to undergo group or individual ART 
counselling) or initiating ART (those receiving the ART starter pack) who were at the health 
facility, available and meeting the criteria for the study were recruited and interviewed until 
the targeted sample size for the facility was reached. I derived the number of patients to be 
recruited from each facility based on the monthly capacity of the health facility to register 
patients for ART, based on whether the facility was low, medium or high burden as 
categorised by the Ministry of Health. While my plan was to recruit all the patients within a 
period of three months, I only managed to recruit the required number of patients over a five 
month period. This was due to two factors. Firstly in most of the facilities, patients who met 
the study criteria could only be recruited two days per week (on the days when the facilities 
conduct group and individual counselling for new patients, or when the patients are 
collecting their first two weeks’ medications). Secondly, in one facility, Nkhoma Mission 
Hospital, most of the patients utilising the facility were from the neighbouring Dedza district 
rather than Lilongwe and therefore it took longer to recruit the required number of patients.
Table 8: Target number of patients for each facility and actual number of patients 
recruited
Facility classification Target number Actual no. recruited
Likuni MH High 70 74
Nkhoma MH High 70 36
Martin Preuss Centre Very high burden 120 107
Kabudula CH Low 40 56
Mitundu CH Low 40 64
Area 18 HC Low 40 44
Kawale HC Low 40 71
Total 420 452
I recruited a team of eight research assistants (RAs) who had a minimum qualification of the 
Malawi School Secondary Certificate (MSCE) and one supervisor who had a Bachelors’ 
degree in Social Sciences from the University of Malawi. Five of the research assistants had 
wide experience in collecting quantitative data on health as they are employees of Research 
for Equity and Community Health (REACH) Trust, a local research organisation, where I am
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based. An additional three RAs also with minimum MSCE qualification were recruited to 
augment the team. All RAs underwent five days’ training which I facilitated so that they could 
understand the study aim and objectives, research processes and ethical issues in this 
research study (see training schedule in appendix 4.7).
4.3.2 Data collection tools and study team
A structured questionnaire was used to collect data for the survey which I formulated based 
on past research findings and literature on studies that explore cost of care seeking for 
tuberculosis in Malawi (Kemp et at. 2007; Mann, 2008). I also discussed the data collection 
tool with Dr Gillian Mann, a health economist, to gain insight on how the tool could be more 
robust for the data that I intended to collect. The study tool was translated into the local 
language, Chichewa, and was pilot tested to ensure its ability to capture required data at 
Area 25 Health Centre, a facility not sampled in the study (Study questionnaire is attached in 
Appendix 2). All interviews were conducted in the local language Chichewa.
The issues that were included in the questionnaire included:
Patients' perception of illness
s Type of symptoms experienced
s Time when the symptoms started
S The condition perceived to have led to ART eligibility
HIV testing
V When the patient received an HIV test
V The reason for an HIV test
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Health care seeking patterns
S The number of episodes of care seeking. This included all health care seeking 
episodes from the time they perceived their sickness was getting serious and needed 
care to the time when the patient is identified as eligible for ART 
v' Reason for seeking care
S Reason for the choice of provider 
•s The treatment received
S Perception of the care received at the health facility.
Direct cost of care seeking
The direct costs of care seeking were calculated by adding together the consultation fees, 
cost of drugs/treatment, return transport costs, the cost of food taken to the hospital if the 
patient was admitted, and the costs of food and other incidental costs for the time spent at 
the facility for the patient.
Indirect costs of health care seeking and of illness
In order to estimate the indirect costs directly related to care seeking, patients were asked 
about the time they spent travelling and the time spent at the health facility. This was then 
converted into working days. The number of days lost due to care seeking and illness were 
added to the time spent in care seeking to estimate the indirect costs of illness. The time 
spent in care seeking included the travel time to and from the health provider and the time 
spent at the provider. To calculate the indirect costs, I have used the average earnings 
reported in the Integrated Household Survey (IHS) 2004-2005 which I have adjusted by the 
inflation rate for each year from 2005 and 2009. The mean per capita income in urban areas 
in the IHS 2004-2005 was MK52594 per person per year and MK22454 in rural areas. I 
therefore estimated the mean per capita income for 2009 at MK88013 for urban areas and 
MK37575 for rural areas. I have estimated the indirect costs as a proportion of the average 
earnings. It is likely that using this approach, some persons particularly those who are not in 
paid jobs or in businesses, such as housewives who spend their time working around the 
home and caring for children, may not be able to report or they may underestimate the 
number of days lost due to illness since they may not count what they do as work.
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Estimating income burden of the costs of care seeking for patients
To understand the impact of the costs of care seeking on urban and rural patients, the total 
direct and indirect costs of care seeking were converted into the equivalent proportion of the 
average income earnings for rural and urban populations. I did this to allow for a comparison 
of the burden presented by the direct and indirect costs of care-seeking across the study 
participants.
4.3.3 Determination of welfare of patients' households and urban/rural residence 
indicators
Assessment of welfare
I assessed the welfare of the respondents by applying a simple proxy means test 
quantitative model of household welfare. The household is the best unit of analysis for 
assessing the costs of illness because decisions about treatment and coping are based on 
negotiations within households (Russell, 2004; Mann, 2008). The advantage of using this 
proxy means test approach to estimating the welfare level of households was that it was 
considerably easier to collect and the data requirements were relatively few compared to 
using income or expenditure measures. In determining which model to use, I assessed two 
tools of proxy measures of welfare in Malawi. One model was applied on the IHS 1997-1998 
(Payongayong et al., 2002) and a more recent measure based on the second IHS 2004- 
2005 (Mathiassen, 2005). The measure by Mathiassen is being used for assessing 
household welfare for the Welfare Monitoring Survey (NSO, 2009) and would have been a 
more preferable model. However, this model is more general for Malawi and the indicators 
are not disaggregated to apply specifically to particular districts and for urban and rural 
populations. I therefore chose to apply the model by Payongayong et al. 2002. In this model, 
the dependent variables used were a consumption-based household welfare indicator that 
can be used to categorize households as poor or non-poor. The independent variables are 
made up of a handful of household characteristics that correlates with welfare status. 
Another advantage for using this model was that it was derived for use for rural and urban 
areas and can be used for district specific assessments (see Appendix 5). The disadvantage 
however was that the coefficients and t-statistic were not provided for Lilongwe district to 
avoid collinearity, therefore I used the specified statistics for Blantyre City and rural areas 
which could be the closest to use as a proxy for Lilongwe district.
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Rural and urban residence
The structured questionnaire included collection of the physical address of each patient, 
including the name of the village/area and traditional authority. Using the map of Lilongwe, 
the residential area was recoded to either urban or rural Lilongwe. This system was used as 
patients from rural Lilongwe can access care in the city and vice versa.
4.4 Phase 2: Determination of factors affecting attrition of patients from 
ART
AN the patients that were recruited in the first phase of the study to understand their health 
care seeking experiences were followed up using routine treatment registers and patient 
master cards at the health facility. On a monthly basis, a research assistant visited all the 
health facilities in this study and checked the treatment outcomes for each and every patient 
in the study. Follow up of treatment outcomes for patients recruited into the study was for a 
minimum of one year. I created a database of all the patients recruited into the survey in 
Microsoft Excel and the treatment outcomes were updated in the database on a monthly 
basis after a research assistant collected updates from the health facilities. Treatment 
outcomes in the database were categorised as (a) alive, (b) dead, (c) loss to follow up, (d) 
transfer out to another facility, and (e) not started treatment.
Apart from the treatment outcomes, other data that was collected from the routine health 
system information included date for starting treatment and the date of an adverse outcome 
of death, loss to follow up and transferred out until the censor date of 31st December 2010. I 
then cleaned the data in Excel and merged the follow up data with the first phase data on 
the health care seeking and associated costs of care seeking in SPSS software.
Studies show that in most cases patients who have been lost to follow up have actually died 
(Yu et al., 2007). In the analysis to identify the factors contributing to attrition of patients from 
ART, Kaplan Meier survival analysis and the Cox proportional Hazards analysis were used. 
In this analysis, the outcome variables recoded from the data were categorised into two: 
those who survived (which included the following treatment outcomes - alive, and transfer
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out to another facility) and those who dropped out from treatment (which included those who 
died or were lost to follow up).
4.5 Data Management and analysis for Phase 1 and 2 of the study 
All data were double entered and cleaned using Epi Info. The data was then analysed using 
SPSS and Excel. Descriptive analysis such as percentage, means, median and univariate 
statistics were used to provide summaries of the variables for the participants included in the 
analysis. I used Mann-Whitney U test to compare data from two independent groups and the 
Kruskal Wallis test if more than two groups were compared. The Mann Whitney U test and 
Kruskal Wallis test are non-parametric tests which can be used in place of t-test and F-test 
respectively in data which is non-normally distributed. I applied the X2 or Fisher Exact test to 
compare the categorical data groups of those patients eligible for ART who did not 
effectively have access to the treatment. Associations were examined at a P<0.05 
significance level.
Logistic binary regression was used to estimate the effect of socio-demographic, health care 
seeking practices and economic factors associated with patients not starting treatment.
I conducted the survival analysis with Kaplan-Meier estimates to describe the cumulative 
survival probabilities curves with log-rank test to test equality of survival functions. Patients\ 
who were lost to follow up were censored on their last documented visit and patients who 
died on the date of death. In cases where only the month of death was provided and not the 
actual date, the mid-month date was used as the date of death.
To compare survival, I carried out a Cox proportional hazards regression analysis to explore 
the effect of several variables on survival of patients on ART. The model is written as:
In h(t) = In h0(t) + b1X1 + b2X2+ baXs... bkXk
Where h(t) is the hazard at time t; x1( x2... xkare the explanatory variables; and h0(t) is the 
baseline hazard when all the explanatory variables are zero and b are the coefficients.
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Continuous variables which had skewed distributions were logarithmically transformed 
before regression.
4.6 Phase 3: In-depth exploration of why patients do not initiate or adhere 
to treatment
The qualitative component was explorative and specific research questions and types of 
respondents were determined and informed from the ongoing quantitative analysis. The 
qualitative study can be defined as applied social research, aiming to respond to key 
research questions developing from the quantitative study (Bryman, 2006). The qualitative 
research questions were issues identified as requiring in-depth understanding, elaboration 
and clarification. The qualitative component involved exploration of the dynamics of decision 
making and factors that cause people to act in the way they do. It explored why patients 
chose to initiate or not initiate ART as well as adhere or drop out from treatment. The 
qualitative component also explored the health system related factors for facilitating or 
presenting barriers for patients to getting an HIV diagnosis and starting ART as well as 
health worker views and the extent to which they felt their services were responsive to 
theneeds of patients (see Appendix 3 for the interview guide).
Patient in-depth interviews
I purposively selected the participants for the qualitative study from the patient treatment 
outcomes from following up patients. A selected number of patients among the sampled 
study population who were identified through patient records as not starting treatment, lost 
to follow up and those who were successful on treatment were followed to their homes (if 
they consented to be followed up). The research assistant with a member of staff from the 
health facility traced the patients to their homes or through mobile phone where the number 
was available. I and a research assistant arranged an appointment to interview the patient at 
a place and time of their convenience. I applied semi-structured interviews in collecting data 
which allows defining the areas to be explored but permits divergence to pursue emerging 
issues in the response in detail (Pope and Mays, 2006). Approaching these groups of 
patients raised some challenges.
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• It was difficult to trace up some of the patients because the physical maps that they 
had provided were complicated or the patients could not be found;
• Some patients may have provided wrong addresses deliberately;
• Some also had transferred out from their residential areas and could not be traced to 
their new areas of residence;
• Poor record keeping at the health facilities - when followed up, some of the patients 
who were identified as not coming to collect their medications were found to be 
taking their drugs but their records were not being updated at the health facilities;
• Other patients who were marked as lost to follow up had actually died.
Key informant interviews (health worker interviews)
Key health workers from the health facilities where the study was conducted were 
interviewed to capture their perspective of the performance of the health system and their 
perceptions of the factors that hinder or facilitate ART access, adherence and attrition (see 
key informant guide in Appendix 4).
The process of undertaking the qualitative interviews
All the qualitative interviews were conducted by myself and the research assistant who was 
responsible for tracking the possible respondents and arranging interviews with them whom 
I had trained on qualitative interviewing. The research assistant also collected some 
information from other patients who were not formerly interviewed but were followed up to 
identify their treatment outcomes. During the visit to trace patients, we were accompanied 
by a health worker from the ART clinic as they were usually familiar with the areas. During 
this visit, the patient was booked for an interview on a day and venue convenient to the 
patient. For other patients who provided phone numbers, interviews were booked via phone. 
Tracing patients with a member of staff from the health facility had certain benefits and 
disadvantages. The assistance of the health staff was more advantageous in the rural areas 
where we were not very familiar with the locations than in the urban areas. While some of 
the facilities had plans to follow up patients, they were not able to due to resource 
limitations. Travelling with us therefore provided them with an opportunity to see for 
themselves how far from the health facility some patients were coming from and also the 
challenges that the patients face and overcome in order to come to the health facility. One of
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the health staff commented that when they had been shouting at patients for coming late 
they had not known how far away those patients were coming from.
While patients were happy that the health facility had taken trouble to go to their homes and 
see how they were doing, because of the presence of the health worker they may well have 
associated us with the health facility. Associating us with the health facility might have 
affected openness of the patients and the responses that they might have given during the 
qualitative interviews. However, to minimize the effect of this, we often introduced ourselves 
on the first day and made an appointment to come on another day for the interview without 
the health worker.
As I was not always present during the tracing of patients, I conducted regular debriefing 
meetings with the research assistant to understand his experiences and perceptions. After 
noting the rich experiences and feedback from these meetings, I have included the data into 
the qualitative study findings. I have therefore shared all the information and quotations that 
I have included with him so that he can check the accuracy and consent to the inclusion of 
this data in the study findings.
4.7 Qualitative data management and analysis
The qualitative data from the interviews were recorded after seeking permission from the 
study respondent. For the other follow up visits where formal interviews were not conducted, 
notes were taken of the visit and the information gathered about the patient. All the data was 
transcribed verbatim into Microsoft Word. The notes were also typed into Word. I analysed 
the data using a thematic framework which I had developed from the emerging research 
questions and through familiarizing myself with the data (Ritchie and Spencer, 1994; Ritchie 
and Spencer, 2003). (I have attached my analysis framework in Appendix 8). I then indexed 
the textual data systematically to a coding index developed in the framework with the 
assistance of a qualitative data analysis software MaxQDA (Ritchie and Spencer, 1994; 
Pope and Mays 2006). After coding, I charted the data into headings and subheadings in a 
manner I perceived would be the best way for reporting the findings. The mapping and 
interpretation was conducted in relation to the quantitative data findings which had been 
used in generating the qualitative research questions and from the extensive literature 
review in Chapter 2 and 3. This approach ensured validation through triangulation from 
different sources of information (Lewis and Ritchie in Ritchie and Lewis, 2003).
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The analysis showed that the factors that may influence patients’ actions and experiences 
are broad and complex. I therefore constructed case studies from the interviews to provide 
illustrations, detail and contextualisation of the factors affecting patients (Creswell, 1998; 
Keen J. 1995). Case studies involve capturing multiple perspectives which are rooted in a 
specific setting and provide detailed understanding which is holistic and contextualised 
(Ritchie and Lewis, 2003).
4.8 Ethical considerations
The health workers were briefed on the objectives of the study and on the criteria of 
sampling procedure. During the group or the individual counselling, the health workers 
briefed the patients and explained the purpose of the study and mentioned that the patients 
might be approached by a member of the study team. The researchers approached the 
patients and repeated the aims of the study to the patient, the benefits and the risk of 
participating in the study. Informed consent was sought using a form that explained the 
confidentiality, privacy and anonymity that would be employed in the study (Consent Form is 
attached in Appendix 6). To facilitate anonymity, the names of the patients were omitted on 
the interview form, instead, unique code numbers were allocated to the respondents. The 
option to stop the interview at any time was clearly stated and participants were informed 
that their refusal to participate in the study would not affect the treatment that they would 
receive from the health facilities or in their communities.
According to the study objectives and design, patients recruited in the first phase were 
followed up through health facility ART patient records, and some were traced to their 
homes. To facilitate the follow up process, names of patients were recorded on the consent 
forms together with the unique patient ID code. The consent forms were kept separately 
from the interview records. Consent was also sought from the patient if they could be 
followed up to their homes or be reached by phone. Only those who consented to be 
followed up were asked to provide detailed physical maps to their residence and where 
available their mobile phone numbers.
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For patients who were interviewed at their homes or another place of their preference, 
consent to conduct the qualitative interview was again sought after explaining the purpose of 
the follow up interviews. Respondents were also asked for permission to record the 
interview.
Patients who were literate were asked to sign on the consent form to show their agreement 
to participate. For patients who were illiterate, verbal consent was sought and the 
researcher signed on the consent form to show that consent had been sought.
There were a number of ethical challenges when following up patients, for example we 
found that some patients had not started treatment because they lived far away from the 
ART sites and they could not afford the travel costs. We also found other patients very sick 
and therefore our visits raised hope among patients and their relations which we could not 
fulfill. This was also psychologically distressing to us as researchers because we could not 
provide the necessary support. As it is cultural to give a gift in terms of money or foodstuff 
when visiting a patient, we provided a packet of sugar to the patients that we visited. We 
also found that it was usually difficult to find private space at the homes of the patients, 
usually the houses were small and other household members would be present in the home. 
In such cases we opted to conduct interviews outside the house but away from people.
By following up patients in their homes, we realized that we were raising ethical challenges 
as the HIV status of a person is confidential, therefore our visit to a home would raise 
curiosity among the patient’s neighbors, and relatives. We put in place the following 
measures to minimize as much as possible the stigma that might be caused through others 
identifying the patient as living with HIV and AIDS due to our visit to the patient:
1. The follow up team did not have any identifying markers that would identify us as 
coming from the hospital e.g. a uniform, or using a hospital vehicle.
2. The researchers did not disclose the purpose of the visit until they were sure they had 
found the person they were looking for. We found however that for most patients; 
because of common knowledge by the relatives or neighbor that the person had been
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sick, most would without questioning explain that the person had died and narrate the 
events relating to a person’s sickness or death.
3. The researchers provided their contact details so that they could be contacted where 
the respondents felt that they had been subjected to negative effects from being 
approached by the research team for the interviews.
The questionnaires and qualitative interview recordings were kept locked in a cupboard with 
access given only to the researchers. All data will be kept securely for three years, after 
which they will be destroyed. Approval to conduct the study in the health facilities was 
obtained from the District Health Office and then from the in-Charges of all the health 
facilities. The study was reviewed and approved by the ethical boards from the National 
Health Sciences Research Committee (NHSRC) of the Ministry of Health and Population in 
Malawi (Appendix 9) and by the Liverpool School of Tropical Medicine (LSTM) Ethics 
Committee.
4.9 Trustworthiness and Quality Assurance Mechanisms
Questionnaires were translated into Chichewa with input from the research assistants and 
piloted to ensure that the meaning of the questions were in line with the meaning of what 
was intended to be collected. The data collection instrument was pre-tested at a clinic not 
included in the study (Area 25 Health Centre) and necessary adjustments were made to 
facilitate the understanding of the questions by the respondents. The data collection team 
underwent training and each questionnaire was checked by myself or data collection 
supervisor (who had a Bachelor’s degree in Social Sciences and had experience of 
collecting survey data).
Quantitative data from the survey was double entered in Epi Info v.6.o4b and cleaned. Data 
was crosschecked and any discrepancies were checked against each completed interview 
form.
To ensure high quality qualitative data, interviews were recorded using mini-disc recorders. 
The batteries of the mini-disc recorder were fully charged before each interview and external 
batteries were also kept handy in case the recorder batteries ran low during an interview. 
The recorder was also checked and tested to make sure it was in good recording condition 
before each interview and a test was also made with the respondent. Tapes from each 
interview were clearly labelled and kept in good condition. Trustworthiness in the qualitative
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component was also maintained through triangulation of respondents (patients who did not 
start treatment, patients who had been lost to follow up, patients who had successfully 
started treatment and were still on treatment and health providers). My own experience in 
conducting qualitative research around HIV in the Malawian context (as discussed in section 
3.2 was useful in maintaining quality of data. The use of quantitative and qualitative methods 
also ensured trustworthiness in the study.
4.10 Study Limitations
The study has a number of limitations that might affect generalisibility of the resuts and 
interpretation of the study findings. These limitiations include:
i. The study respondents were sampled from the health facilities after they had made 
contact with HIV services and therefore that only patients who had made it into the health 
system were captured. Patients who make it into accessing HIV testing and assessment 
for ART eligibility are more likely to be those who might have managed to overcome 
barriers that keep people away from utilising HIV and AIDS services. This means that the 
population I have studied may not be truly representative as it does not include those 
who have not made it into the care system and those are the people who may be most 
vulnerable inequities to HIV treatment and care.
ii. The recruitment of patients into the study was done sequentially. This might have 
introduced a potential bias than compared to randomly selection of patients: There is a 
possibility of clustering of people arriving for treatment, for example families coming 
together, agricultural seasonality or people in employment being more likely to come at 
the end of the month when they have received their salaries.
iii. Data about treatment and costs was based on when the patients defined their illness to 
have become serious. This introduces a potential for recall bias is as patients may have 
found it difficult to remember when they had started experiencing illness, care seeking or 
tested for HIV if this had occurred several months or years previously.
iv. The methodology that was used to estimate lost income from days lost due to care 
seeking and illness might underestimate lost income for people who were not formally 
employed. Such people eg women and farmers might not have considered not doing their 
daily chores as a day lost and therefore might have underreported the number of days 
lost from work.
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v. Most patients were only followed up for a relatively short time (minimum of one year) It is 
well established that retention in care tends to reduce the longer patients are on 
treatment. This study may not have captured long term factors that might affect treatment 
outcomes.
vi. . The analysis of factors that affect survival was unable to include clinical disease staging 
at the time of initiating treatment because of the extend of missing data. A number of 
studies have shown that survival is affected by clinical disease staging (Lawn et al., 2010; 
Braitstein et al., 2006; Brinkhof et al., 2009) and therefore my analysis may have missed 
an important factor affecting survival.
vii. Only staff working in the ART clinic were included as respondents in the qualitative 
sample of health workers, This group of health workers are more enlightened about 
routine HIV testing and referral for HIV services and so the results may not reflect the 
views of all health workers.
4.11 Conclusion
This chapter has outlined the methods and processes that were followed in implementing 
the study. The study used quantitative methods to respond to the first objectives of the study 
which aimed to document the health care seeking pathway of patients and the associated 
direct and indirect costs of care seeking. The quantitative study also provided initial 
information for deriving questions which needed to be followed up through qualitative study 
design.
In the next chapter, Chapter 5, I will present the findings of the study objectives from the 
quantitative study. The chapter will present the symptoms that patients experienced prior to 
care seeking and how they interpreted their illness and their perception of what caused their 
clinician to refer them for ART. The chapter will outline the different costs of care seeking 
and indirect costs. The chapter will also present the patients who started treatment and who 
did not start treatment and from the quantitative data attempt to identify factors that might 
have contributed to patients not starting treatment. Finally, I will present the patient 
treatment outcomes from following up the patients and identify the contributing factors to 
patient attrition from treatment through death and loss to follow up. The findings from the
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quantitative study then led to the development of the key qualitative questions which are 
presented in Chapter 6.
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Chapter 5: Does patient socio economic status and health care seeking 
behaviour influence ART treatment outcomes
5.0 Introduction
This chapter presents the study findings of the baseline survey and results of the follow up 
of patient treatment outcomes. The chapter’s aim is to present the findings from the 
quantitative component of the study. The chapter presents findings on the patients’ 
interpretation of their symptoms and illness; the health care seeking behaviour of patients 
prior to initiating ARV treatment and the delay to HIV diagnosis and ART initiation. It also 
presents findings from tracking patients who, after being identified as eligible for treatment, 
initiate treatment and those who do not. It presents the factors identified that contribute to 
patients initiating treatment or not. The chapter also explores retention in HIV treatment and 
the factors associated with attrition from ART through death or loss to follow up. Finally, the 
chapter identifies the key questions that needed to be followed up through qualitative 
interviews.
5.1 Respondents characteristics and of their households
In this section, I present the analysis of the patients; characteristics recruited in the study. 
The section shows the gender, marital status, age, residence by rural and urban, and their 
poverty status whether they are poor or non poor. I also show characteristics of the patients' 
households and the type of facility where the patients were recruited from.
5.1.1 Respondents characteristics
I recruited a total of 452 patients from seven health facilities into the survey. There were 
more female respondents (62.6%) recruited in the study than males (37.4 %). Among the 
respondents who provided their marital status (n=446), the majority were married (65.5%), 
18.6% were divorced or separated, 12.8% were widowed and only 3.1% were single. The 
mean age was 35.4 years (SD=9.2), with the minimum age of 15 years and a maximum of 
70 years. Most of the patients recruited were between the ranges of 26-45 years. Using the 
residential areas provided by patients, I categorised the data into rural and urban residence: 
51.1% of the study participants lived in urban Lilongwe while the rest were from rural 
Lilongwe. The main respondents’ occupations were farming (34.0%), business (24.2%),
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home worker (19.9%), employed (16.0%) and other occupations (6.0%). Table 9 shows the 
characteristics of patients recruited in the study.
Further breakdown of marital status by sex showed that more than four fifths of the males 
were married and that most of the widowed and separated/divorced respondents were 
female. The distribution of the female patients by age was highest in age group 30-34 while 
for male patients, they were highest in the age group 34-39, as shown in Figure 11.
Figure 11: The age distribution of respondents by sex
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Using the methodology described in Chapter 4, I estimated the welfare status of the 
respondents dividing them into poor or non-poor. Amongst the overall study population, 
58.8% were poor. Among the poor, 49.8% were urban residents, while among the non poor, 
54.1% were urban residents as shown in Table 9. In terms of gender, among the poor, 
60.5% were female patients whilst among the non poor, 67.2% were female.
Female
Male
Table 9: Welfare of patients by residence and gender
Characteristic Poor
n %
Non poor
n %
All patients (n=451) 265 58.8 186 41.2
Residence (n=448)
Urban 132 49.8 99 54.1
Rural 133 50.2 87 45.9
Gender(n=447)
Female 158 60.5 125 67.2
Male 103 39.5 61 32.8
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Most of the patients (74.5%) were recruited from government health facilities. 48.3% of the 
patients were recruited from secondary level health facilities while 26.3% were from 
community hospitals and 25.4% were from health centres. As shown in Table 10 more 
patients from urban residence were recruited from the government facilities (57.0%) while 
the rural residents used the mission facilities more. All patients who were recruited from 
community hospitals were from rural areas while most from the secondary level facilities 
were from urban areas. Most of the patients who reported farming as their occupation were 
from the rural areas (94%). More people who owned businesses or were farmers and were 
poor, while relatively more patients who were employed were non poor.
Table 10: Characteristics of respondents categorised by gender, residence and 
poverty level
Characteristic Gender Residence Poverty level
Male Female Rural Urban Poor Non poor
Type of health facility
Government 
health facility (n 
= 341)
39.0 61.0 42.5 57.5 56.5 43.4
Mission health 
facility (n=111)
32.4 67.6 68.5 31.5 65.8 34.2
Level of health facility
Secondary
facility
33.5 66.5 40.4 59.6 61.0 39.0
Community
facility
45.4 54.6 100.0 - 55.9 44.1
Health centre 36.5 63.5 12.2 87.8 57.4 42.6
Occupation
Farmer (n=149) 39.6 60.4 94.0 6.0 65.8 34.2
Own business 
(n=103)
43.7 56.3 25.2 74.8 61.2 38.8
Home worker 
(n=90)
1.1 98.9 23.3 76.7 56.7 43.4
Employed
(n=57)
57.9 42.1 24.6 75.4 35.1 64.9
Other (n=26) 53.8 46.2 42.3 57.7 61.5 38.5
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Age
15-25 (n=53) 81.1 18.9 34 66 43.4 56.6
26-35 (n= 206) 26.2 73.8 48.5 51.5 58.3 41.7
36-45 (n= 125) 54.8 45.2 52.4 47.6 66.4 33.6
46 and above 
(n=59)
54.2 45.8 55.9 44.1 54.2 45.8
5.1.2 Characteristics of the patients’ households
The mean number of household members was 5.3 (SD = 2.4), and 56.7% of patients had 
between one and five household members while 40.2% had between five and ten members. 
The patient him/herself was the head of the household for 57.5% of the respondents, 
followed by the spouse (32.5%) and parent (6.0%). The head of household was male in the 
household of 60.5% of the patients. The commonly reported occupations of the head of 
household in urban areas were micro-business (30.7%), salaried unskilled employment 
(16.2%) and salaried skilled employment. In the rural areas, subsistence farming (43.9%) 
and cash crop farming (22%) were the most commonly reported occupations. Table 11 
summarises the household profile for all the respondents.
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Table 11: Household characteristics for respondents
Characteristic
n
Urban
% n
Rural
% n
Total
%
Household size (n= 448)
1-5 members 136 59.1 118 54.1 254 56.7
6-10 members 87 37.8 93 42.7 180 40.2
10+ members 7 3.0 7 3.2 14 3.1
Relationship to head of household (n = 449)
Self 119 51.7 139 63.5 258 57.5
Spouse 85 37.0 61 27.9 146 32.5
Parent 14 6.1 13 5.9 27 24.1
Other 12 5.2 6 2.8 18 4.0
Sex of head of household (n=446)
Male 144 63.2 126 57.8 270 60.5
Female 84 36.8 92 42.2 176 39.5
Walls for respondents both residing in urban and rural areas were generally made of sun 
dried bricks (43.4%) or burnt brick (37,0%). Iron sheet roofs were more common among 
respondents residing in urban areas (82.6%) while in rural areas, grass thatched roofs were 
more common (72.1%). The traditional latrine toilet was common among respondents both 
in rural and urban areas (69.5%). Most of the respondents residing in urban areas (81.2%) 
were using piped water as a source of drinking water while among those resident in rural 
areas, the borehole was more common (57.5%)..
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5,2 Patients' experiences of HIV and AIDS related illness/condition
Patients were asked to recall the experiences of their illness retrospectively from the time 
they perceived their illness to be getting serious to the time that they were deemed eligible 
for ART. The median recall period (n=427) for patients was 3.8 months (1QR = 2.0 - 7.5 
months).
Patients sought care based on their perception of what they were suffering from according 
to the symptoms that they were experiencing. Patients who had experienced illness 
symptoms were therefore asked to report a maximum of three illness symptoms that they 
had experienced. The most common reported symptoms were fever and malaria (63.4%), 
cough (42.2%), diarrhoea (31.1%), body weakness (23.7%) and skin conditions (20.7%).
Due to the symptoms that patients experienced, patients described the perceived illness that 
they thought they might have been suffering from. Malaria was mentioned by 37.1% of the 
patients, 11.3 % suspected themselves to have TB, 8.8% perceived themselves to have HIV 
and AIDS, 6.5% thought they had diarrhoea, only a very small number of patients (3.5%) 
thought they had been bewitched. Patients’ beliefs about their illness are likely to influence 
where they seek care.
Patients were asked what symptoms in their perception caused their clinician to refer them 
for ART. Most patients perceived they were referred for ART by the clinician because of 
fever/malaria (37.5%), body weakness and body pains (25.6%), cough (25.2%), low CD4 
count (24.5%), diarrhoea (21.2%), and weight loss (15.7%) as in Table 12.
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Table 12: Symptoms/conditions perceived to lead clinician to refer for ART (n=441)
Symptom/condition Frequency Percentage
Fever/malaria 170 37.5
Body weakness and body
pains
116 25.6
Cough 114 25.2
Low CD4 Count 111 24.5
Diarrhoea 95 21.2
Weight loss 71 15.7
Skin conditions (rashes,
wounds, sores)
70 15.5
TB 45 9.9
HIV/AIDS 42 9.3
Swollen/hot parts of the body 25 5.5
Heart bum/indigestion 20 4.4
Pneumonia 15 3.3
Shingles 9 2.0
PMTCT 9 2.0
Mouth sores 8 1.8
Other 28 6.1
Not Known 11 2.5
*The total percent is more than 100% as Patients reported up to three 
symptoms/conditions
5.3 HIV testing
Most of the study participants had an HIV test because of illness symptoms/ill health 
(56.5%), followed by 18.8% who were tested because they wanted to know their HIV sero- 
status, PMTCT was the reason fortesting for 10.5% of the respondents. Most of the patients 
who tested because of referral from a health worker were recruited from the health centre 
(primary level care) as shown in Table 13. Being sick is the major reason for accessing an 
HIV test.
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Table 13: Reason for an HIV test by level and type of facility
Reason for HIV test Facility type (%) Type of 
facility (%)
n % Secondary
hosp.
Communit- 
y hosp.
health
centre
Govt CHAM
Symptoms/ill health 252 56.5 50.4 31.3 18.3 78.6 21.4
Want to know sero status 84 18.8 42.9 25.0 32.1 66.7 33.3
PMTCT 47 10.5 55.3 21.3 23.4 66.0 34.0
Partner/child died 23 5.1 52.2 13.0 34.8 78.3 21.7
Referral by a health worker 17 3.8 23.5 11.8 64.7 82.4 17.6
Partner/own sexual behaviour 8 1.8 37.5 0.0 62.5 75.0 25.0
Told to get tested by partner 6 1.3 33.3 33.3 33.3 100.0 0.0
Other 10 1.1 40.0 10.0 50.0 80.0 20.0
5 respondents did not report reason for testing
5.4 Health care seeking behaviour
Most of the patients sought care from formal health care facilities though self treating, visits 
to traditional healers and religious leaders were also reported. Government health facilities 
and mission facilities were the most utilised for care seeking. The most common reason for 
seeking health care was sickness. Closeness of the facility was commonly reported as 
reason for choice of a health provider. The study results in this section show there are 
differences in the mode of transport by rural or urban residents with urban residents more 
likely to use a bus/minibus as the mode of transport for care seeking.
5.4.1 Choice of health providers and modes of transport to facilities
In order to estimate the choice of providers, the cumulative number of health visits for all 
patient was added together in order to analyse patterns of care seeking as shown in Table 
14. The most visited health providers were the government hospitals (41.2%), government 
health centres (21.3%) and the mission hospitals (15.1%). Health care seeking by rural and 
urban residents showed that urban residents were proportionately more likely to use 
government health centres (26.9%) than rural residents (15.4%) and urban residents also 
visited private hospitals more (1.1%) than rural residents (0.7%). Lilongwe has more
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government health centres, however, because ART services are more available in the urban 
government health centres than in the rural government health centres, it is likely that the 
number of visits to these facilities are high because people are referred to these facilities for 
further HIV care and treatment. The visits to government health centres by urban residents 
is higher than in the rural areas because relatively more health centre level facilities in urban 
areas offer ART initiation and management services.
Table 14: Choice of health providers visited by patients from rural and urban areas
Rural % Urban % Total %
Government hospital (including 
community hospitals) 616 42.9 594 39.6 1210 41.2
Government health centre 221 15.4 403 26.9 624 21.3
Mission hospital 261 18.2 182 12.1 443 15.1
Private clinic 120 8.4 123 8.2 243 8.3
Self treat 128 8.9 109 7.2 237 8.1
Traditional header 43 3.0 32 2.1 75 2.5
Private hospital 10 0.7 17 1.1 27 0.9
Religious leader 10 0.7 2 0.1 12 0.4
Other 26 1.8 38 2.5 64 2.2
1435 100.0 1500 100.0 2935 100.0
The major reason for seeking care was sickness. Along the care seeking pathway for HIV 
treatment, ART counselling, CD 4 count tests and HIV testing also contribute to the visits 
that patients make in health care seeking. The choice of the facility was determined by 
closeness (24.5%), referral to the facility (19.3%) and low cost or provision of free services 
(19.1%). Patients were asked who made the decision for them to visit the provider they 
visited. In about half of the care seeking episodes (51.5%), patients themselves had made a 
decision as to which provider to seek care from while a health worker at a facility had made 
a decision on where the patient should seek for 25.8% of the care seeking episodes.
Amongst all the health care seeking episodes amongst all patients, (excluding visits where 
patients did not travel to access care), using a bus or a minibus (40.0%) and walking 
(35.6%) were the common means of travel. Walking was common among both urban and
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rural residents. However when other means of travel are compared by urban and rural 
residents, the urban residents were more likely to use a bus/minibus (59.5%) than the rural 
residents (19.2%). Use of a bicycle (whether own, borrowed or hired bicycle) was common 
in rural areas and was used by 36.1% of rural residents, whereas in urban areas where only 
2.8% used bicycles. Other means of transport which were less commonly used were own 
vehicle, hired car/taxi and stretcher among others.
Most of the patients perceived that they received good reception from the health providers 
(91.6%) and only 0.7% perceived the quality of care to be bad. Experience of problems at 
the health facility were rare as the majority of patients (91.1%) mentioned that they did not 
face any problems: the main concern was long queues which were only reported by 6.1% of 
respondents, late opening times (1.4%) and other problems reported by a few patients were 
poor staff attitudesand stock out of drugs.
5.4.2. Illustration of health care seeking for the first three health visits
Changes in patterns of utilisation of facilities over time were examined. Overall the 
government hospital was the most frequented health provider for the first, second and third 
visits, followed by the government health centre (See Table 15). While self treatment by 
either home remedies or buying drugs from a grocer was the third most common for the first 
and second health visits, by the third visit self treatment declines to 10.1% from 18.8% 
during the first visit. While the use of traditional healers is minimal, it has been consistently 
reported for all the first three visits. It is also surprising that not many patients mentioned 
home based care groups as these are usually within the communities where people reside.
The main reason for choice of the provider was closeness to home /short distance followed 
by low cost or free treatment. However it is also striking to note that referral as a reason for 
choice of provider increased from 0.9% during the first visit to 12.6% in the third visit. 
Referral as a reason for health visits also increased during subsequent visits which might 
show that facilities with no ART services were referring patients to ART sites.
For the first, second and third health care visits, there were no variations in the health 
provider visited by gender, residence or welfare of patients.
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Table 15: Illustrations of care seeking for first, second and third health visits.
First Health visit
Health Provider n % Reason for choice of provider n %
Govt hospital 147 32.5 Close to home/short distance 143 31.8
Govt health centre 93 20.6 Low cost or free treatment 101 22.4
Self treat 85 18.8 Treatment effective for ailment 62 13.8
Mission health facility 54 12.0 Quick service 56 12.4
Private clinic 42 9.3 Minor ailment 37 8.2
Traditional leader 18 4.0 Recommended by others 28 6.2
Private hospital 5 1.1 Beliefs 14 3.1
HBC provider 3 0.7 Referral 4 0.9
Other 4 0.8 Other 5 1.1
Second Health visit
Health provider n % Reason for choice of provider n %
Govt hospital 158 35 Close to home/short distance 125 27.8
Govt health centre 97 21.5 Low cost or free treatment 93 20.7
Self treat 66 14.6 T reatment effective 67 14.9
Mission hospital 55 12.3 Quick service 54 12.0
Private clinic 46 10.2 Referral 38 8.5
Traditional Healer 12 2.7 Recommended by others 29 6.5
Private hospital 6 1.3 Minor ailment 26 5.8
Prescribed 5 1.1 Beliefs 9 2.0
Other 13 2.2
Third Health visit
Health Provider n % Reason for choice n %
Govt hospital 181 41.3 Close to home/short distance 111 25.5
Govt health centre 83 18.9 Low cost or free treatment 92 21.1
Mission hospital 56 12.8 Treatment effective 66 15.1
Self treat 44 10.1 Referral 55 12.6
Private clinic 44 10.0 Quick service 47 10.8
Traditional healer 13 3.0 Recommended by others 3 7.3
Private hospital 6 1.4 Minor ailment 14 3.2
Religious leader 5 1.1 Beliefs 11 2.5
Other 6 1.4 Other 8 1.8
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5.5 Delays in care seeking
From the health system perspective, it is felt that patients present late for HIV treatment 
leading to poor treatment outcomes in the first few months of treatment. The findings in 
section 5.2 show that most patients were likely to visit formal health facilities particularly 
government and mission health facilities. This section will therefore explore the three 
potential delays before HIV treatment. The first delay is the delay from the time that the 
patient perceived their illness to be serious to the time they received an HIV test, the second 
delay explores the time between an HIV to ART referral and the third delay is from being 
deemed eligible for ART to the time of starting treatment. The findings show that there is 
long delay from the time that patients perceive their illness to be serious to the time that they 
get an HIV test, and consequently to starting ART.
Most of the patients had sought health care several times from the time they felt their 
sickness was getting serious to the time they were actually were being initiated on ART. The 
median number of total visits to health providers from patients perceiving their illness to be 
serious to the point of group counselling was 6.0 (IQR = 5.0 - 8.0). Patients reported more 
health care seeking episodes as these included self treatment and any other health visits 
they might have made, whether to formal health providers or to informal health providers 
such as religious leaders or to home based care providers. There were differences in the 
number of health care seeking visits by poverty status, with patients from poor households 
making more care seeking visits than the non-poor (P=0.003) as shown in Table 16.
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Table 16: Delays from illness being serious to starting ART by gender, residence, 
poverty status and type of facility
Gender Residence Povery Status Type of facility
Male Female Urban Rural Poor
Non
Poor Govt CHAM
Number of care seeking episodes (n=452
Median 6.0 6.0 6.0 6.0 7.0 6.0 6.0 7.0
25th quintile 5.0 5.0 6.0 5.0 5.0 4.0 5.0 5.0
75th Quintile 8.0 8.0 8.0 8.0 9.0 8.0 8.0 8.0
P-value 0.974 0.703 0.003 0.280
Delay from being ill to an HIV test in days (n=344)
Median 50.5 55.5 46.0 58.0 66.0 42.0 44.0 78.0
25th quintile 20.3 19.0 15.0 25.0 26.0 12.0 16.0 29.5
75th Quintile 140.0 145.5 123.0
167.
5 170.0 115.0 131.0 220.0
P-value 0.945 0.077 0.004 0.003
Delay from HIV test to ART referral in days (n=404)
Median 9.5 17.5 20.0 6.0 10.0 17.0 11.5 34.5
25th quintile 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0
75th Quintile 79.0 126.0 111.3
86.
3 103.0 84.0 82.0 154.5
P-value 0.192 0.004 0.251 0.066
Delay from eligibility to starting ART (n=382)
Median 19.0 21.0 16.0 23.0 19.0 21.0 22.0 14.0
25th quintile 8.0 11.0 7.0 13.0 8.0 11.0 12.0 8.0
75th Quintile 44.0 54.5 45.0 52.0 50.8 49.0 55.3 28.5
P-value 0.336 0.006 0.489 0.001
Amongst the respondents who had accessed an HIV test after they perceived their illness to 
be getting serious, the median number of days to HIV testing was 52.5 (1QR = 19.0 -143.5 
days) as shown in Table 17 above. There were also significant differences in the delay from 
Illness being series to HIV testing among the poor (66.0 days) and non poor (42.0 days) 
(p=0.004) and those recruited from CHAM facilities also took longer to HIV testing than 
those from government facilities (p= 0.003). However, there were no significant differences 
by gender and rural or urban residence.
The median number of days from HIV testing to ART referral was 14.5 days. There were 
significant differences by residence from the time of HIV testing to ART referral, with the
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rural residents having shorter days than those in urban areas (6.0 days and 20.0 days 
respectively) (p=0.004). The shorter time to ART referral shows that at the time of HIV 
testing most of the patients were already in advanced stages of HIV.
There were also delays for some patients between eligibility for ART and the time that they 
actually started ARV treatment. An analysis of the delay was conducted for 382 respondents 
(49 patients did not start treatment and 21 respondents did not have complete information 
on date for ART eligibility). The median number of days from ART eligibility to starting 
treatment was 20.0 days (IQR 9.0 - 50.0 days). There were significant delays by residence 
and type of facility. Rural residents had a longer delay (23.0 days) from ART eligibility to 
starting ARV treatment than those in residing in urban areas (16.0 days) (p=0.006). Patients 
initiating in CHAM facilities also had a longer than those in government facilities (p =0.001). 
However, no significant differences were observed by welfare and gender.
Figure 12: Showing a diagrammatic example of delay among the poor and non poor 
patients
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5.6 Direct and Indirect costs of care seeking
Patients reported the costs that they had incurred for the different visits made to health 
providers from the time they perceived their illness to be serious to the time they were 
initiated on ART. Patients initiating treatment in CHAM facilities were likely to incur higher 
costs than those initiating in government facilities. Costs of care seeking were also likely to 
increase with increasing number of care seeking episodes. The findings also show that 
patients from rural areas, the poor and those initiating in CHAM facilities have a longer travel 
time to a health provider. Rural residents also spent longer at the health facility. The longer 
thavel time and time spent at the health provider lead to increasing opportunity costs of care 
seeking.
The total median cost of care seeking was MK1600.00 (IQR MK500- MK3860) as presented 
in Table 17. These costs included expenditures on consultation fees (median = MK0.00), 
cost of drugs or treatment (median = MK215.00), transport costs (median = MK500.00), food 
carried to the health facility (median = MK0.00) and food and incidental costs (median 
MK50.00).
Table 17: Direct costs incurred by patients during care seeking
Type of cost Median (MK) 25tn quartile 75™ quartile
Consultation fees 0.00 0.00 100.00
Drugs/treatment 215.00 0.00 1350.00
T ransport costs 500.00 0.00 1255.00
Food carried 0.00 0.00 0.00
Food and incidentals 50.00 0.00 585.00
Total Cost 1600.00 500.00 3860.00
5.6.1 Differences in direct costs among patients initiating treatment
Variations in costs of care seeking by gender, rural or urban residence, welfare and the type
of facility where patient initiating ART (government or CHAM facility) were explored using
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the Mann Whitney test (Table 18). There were no significant variations for most of the direct 
costs by sex, except for the food and incidental costs. Male patients were likely to spend 
more on food and incidentals than female patients (p=0.030, Z =-2.175).
There were very significant differences in the different types of direct costs incurred by 
patients between urban and rural residence. The patients residing in rural areas paid higher 
costs for consultation fees (p=0,013, Z=-2.480), drugs and treatment (p=0.001, Z=-3.219), 
and on food and incidentals (p=0.008, Z=-2.671). The patients from urban areas however 
incurred higher transport costs (P<0.001, Z=-4.225). However, when all the different costs 
incurred were added together, there was no significant difference between the total costs 
incurred by urban and rural patients.
There was no significant difference in costs by poor and non poor residents for consultation 
fees, transport costs, drugs/treatment and food carried. There was significant difference 
between the poor and non poor on costs for food and incidentals, the poor spent more on 
food and incidental costs than the non poor (P=0.011, Z=-2.566).
The costs of care seeking varied significantly by whether the patient was initiating treatment 
at a government or CHAM facility. Patients initiating in CHAM facilities were more likely to 
spend more on consultation fees (P<0.001, Z=-5.931), drugs and treatment (<0.001, Z=- 
6.636), food carried (P<0.001, Z=-3.679) food and incidentals (P<0.001, Z=-5.169). The total 
costs of care seeking were therefore higher amongst patients who initiated treatment at 
CHAM facilities than in government facilities (P<0.001, Z= -5.747). However there was no 
significant difference in the costs of transport.
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Table 18: Variations in Direct costs of care seeking
Direct costs by gender
Male (n=169) Female (n=283) P-value
Median 25th 75th Median 25th 75th
Consultation fees 0.00 0.00 135.00 0.00 0.00 50.00 0.065
Drugs/treatment 370.00 0.00 1390.00 140.00 0.00 1300.00 0.071
Transport cost 600.00 0.00 1500.00 440.00 0.00 1130.00 0.291
Food carried 0.00 0.00 00.00 0.00 0.00 0.00 0.930
Food and 
incidentals
100.00 0.00 780.00 0.00 0.00 450.00 0.030
Total Cost 1920.00 600.00 4280.00 1500.00 440.00 3580.00 0.153
Direct costs by residence
Rural (221 ) Urban (n=231)
Consultation fees 0.00 0.00 150.00 0.00 0.00 0.00 0.013
Drugs/treatment 400.00 0.00 1580.00 30.00 0.00 1000.00 0.001
Transport Costs 80.00 0.00 1350.00 600.00 300.00 1200.00 <0.001
Food Carried 0.00 0.00 0.00 0.00 0.00 0.00 0.051
Food and 
incidentals
110.00 0.00 710.00 0.00 0.00 400.00 0.008
TOTAL COST 1920.00 420.00 4475.00 1480.00 550.00 3450.00 0.454
Direct costs by poverty status
Poor (n=265) Non poor (n=186)
Consultation fees 0.00 0.00 100.00 0.00 0.00 70.00 0.365
Drugs/treatment 300.00 0.00 1302.00 75.00 0.00 1377.00 0.174
Transport Costs 510.00 0.00 1375.00 400.00 0.00 1140.00 0.148
Food Carried 0.00 0.00 0.00 0.00 0.00 0.00 0.210
Food and 
incidentals
150.00 0.00 650.00 0.00 0.00 371.25 0.010
TOTAL COST 1820.00 675.00 4175.00 1442.50 400.00 3747.00 0.091
Type of facility
Govt (n=341) CHAM (n=111)
Consultation fees .00 0.00 0.00 50.00 0.00 250.00 P<0.001
Drugs/treatment 50.00 0.00 900.00 1000.00 180.00 3000.00 P<0.001
Transport Costs 500.00 0.00 1280.00 450.00 0.00 1200.00 P=0.686
Food Carried .00 0.00 0.00 .00 0.00 200.00 P0.001
Food and 
incidentals
.00 0.00 440.00 270.00 0.00 1150.00 P<0.001
TOTAL COST 1220.00 400.00 3045.00 3169.00 1185.00 6800.00 P<0.001
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5.6.2 Direct costs compared with the number of care seeking visits 
According to Figure 13, there was a general upward trend in the total costs for accessing 
health care (P<0.001) with the increasing number of health visits made by patients. The 
higher the number of health visits made, the higher the total costs of health care seeking.
Figure 13: showing the median costs incurred during health care seeking by the
number of health care seeking episodes
Costs of care seeking by patient number of health care 
seeking episodes
m tH 00 o »—1 m LO U5 '3'm ^r 00 UD If m CM r\iII ii n ii n II ii II li II
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Consultation fees 
Drugs/treatment 
Transport Costs 
Food Carried 
Food and incidentals 
TOTAL COST
Number of health care seeking episodes
5.6.3 Median Time spent on care seeking for a single visit 
The time spent on care seeking includes the travel time and the time spent at the health 
provider. The median travel time to and from a health provider was 177.0 minutes (IQR 
123.2 - 270.0 minutes). Table 19 summarises the travel time to the health providers by 
gender, residence, welfare, and type of facility where patients were recruited. There was 
significant difference in average travel time to the health provider amongst the urban and 
rural residence (p<0.001, Z= -6.226), the poor and non poor (p<0.004, Z= -2.855) and those 
initiating treatment whether in government or CHAM facilities (p = 0.023, Z= -2.275). 
Patients from rural areas, the poor and those initiating in CHAM facilities had longer travel 
time to health providers.
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Table 19: Average Travel time to a health provider for a care seeking episode (in 
minutes)
n Median 25th "75^ P-value
All patients
445 177 123.2 270.0
Gender
Female 279 180.0 124.3 267.1 0.394
Male 166 161.0 120.0 280.0
Residence
Rural 218 214.1 139.6 313.6 <0.001
Urban 227 150.5 117.0 217.0
Poverty status
Poor 261 188.6 130.2 288.9 0.004
Non Poor 184 165.0 117.5 240.0
Facility type
Government 336 171.5 120.0 253.0 0.023
CHAM 109 204.0 136.6 300.0
Tests using Mann Whitney
5.6.4 Total time spent at the health provider
The median time spent at the facility was 108 minutes for each visit (IQR = 73.5 - 160 
minutes). The rural residents spent a significantly longer time at the health facility than the 
urban residents (p=0.005, Z= -2.798). There was no significant difference in the time spent 
at the health provider by gender or poverty status as presented in Table 20.
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Table 20: Median time spent at a health provider for a visit (Minutes)
N Median 25th 75th P-value
All patients 405 108.0 73.5 160.0
Gender
Female 258 108.2 73.2 160.4 0.812
Male 147 105.0 75.0 152.0
Residence
Rural 207 120.0 78.0 168.0 0.005
Urban 198 98.7 72.2 135.3
Welfare
Poor 243 112.9 77.1 160.0 0.072
Non Poor 162 96.8 67.7 150.5
Using Mann Whitney tests
5.6.5 Indirect costs related to care seeking
The total time of care seeking included the time spent travelling to and from the health 
provider, time spent at each health provider and total admission days. Patients directly spent 
a median of 1.4 days in directly seeking care. However, patients also lose productive 
working days while they are seeking care. The median productive days lost during care 
seeking was 8.8 days.
Using the methodology described in Chapter 4 section 4.4.2, the number of productive days 
lost while sick and seeking care was converted into the equivalent of income that estimated 
using the average income earnings. The median average income lost due to care seeking 
was MK1838.00 (IQR). The median losses are higher for urban residents than for rural 
residents as urban populations tend to earn higher income. The poor significantly lose more 
income to seeking care than the non poor and this difference is evident even after taking 
residence into account. Both the rural and urban poor lose more income from care seeking 
than the non poor (p<0.001). However, there are no significant differences in indirect costs 
by gender and marital status.
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5.6.6 Total health Costs (direct and indirect Costs) and the economic burden of care 
seeking
The median total of direct and indirect costs related to care seeking was MK5286.90 (IQR 
MK1395.33 - 17214.70). The total costs of care seeking were significantly difference by gender 
^=0.007), the median costs of care seeking were higher among male patients (MK7036.20) 
than among female patients (MK4246.00). Although the difference was not significant by 
residence rural residents experienced higher total costs than the urban residents as shown in 
Table 22.
Table 22: Total Cost of illness and care seeking (MK)
characteristic n Median 25% 75% P-vaiue
All patients 450 5286.90 1395.33 17214.70
Gender
Male 169 7036.20 1988.00 21595.75
0.007Female 283 4246.00 1348.90 13532.60
Residence
Urban 231 4176.90 1376.00 17724.60
0.645Rural 219 6149.80 1410.60 16836.80
Welfare
Poor 265 5547.80 1656.20 18790.70
0.069Non poor 185 5138.55 1081.35 13655.75
Tests using Mann Whitney
In meeting the cost of care seeking, the median income required to meet the direct and indirect 
costs of care seeking and illness was equivalent to 0.8 monthly expenditure (IQR 0.2 - 2.7 
months). Male patients spent a median income of 1.2 months while for female patients a 0.7 
monthly income was required to cover health care costs. Rural residents significantly spent a 
higher median income than urban residents (p<0.001) as shown in Table 23. Both the rural non 
poor and poor patients lost income for a higher number of weeks than for the urban residents.
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Table 23: Monthly income required in meeting health costs
characteristic n Median 25% 75%
All patients 450 0.8 0.2 2.7
Gender
Male 167 1.2 0.3 3.3
Female 283 0.7 0.2 2.4
Residence
Urban 231 0.4 0.1 1.8
Rural 219 1.4 0.3 4.0
Welfare
Poor 264 0.9 0.2 3.3
Non poor 185 0.8 0.2 2.2
5.6.6.1 Sources of funding to meet health care costs
The majority of patients fund their health care seeking on their own (50.2%) or are supported by 
their spouses (21.6%). Relatively more non poor patients have the capacity to fund their health 
care seeking through their own or their spouse’s contribution. More poor patients proportionately 
mentioned funding their health expenditures through money from friends and relatives, children 
or parents, selling assets, and begging than non poor patients, as shown in Table 24.
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Table 24: Source of funding for health costs by poor and non poor patients
Poor % Non poor % Total %
Own 706 48.1 475 53.7 1181 50.2
From spouse 284 19.4 223 25.2 507 21.6
From friends/Relatives 158 10.8 72 8.1 230 9.8
From children/parents 160 10.9 51 5.8 211 9.0
Sold asset 48 3.3 5 0.6 53 2.3
Borrowed without interest 25 1.7 3 0.3 28 1.2
Borrowed with interest 12 0.8 5 0.6 17 0.7
Begging 6 0.4 0 0.0 6 0.3
Other 68 4.6 50 5.7 118 5.0
Total 1467 100.0 884 100.0 2351 100.0
Most (91.7%) of the patients reported that they did not have to wait to have money before 
seeking care. For a few visits (10.4%) patients reported that they had had to wait for sometime 
before they could find money to go to a provider.
5.7 Patient intentions about treatment continuation
All the patients had intentions of starting and continuing ARV treatment. While most of the 
patients mentioned that they would start their treatment in a facility close to their homes 
(61.1%), others chose to initiate treatment in another facility other than the one close to their 
homes. Bypassing a closer facility was more common for those attending a secondary level 
government hospital. Forty nine percent (49%) of the patients (out of 106 patients) interviewed 
from this facility mentioned they would bypass a facility closer to their homes for their ART 
treatment. The reason for bypassing other facilities were mainly recommendation from others 
(30.8%), perceived to provide good quality services (19.2%) and to provide effective treatment 
(13.5%).
In order to travel to the ART facility, most patients reported that they would have to use a bus/ 
minibus/matola (43.3%), walk (35.0%), use a bicycle (17.0%) or use own vehicle or taxi (4.7%) 
Other few patients reported that they would use matola, their own or hired vehicle. There was
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significant difference on the means of transport to be used when going to the ART facility by 
gender (X2=18.0, p<0.001) and residence (X2=114.5, p<0.001). More female patients were 
intending to walk to the ART site while male patients would use a bicycle as presented in Table 
25. Most patients in the urban areas would likely use a bus/minibus/matola, while in the rural 
areas most would use a bicycle. There was no significant difference by welfare level.
Table 25: Mode of transport by to the ART site by patient characteristic
Gender Residence Welfare
Transport mode Male Female Urban Rural Poor Non
poor
Bus/minibus/matola 42.2% 43.9% 63.0% 22.8% 43.1% 43.5%
Walk 26.5% 40.0% 32.6% 37.4% 38.2% 30.4%
Bicycle 25.9% 12.0% 0.9% 33.8% 14.5% 20.7%
Own vehide/taxi 5.4% 4.0% 3.5% 5.9% 4.2% 5.4%
Most patients (96.9%) felt they would be able to continue with treatment as per clinicians 
instructions and 86.5% did not expect to have any challenges that could hinder them from 
continuing with treatment while 1.6% did not know if there would be any challenges.
Among those (53 patients) who mentioned that could face some challenges to adhere to 
treatment, distance to the facility (54.7%), financial challenges (20.8%), side effects (11.3) and 
lack of food (7.5%) were mentioned.
5.8 Factors that contribute to patients not starting treatment 
The definition of not starting treatment in this study refers to patients who did not start treatment 
in the facilities where they were recruited; this excludes patients who transferred through formal 
processes to start ART at another facility. Out of the total 452 patients that were recruited into 
the study, 89.2% (404 patients) started ART, and 10.8% (49 patients) did not start treatment as 
shown in Table 26. Using the Fisher exact test, the characteristics of the patients showed that 
there were no significant variations between those who started and those who did not by 
gender, residence and poverty status.
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Table 26: Characteristics of patients who started and those who did not start treatment
Characteristic Started treatment Did not start treatment
n % n %
Gender
Male 152 37.8 17 34.7
Female 250 62.2 32 65.3
Welfare
Poor 235 58.6 29 59.2
Non poor 166 41.4 20 40.8
Residence
Urban 201 50 29 59.2
Rural 201 50 20 40.8
In order to determine the factors that contribute to patients not starting treatment, I used logistic 
regression analysis. The variables entered for the logistic regression included sex, age, 
residence, type of facility, transport cost, total direct costs of care seeking, indirect costs of care 
seeking and the burden of care seeking on income. The cost related variables and the income 
burden of care seeking were categorised into high or low using the median as the cut off point. 
Cost or burden was considered to be high, if it was the median or higher. The logistic 
regression model using univariate explanatory variables showed that patients who were 
recruited at the government district/secondary level hospital were more likely not to start 
treatment than those recruited at the mission secondary level hospitals (OR = 2.91 [Cl = 1.27 - 
6.64]) and patients with higher direct costs were twice as likely not to start treatment (OR=2.06, 
[Cl= 1.12- 3.81]) as shown in univariate analysis in Table 27. However, when multiple variables 
are included in the logistic model using a force entry method as in Model 1, then only high 
transport costs were associated with not starting treatment (OR 2.05, Cl = 1.01 - 4.14).
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5.9 Patient treatment outcomes
The patients who started ART (n=404) were followed up for a mean period of 15.0 months (SD 
= 7.2). Of those who started treatment as shown in Table 28, 65.6% were alive and continuing 
on treatment, 9.4% had died, 9.9% were lost to follow up and 14.6% transferred out to other 
facilities, and unknown for 0.5% patients. Eighteen (4.5%) of the patients who died during the 
follow up period, died within the first three months of treatment. The treatment outcomes 
showed a significant difference by gender (p= 0.019). More male patients died (14.5%) than 
female patients (6.4%), and more male patients (12.5%) were lost to follow up than female 
patients (8.4%). However more female patients (16%) transferred out to other ART sites than 
male patients (12.5%) as shown in Table 29.
Table 28: Showing treatment outcomes of patients who initiated ART
Treatment outcome Frequency Percent
Alive 265 65.6
Dead 38 9.4
Lost to follow up/Defaulted 40 9.9
Transfer out 59 14.6
Unknown 2 0.5
Total 404 100
Table 29: Treatment outcomes by sex
Female Male
Alive 69.2 60.5
Died 6.4 14.5
Lost to follow up 8.4 12.5
Transfer out 16 12.5
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5.9.1 Patient survival on ART
To determine the patients who survived on treatment the treatment outcomes (alive, dead, loss 
to follow up and transfer out) were recategorised into two: those who survived (which included 
- alive, and transfer out to another facility) and those who were not retained on treatment (which 
included those who died or were lost to follow up) at the end of the study follow up period.
Of the 404 patients, 4 patients were excluded from the analysis due to missing data: the 
treatment outcome was not known for two patients and 2 patients had missing data on date of 
initiating treatment.
On average, patients were followed up for 15.0 months, (min 0.4 and max 23.9 months). The 
survival curve using Kaplan Meier survival analysis is presented in Figure 14.
Figure 14: Showing the overall survival curve for patients who started ART
Number of months
Survival Function
Analysis using Kaplan Meier was used to see if there were differences in the survival by socio­
economic characteristics of the patients and the type or level of the health facility. The log-rank 
test to compare the survival times showed that there was a significant difference by gender 
(p=0.005) and welfare (p=0.028) on having a shorter time to attrition. According to Figure 15 
and 16, female patients have better cumulative survival time than male patients, and the non
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poor have better survival than the poor. There was no significant difference in attrition from ART 
by rural and urban residence (p=0.970) as can be seen in Figure 17.
Figure 15: Patient cumulative survival by gender
— 0 8-
Numbcr of months
Patient
Sex
—f-1 Female 
—1—1 Male
Figure 16: Patient cumulative survival by welfare
Poverty
status
Non poor_ 06-
.2 0 4-
Number of months
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Figure 17: Patient cumulative survival by residence
Number of months
Residence
—i-'Urban 
—i-1 Rural
Using Cox proportional hazards to analyse the effect of survival by the explanatory factors, I first 
used univariate explanatory variables to test the impact of each explanatory variable. The 
findings in univariate Cox regression showed that being male was associated with more 
likelihood of death and loss to follow up from treatment (HR = 1.87 [1.20 - 2.93], p=0.006). Poor 
patients were also more likely to die or be lost to follow than non poor patients (HR 1.72 [1.05 - 
2.81], p=0.03). The transport costs and total direct costs of health care seeking prior to ART 
initiation did not have significant impact on death or loss to follow up from treatment.
In the multivariate analysis, I used the stepwise regression analysis only taking into account 
covariates that were significant at 95% confidence interval and socio-economic characteristics 
of the patients and the type of health facility from where they initiated treatment (Table 30). In 
the model, male sex of patient and being poor continued to have significant impact on patient 
survival. As indicated in the table, men have a higher likelihood of death and loss to follow up 
than female patients (HR = 1.97) and the poor have high risk of death (HR = 1.7).
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Table 30: Factors associated with loss to follow up and death among patients
Univariate analysis Multivariate model
Characteristic Exp (B) 95%CI Exp(B) 95%CI
Sex
Female 1 1
Male 1.88 (1.199 -2.933) 1.97 (1.215-3.187)
Age
Older than 30 years 1 1
Younger than 30 years 1.05 (0.655- 1.683) 1.31 (0.971 -2.187)
Residence
Rural 1 1
Urban 1.01 (0.645-1.577) 1.65 (0.797-3.397)
Welfare
Non Poor 1 1
Poor 1.72 (1.054-2.807) 1.72 (1.044-2.829)
Facility type
Mission hospital 1 1
Government Hospital 0.70 (0.349-1.413) 0.50 (.222-1.129
Health Centre 0.79 (0.430-1.436) 0.52 (0.252- 1.090)
Community Hospital 0.99 (0.552- 1.773) 0.97 (0.521 - 1.979)
Transport costs
More than MK500 1
Less than MK500 1.01 (0.646-1.585)
Direct costs of care seeking
More than MK1600 1
Less than MK1600 0.10 (0.637-1.556)
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5.10 Conclusion
I found that most of the patients seek care for common illnesses such as fever, malaria and 
cough. About a third of the patients when they seek care think they have malaria. Patients make 
multiple visits to different health providers ranging from self-treating to visiting private clinics, 
public hospitals and health centres which results in delay to HIV testing and, ultimately, delay in 
initiating ART. This was reflected in the fact that most of the patients sought an HIV test due to 
illness and there was usually not a long delay from the time of HIV testing to the process of ART 
initiation. The study showed that most patients initiating treatment at are advanced stages of 
illness. Over half of the patients in this study, (close to 60%), in this study were poor and among 
the direct costs that they incurred, transport costs were more common and higher than other 
direct costs of care seeking.
The quantitative findings have showed that inequities exist in how patients experience care 
seeking for HIV and ART services. Health care seeking is influenced by the socio-economic 
factors which also affect patient treatment outcomes. Most of the patients in this study are poor. 
The health care seeking behavior was characterized by multiple visits to health providers 
leading to delay in HIV diagnosis and ART access. The cost of care seeking was high with 
about half of the patients spending close to one month’s income on care seeking. The rural 
residents particularly spent more of their income on care seeking. There were some patients 
who did not start treatment despite their knowledge of the need to start treatment. The study 
has shown that the type of health facility and direct costs of care seeking (particularly transport 
costs) have an influence on whether patients start treatment or not. Socio-economic factors 
such as sex and poverty were identified as factors that affect patient retention in care.
The quantitative data raised a number of critical questions which require further inquiry and 
these were followed up through qualitative exploration. The qualitative follow up study was used 
to find out why patients had delayed HIV diagnosis; why patients do not start treatment when 
they know they need to start treatment; the factors hindering retention in ART programs and the 
experiences of health workers in providing and supporting patients on ART. The findings from 
the qualitative study have been presented in Chapter 6.
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Chapter 6: ART initiation, adherence and loss to follow up from 
antiretroviral treatment: Patients, health worker perspectives and 
experiences from the field
6.0 Introduction
This chapter presents the findings from the qualitative study to understand key research 
questions arising from the quantitative analysis. The questions in the qualitative study included:
• Why are most patients diagnosed at late stages of HIV infection?
• What are the factors that contribute to patients not starting ART?
• What are the facilitators and hindrances to ART adherence among patients on ART?
• For patients who adhere to treatment, what are the facilitators to treatment adherence?
• What are the issues that health workers experience in providing services and supporting 
patients on ART?
In the qualitative component we interviewed four categories of participants. These included:
a. Patients who were lost to follow up
b. Patients who had not started treatment
c. Patients who were on ART and were continuing with treatment
d. Health workers.
Health workers were included to capture the understanding of health workers about factors that 
they feel influence experiences of patients from the health system perspective. A total of 6 
health workers were interviewed.
Over the study period we followed up a total of 52 patients. Thirty four (65.4%) of the patients 
were female. Over 65% of the patients followed up were poor and 48% were from urban areas. 
We traced the respondents through the physical maps that they had provided us or through a 
phone call to make an appointment to meet at a time of their convenience (if they had provided 
a phone number). The patients we followed up had given us prior consent to be followed up 
during the time they were being recruited into the study. A summary of the patients followed up 
and the reason for following are presented in Table 31.
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Table 31; Summary of reasons for following up patients by residence and poverty level
Reason for
follow up
Rural Urban Total
Male Female Male Female
Not started treatment (Interviewed = 14)
Poor 2 5 2 4 13
Non poor 2 3 1 3 9
Loss to follow up (Interviewed = 5)
Poor 4 4 4 5 17
Non poor 1 3 1 3 8
Successfully on treatment (interviewed = 6)
Poor 2 1 1 4
Non poor 1 1 - - 2
Total 52
Not all the patients who were followed up were interviewed Out of the 24 patients who were 
identified as lost to follow up: 11 patients had died; 4 patients had not missed any of their 
treatment appointments, but their treatment cards had not been updated and that was why they 
were identified as defaulters; 2 patients were not found based on the maps they had provided; 
one woman used a name she does not use and we were not able to reach one woman because 
of a damaged bridge. In total therefore we interviewed five patients who had been lost to follow 
up from treatment.
So we were able to interview 14 patients among those who had not started treatment; one 
patient could not be found, six had died and one patient was on treatment but under a different 
name. Of the 14 patients, eight patients had been told they were not yet eligible for ART (the 
analysis of the findings for these patients have been included as they provide insight into the 
challenges for pre-ART care and ART eligibility assessment for patients not in WHO Clinical 
stages 3 and 4 requiring CD4 cell count tests).
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6.1 Factors contributing to delay in HIV diagnosis and ART access
6.1.1 Delay to HIV testing
The results from the quantitative study showed that the most common reason for having an HIV 
test is sickness. Almost 60% of the study participants had had an HIV test due to sickness. 
Similarly among the respondents followed up for qualitative interviews, two thirds of the 
participants had an HIV test because of sickness. The quantitative results showed that most 
patients had a long health care seeking pathway and made a median of six visits from the time 
they perceived their sickness to be serious to having an HIV test, to the time they attended 
counselling for ART initiation. Among patients who had perceived their illness becoming more 
serious before they had had an HIV test (n=344), the median delay from perceiving their illness 
to be serious to having an HIV test was 52.5 days (IQR 19-143.5). During the qualitative 
interviews, some patients explained how they had sought health care from different providers 
until they felt that their health was not improving and then opted to have an HIV test. Both 
shopping for care from different providers and waiting until the condition is very bad before 
seeking an HIV test contributes to delay in HIV treatment access, as shown in the 
representative quotes below:
That time I had tumors in some parts of my body, i tried many ways to heal the sickness 
but it all failed, then I decided to go to the hospital for help. I went even to Mtengo wa 
nthenga hospital but it did not help as well, so I decided to come back to Kabudula 
hospital. After seeing that the problem was becoming bigger and bigger, I decided to test 
for HIV.’(Rural, none poor, Male patient on treatment, Tsare village)
"/ went to a traditional doctor, I never went to the hospital where they provide tablets no, 
but I went to a traditional doctor. I went there to take traditional medicine. So when I was 
taking these traditional drugs, I felt that I was not getting the real medication because I 
could feel better today and tomorrow and the third day you will find that it’s getting worse 
and that means I will start suffering from cough again... I started going to the hospital 
because I was very sick, I had pneumonia, I had breathing difficulties, and I couldn't 
manage to sit upright. So I went to Namitete hospital and they also gave me injections 
and the pneumonia improved, I felt at least better. Then I started suffering from cough. 
So that is when my sister encouraged me to go for HIV testing." (Poor, urban female 
patient, lost to follow up, Area 18 Health Centre)
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6.1.2 Challenge of disclosure of HIV status within the family
Most of the patients reported that they accepted the HIV results and had at least disclosed to 
someone in their family about HIV. There were however some experiences among patients that 
showed that disclosure was not easy due to several factors. These included fear of stigma and 
not wanting to cause anxiety or worry for loved ones especially children. For women, disclosure 
to their husbands was more challenging particularly in the light of PMTCT. The case study 
below presents an illustration where in a polygamous family, one of the wives was not able to 
disclose her HIV status to her family which led to the husband shopping for care from different 
providers before considering an HIV test.
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Case Study 1: My wife did not tell me she was HIV positive
Mr Chemusa is 46 years old and is married to Rute (36) and Nangozo (34). Nangozo had an 
HIV test in December 2008 when she was pregnant and attending ANC. Nangozo was found 
HIV positive, but she kept her status to herself. In March 2009, Mr Chemusa got ill, the signs 
and symptoms he experienced included fever, body weakness and sores on his body. He then 
started seeking care from different providers. Because of the sores he went to a mission health 
facility which is quite far from his village. He then bought drugs from a grocery store close to his 
home a few times, mainly because of the fever which he thought was due to malaria. When he 
saw that he was not getting better, he visited traditional healers and later decided to visit a 
health facility again. Upon seeing that his health was still deteriorating, he then decided to have 
an HIV test. It was when the test turned out positive that he was referred for ART. The health 
workers at the ART clinic expected that he would go to the hospital with his wife, Nangozo, as 
they had told her sometime back, for the PMTCT programme to go to the hospital with her 
husband. It was at this point that he learnt that his wife had known of her HIV status but had not 
revealed it to him. The man then asked his second wife, Rute to also go for an HIV test and she 
was also tested HIV positive. When we visited the family in October 2010, Mr Chemusa was on 
ART and very thankful, pointing out that if he had not gone for the HIV test he would have been 
dead by now. Nangozo was expectant with another child and on PMTCT, while Rute was on 
cotrimoxazole prophylaxis. {Constructed from interview with a rural non poor male patient on 
ART and his two wives who had not started treatment)
The health workers also confirmed that disclosure was a challenge that married women in 
particular faced, even though they promote that the first choice for a treatment guardian for 
married patients should be their spouse.
‘We sometimes face this problem that partners do not disclose to one another because 
they know that if they tell their partners, especially women, they think that the husband is 
going to marry another wife, or that if they tell their relatives, they will be sidelined. When 
they come here, it is our responsibility to encourage them and even unite them as a 
family. We tell them that if a person is HIV positive, it does not mean that he or she is not 
supposed to be married because this should not be a barrier” (ART nurse, Mitundu)
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6.1.3 Health workers' role in referring patients for HIV testing: Facilitates or causes 
health system delays?
The quantitative results showed that cumulatively of all the health care seeking visits reported 
by patients, referral by health workers was the third most common reason for the choice of a 
health provider among patients. The qualitative data showed that about half of the patients who 
were tested due to sickness mentioned that they were referred for HIV testing by a health 
worker. Patients mentioned that when the health workers saw that a patient was not responding 
to treatment, they referred him/her for HIV testing. WHO/UNAIDS (2007) guidelines 
recommends that all adults and adolescents patients should be referred for HIV testing through 
Provider initiated Testing and counselling (PITC) regardless of reason for presenting to a health 
facility. However the results in this chapter show that health workers were motivated to refer 
patients for HIV testing if they had been sick for some time and they felt they were not getting 
better, as illustrated in the quotes below:
“Most of the times I used to go to Kasiya Health Centre due to malaria and when the 
nurse at that facility saw that I was coming time and again she took me for HIV testing 
and the results showed that I was found positive" (A rural poor female patient on ART, 
Nkuwila Village).
While the health workers played an important role in referring patients for HIV testing, the 
qualitative data shows that health workers selectively refer patients for HIV testing based on 
suspicions raised by symptoms being presented, or because treatments prescribed previously 
are not being effective. (This is apart from certain types of patients e.g. pregnant women and TB 
patients, where explicit guidelines are available for routine HIV testing) as illustrated in the 
quotation below.
“There are some who make requests on their own for them to be tested in order for them 
to know their status but there are some whom we suggest should be tested according to 
the condition of their sickness and if they say no, then we don't force them. We don't 
offer an HIV test to each and every patient but we only suggest to those whom we 
suspect might have HIV. Let's say some one is on TB treatment, we have to ask that 
person to be tested for HIV, and also pregnant women - we tell them to go through HIV
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testing as well as those who fall sick time and again and if they have been receiving 
treatment, but they are not improving to the extent of coming again to the hospital with 
the same problem, we tell them to be tested. There are certain diseases which we know 
that if a person is having them, definitely this person is HIV positive. ” (ART clinician, 
Kawale Clinic)
The situation above results in some departments and clinicians actively referring patients for 
HIV testing while others do not as such leading to delay in patients accessing treatment. The 
literature review in section 2.2.3.4 and in section 6.6 referred to negative attitudes of health 
workers, a lack of sufficient supplies and insufficient training in PITC as a hindrance to PITC.
7 can say some clinicians refer patients for HIV testing, others do not. Others refer them 
earlier after seeing on the visit what that patient has been going through, while others 
due to pressure of work just prescribe treatment to the complaint brought by the patient 
at the particular visit and tell him to come again if there will be no changes. But if they 
see the patientcoming for some time, they then refer that patient for HTC, so that is what 
causes the delays to starting treatment. There are usually more patients, who are 
referred for testing from some wards compared to other wards. For example the 
pediatric department, and many patients also come from the Male Ward (patients 
admitted in the Male Medical ward at the hospital) and those who have been diagnosed 
with TB,as it is a must for every TB patient to be tested. But few patients come from the 
outpatient department (OPD)” (ART nurse, Nkhoma Hospital).
The failure of some health workers to refer patients for HIV testing was reflected by one patient 
who complained that while he had been making repetitive visits to the hospital with his wife who 
had been very sick, none of the health workers referred them for HIV testing and it had taken a 
friend from their neighborhood who was also on ART to encourage them to go for HIV testing.
“My wife was very sick, it is unbelievable that she is still alive. She was not like this. We 
were going to the hospital for treatment but it was not helping. We went to different 
facilities to Bwaila, Likuni but her illness kept getting worse. One day a friend came and 
asked her to go to the hospital to have an HIV test as she was also on ARV treatment. 
She mentioned how she had also been very sick but no one could now recognize that
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she had HIV because of the treatment. Therefore we agreed for both of us to go for the 
HIV test and we were both HIV positive" {Urban poor male patient on treatment, Likuni)
The quote above shows that the patients trusted and expected that the health worker should 
have been able to make a decision regarding the condition of the patient and direct them to the 
appropriate next steps and treatment which would include the option of HIV testing. The health 
worker not referring for HIV might be interpreted by this patient as providing poor quality of care. 
It is also unlikely the patient right would have hindered by an offer of a test for HIV as they were 
able to accept a suggestion from a friend. By health workers not offering an HIV test, patients 
rights to health through early ART initiation is denied.
6.1.4 Delay from HIV testing to ART referral and starting ART 
The quantitative data showed that 58.4% of the patients had been referred for ART within 30 
days of having an HIV test while 26.2% were referred more than 90 days after the HIV test. This 
shows that most of the patients were already in advanced stages of HIV by the time that they 
had an HIV test. The analysis showed that there was a time lapse from the time that patients 
were identified eligible for treatment to the time that they actually started ART. This included the 
period where patients were supposed to undergo ART counselling to make sure they 
understood the implications of ART and also had a guardian to support treatment adherence. 
The median period from being identified eligible for treatment to starting treatment was 20 days. 
However, there were some patients who took longer to initiate treatment. Interviews with health 
workers showed that this was common among patients but indicated that they did not follow up 
these patients, as starting ART is voluntary and patients are not forced.
Health workers mentioned that they came across patients, who were referred for ART or even 
attended the ART counselling, who return to the facilities for ART several months later. The 
health workers felt this might result not because of the patient him or herself, but sometimes 
because there are some problems when communicating the test results to the patient during 
HIV testing and counselling.
"We sometimes come across patients that had been taught about ARV and have
undergone ARV counselling coming six months later to start treatment yet when they
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received ART counselling they were told to come the following day to start treatment. 
Sometimes, the problem arises because the counselling was not properly conducted and 
the patient does not really understand about why they needed to start ARVs. For some 
patients it is because they did not believe that they were HIV positive although they were 
told about their HIV status result. There are some patients who are referred here (ART 
clinic) without being told why they are coming to this department and, not knowing their 
status, so there are problems that also come from poor communication from the HTC 
counsellors” {ART clinician, Kabudula).
From the patient perspective, delay to starting treatment was influenced by challenges in 
acceptance of an HIV positive test and among some patients it was because of a lack of 
financial resources for accessing treatment. Patients reported how difficult it was for them to 
make a decision to actually have the HIV test and that, after receiving the results, it takes 
courage to take the test and accept the results. A male patient, who after knowing his HIV status 
and needing to start ARVs, had waited for a year before going for ART. He mentioned how 
difficult it was for him to accept his HIV test result.
7 took long for me to start treatment after I had an HIV test because for one to make up 
his /her mind to go for VCT it is not easy, it requires one to make a very tough decision 
because one has great fears. It was by grace that we went there [with his wife] because 
of the sickness of my wife. At that time we were thinking that it was just malaria and in 
the process of getting help, she was also diagnosed with TB as well. To accept such 
results it was not at all easy for me, I have to testify, I have heard that people do commit 
suicide after getting HIV positive results.” (Urban poor Male patient on treatment, 
Chinsapo)
Health workers reported that most of the patients who delayed going to start treatment after 
knowing their eligibility usually returned to the hospital at a more advanced stage of illness.
A female patient, who also delayed for about a year before starting ART, reported that poverty 
contributed to her delaying starting treatment. However, this only led to her health deteriorating 
further as shown the illustrative quotation below:
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“...I was very poor it was very difficult for me to go to the hospital to start treatment due 
to lack of transport. So because of that I stayed for a year without starting treatment 
while the diseases increased then my children took me here because I was very ill and I 
was admitted here where I was diagnosed with TB. I stayed in this hospital for 14 days 
and I was told to continue the TB treatment.” {Rural poor female patient on ART, Nkuwila 
Village).
6.1.5 Health system delay from ART eligibility to initiating ART
In spite of following the ART guidelines for initiating patients on ART, variations persisted in the
time that it took to finalise the clinical staging, ART counselling and initiation of drugs for some 
patients, in the secondary level hospitals, the ART clinic were open all working days of the 
week, and group counselling sessions were at least twice a week. In health centres and the 
community hospitals, the ART clinics were running on at least two days a week and group 
counselling sessions were usually once a week. The number of counselling sessions also varied 
in most of the facilities: in some, one group counselling session was conducted and then one to 
one counselling with the patients, while in some clinics, two group counselling sessions were 
necessary. In these facilities it took the patient up to three weeks from the time they presented 
at the ART clinic before starting treatment.
“For a person who has just known their HIV status, it takes three weeks before they start 
ARVs because they would need to come next week for group counselling, then the other 
week for another session of counselling, then the week following this second session, 
they start treatment” {ART nurse, Nkhoma Mission hospital)
Health workers pointed out that they needed to make sure that they carefully deliver the 
counselling so that patients could understand the treatment process. It also gave people who 
had just realised their HIV positive status the time to come to terms with their diagnosis. 
However, where they felt it necessary, the health workers could fast track some patients through 
the ART initiation procedures but still make sure that the patient understood the commitment 
and requirement that they were getting into when starting treatment.
“The reason is that these drugs are dangerous so it requires that the patient is taught 
and clearly understands the procedures about how to take these drugs. This is because
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once a person accepts their condition and start these drugs the person wiil not stop 
taking them ... while those who have just started without accepting their condition and 
without understanding the procedures and what is expected of them are the ones who 
default easily. Sometimes they only receive the starter pack and don’t return to take their 
subsequent refills.” (ART clinician, Area 18 Health Centre)
Health workers also felt that the initiation process was important and even if it was long, it
should not demotivate patients from initiating ART.
“I don’t think that this procedure which takes between two to three weeks can make a 
patient not to come here at the hospital to start treatment but to me it is one way of 
helping the patient to understand better the whole process of the drug. Because if we 
say they should be counselled and start treatment on the very same day they have been 
tested and staged, the patients will not know when they experience some side effects 
that these are due to the ARV drugs if they were not properly counselled, as even the 
starter pack has its own side effects.” (HS A, Kabudula Community Hospital).
6.1.6 Health workers' attempts to cut delay to starting ART
While the ART guidelines require patients to have a treatment guardian, and in most cases
health workers make sure all the requirements were followed, health workers also pointed out 
that there are instances where they might go against the guidelines to protect a patient’s health 
from worsening further.
“In some cases we initiate a patient on treatment without a guardian because some 
patients will come to attend group counselling without a guardian, and we will tell them to 
go back and bring a guardian but you find the patient still comes another time without a 
guardian. So in such cases we know that the patient is delaying in starting treatment and 
to avoid the patient’s condition from worsening, we do allow some of the patients to 
attend the group counselling and start treatment but we know this is against the ART 
guidelines” (ART clinician, Kabudula Community Hospital).
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6.2 Why do patients not start ARV treatment?
The quantitative results showed that 49 out of 452 (10.8%) patients recruited, did not start 
treatment. In the quantitative univariate regression analysis, patients with high direct 
expenditures for care seeking were less likely to start treatment than those with lower health 
direct cost and patients initiating treatment at government or secondary district level health 
facilities were less likely to initiate treatment. The regression model analysis showed that high 
transport costs were almost twice as likely to defer patients to not start treatment. Data from 
following patients and also from the health facility treatment records showed that 8 patients 
(16.3% of the patients who had not initiated treatment) had died (as not all patients who had not 
started treatment were followed up, the actual number of patients who might have died before 
starting treatment is not known). 14 patients were interviewed and as shown from the section 
6.1, eight of the patients followed up reported that they were later told by their clinicians that 
they were not yet eligible for treatment. Six patients who were supposed to start treatment but 
had not returned to the health facility for different reasons were interviewed. The reasons 
reported by the patients for not starting treatment included challenges with transport, temporary 
migration, lack of support, fear of stigma and discrimination. However, though patients 
mentioned the main reason for not starting treatment, it was clear that these factors were 
influenced by broader social relations and circumstances around the household and highlighted 
the uniqueness and complexity of each individual patient’s case. The reasons reported for not 
starting treatment are explored in detail in sections 6.4.1 to 6.4.3, which include case studies to 
provide a broader context for why patients did not start treatment.
6.2.1 Lack of money for transport
Most of the patients reported that transport was a challenge for them to continue accessing 
treatment, even though they knew they were eligible for starting ART. Transport challenges 
were not unique to patients who did not start treatment but have also been reported by patients 
who were adhering to treatment.
While other patients also mentioned that transport was a challenge for them in accessing ART, 
two female patients reported it as the main reason for them not initiating treatment. One of the 
female patients reported that she had not started treatment due to lack of financial support. She 
mentioned that though her husband or brother could have used a bicycle to take her to the 
hospital, both of them had gone to Mozambique to work on tobacco farms. 33.8% of the rural
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patients in the quantitative study mentioned that they would use a bicycle to travel to the ART 
facility.
Below is the case study of the other female patient who had been unable to return to the clinic 
because she did not have transport money. At the time of the follow up interview she was on 
the PMTCT programme in a clinic close to her home, but it did not offer other ART services.
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Case Study 2: I do not have transport money
Linda Fikiwe, a 28 years old female, is a single mother. Her husband left her the previous year 
to go to his village in another district. During the survey, she reported she had known her HIV 
status in April 2009, but as we had followed her to find out why she had not started treatment 
she tells us that she first learned her HIV status in 2007 during the pregnancy of her first born 
and had been on a PMTCT programme. Her son was born healthy and was HIV-negative. In 
2009, she had another HIV test because of sickness. She explained that in May 2009, after she 
had attended the group counselling, she was given bactrim and advised to go back to the 
hospital the following week so that she could start ARVs. For Linda to go to the hospital, she 
travels using matola and pays K200 each way. However, Linda never went back to the facility 
as she did not have money to pay for the transport. Linda lives within the network and support of 
her mother and other relatives; but none of the relatives has provided money so that she can be 
on treatment. The family has enough food as evidenced by the full granary behind their house. 
At the time that we visited her, she was in her 9th month of her second pregnancy. She had just 
been ill from measles and had been admitted in a health centre close to her village for a few 
days. Linda seems to have lost a lot of weight, was very weak and she had to crawl on her 
knees in order to come out of her small house to the veranda. She tells us that she is on 
treatment which she is receiving from a nearby health centre but does not know the purpose of 
the drugs she is taking. She shows us her drugs which she explains she takes in the morning 
and evening. We notice that the drugs are a dual combined therapy for PMTCT. As we are 
leaving, some of her relatives tell us how their relative is suffering from 'chifuwa chachikulu’ (TB) 
and ask us if we will be providing support for their sick relative, particularly transport so that she 
can go to the hospital. Her 3 year old son is the heir to the chieftainship of the village and all the 
necessary cultural celebrations had been held the week before our visit. As we leave her house 
we are not sure how the delivery of her baby will impact on her already weak body and whether 
she will survive the delivery and live to see her son become the traditional leader. (Constructed 
from an interview with a rural non poor female patient who had not started treatment, Kazumba)
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6.2.2 Not feeling ill
In the area surrounding the rural hospitals where the study was conducted, it was common for 
people to travel to neighbouring Mozambique (which is not very far from these areas) to work in 
tobacco farms and estates. A male patient reported that he had travelled to Mozambique to 
work, and that is why he had not started treatment. After returning, however, he made no an 
attempt to return to the ART clinic because he said he was feeling well and he did not have a 
bicycle that he could use to go to the hospital.
Another male patient mentioned that because his wife refused to be his treatment supporter and 
because of fear of stigma at work, he had not gone to start ART, however, the interview showed 
that this was also because he had been feeling well.
Case Study 3: My wife is refusing to be my treatment supporter
Mr Mvula, a 45 year old man, had been sick and thought he had malaria for sometime. During 
the time he was ill he had made a number of visits to Likuni Hospital and he was referred for an 
HIV test. He decided to accept the HIV test because of his sickness and also because of the 
death of his child. He was then referred for ART and group counselling after being assessed as 
eligible to start treatment. He attended the first ART counselling session and was asked to 
return the following week. As a patient is required to have a treatment supporter, he reported 
that his wife refused to go with him to the ART counselling session because they had a 
disagreement the night before they were supposed to go to the hospital. Mr Mvula reported that 
his wife had been angry with him because he had gone for some drinks in the evening and 
returned home very late at night and refused to go with him to the health facility. Mr Mvula, 
seeing that his wife was no longer interested in going to the hospital, also decided not to return 
to the health facility as he was feeling better. Mr Mvula said he was also afraid of being 
stigmatised at his work because he had also been a person who had been stigmatising others 
and gossiping behind their backs. Therefore knowing how his workmates behave, he feared that 
his friends would gossip about him if they realised his HIV status. Mr Mvula mentioned that 
although he was willing to go back to hospital, he was not sure of the reception he would 
receive at the hospital. (Constructed from an interview with a rural non poor male patient who 
had not started treatment, Malingunde).
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6.2.3 Lack of information about patients who delay or do not start treatment 
Most of the facilities do not have formal lists of patients that have been referred for ART, and the 
number of patients who finally start treatment. Patients are then registered after they have gone 
through the counselling session and are starting ART, as in the quote below:
“We don't track or keep records that these are the patients we were expected to have on 
the day of treatment commencement; of course, we do indicate in our note book the 
number of people who attended group counselling, but you will find out that out of 12 
people who attended only 3 come to start treatment So we don't follow them and ask 
why they have not come, but we only register those who have started treatment and are 
followed up if they are not coming.” {ART clinician, Kabudula)
6.3 Early deaths among patients on ART
Patient record keeping was done manually in most of the health facilities. Only one ART study 
site (Martin Preuss Centre) had an electronic register but for the rest, all patient data was 
managed manually. The ART clerk therefore updated patient master cards each time the 
patient came to the ART clinic. Among the patients recruited in the study, 65.6% were alive and 
continuing on treatment, 9.4% had died, 9.9% were lost to follow up and 14.6% of the patients 
transferred out to other facilities.
Among 404 patients who had started treatment in this study, 38 patients (9.4%) died during the 
follow up period. Among all the patients who had died, 18 patients (47.4%) had died during the 
first three months of initiating treatment. This was confirmed by the health workers who reported 
that most of the patients that die while on ART die within the first three months of treatment.
Factors contributing to early ART deaths: Health worker perspectives
Health workers reported a number of factors that they felt contribute to early deaths amongst 
patients on ART, but a major factor was treatment initiation at advanced stage of illness 
resulting in treatment failure, as shown in the quote below:
“The problem is that many of the patients who die after starting the ART started 
treatment very late when they were very weak and sick at stage 4. As a result they don't
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do better and they die soon. When we go into our medicai books, sometimes when a 
patient starts treatment there is a reaction in the body which is called Immunal 
Reconstitutional Syndrme (IRS) which means a reaction between drugs and the 
diseases in the body, so sometimes a patient might die due to this reaction” (ART 
clinician, Kabudula Community Hospital).
Poor nutrition was also cited,as most patients were usually wasted when they start ART. Due to 
poverty, patients are not able to provide themselves with good nutrition. Some facilities were 
not able to provide nutritional supplements to patients who needed them due to erratic supplies.
“The other reason is to do with nutrition because there are some who come here let’s 
say at 29kgs and at that time we don’t have plumpy nut, no maize meal, no oil and they 
are also poor in their homes; they don’t have anything. As a result they also die due to 
lack of nutritional support. We hear that some clinics provide food supplements but here 
we are not providing regularly as the supply is not sustained, but when plumpy nut is 
available we provide to the patients.”(ART clinician, Kabudula)
Lack of support for patients due to patients not disclosing their HIV status was also reported as 
leading to early deaths.
“A patient may be very sick at the time they have finished their drug supply and if there is 
no one at the time to come to the hospital to collect their refill drugs, the patient may go 
without the drugs. The challenge is that most people don't disclose their status to their 
relatives and the patient may come to the group counselling without a guardian and 
sometimes it is because at the time of the ART counselling, they were too sick to 
remember what they were taught and, as such, go without taking drugs.” (ARTnurse, 
Kawale)
However, health workers were encouraged by the fact that more people were now becoming 
more knowledgeable about ART and the importance of knowing their HIV status; they are 
finding that more patients are accessing treatment at earlier stages of illness. The presence of
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support groups in the communities was felt to be making a difference to promoting early HIV 
diagnosis.
"At first people were not coming to test their blood while in good health condition, they 
were waiting until they were very sick. But now when they have started the ARVs, they 
go to their homes and join support groups present in their areas and receive 
encouragement from other members. This is influencing other people to come and want 
to know whether they are HIV positive or not. So those people who are coming for 
testing as a result of those community influences start treatment while strong and when 
they tested to find out their CD4 count, they start treatment at the right time and this is 
really very good." (ART nurse, Nkhoma)
6.4 Loss to follow up and challenges and facilitators to adherence
During the follow up period of the patients who had started ART, a total of 40 patients were lost 
to follow up. Over the study period we followed up a total of 24 patients who had been lost to 
follow up. There were challenges in determining true loss to follow up amongst patients on ART. 
During the follow up of patients 11 patients (45.8%) out of the 24 patients, who had been 
classified as lost to follow up had actually died. Additionally due to challenges of updating 
patient records, 4 patients (16.7%) who were continuing with their treatment had also been 
classified as lost to follow because their treatment cards had not been updated on some of their 
clinic visits. We had not been able to trace three patients, therefore 6 patients out of the 24 that 
were followed up were found to have indeed been lost to follow up or had missed treatment 
appointments at one point. We were then able to interview five patients (three women and two 
men).
All the patients who were on ART (including those who had been lost to follow up) agreed that 
adherence to antiretroviral drugs was very important and believed that interrupting treatment 
could have consequences, such as sickness and death.
"I feel like what could happen if l am not adhering to treatment is that at any time I can 
fall sick and even die a sudden death because l have stopped taking the drugs, in fact 
had it been that I was not taking the ARVs, I could have been dead by now. But I am 
alive because I started taking the drugs. Stopping taking the drugs along the way can
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cause my immunity go low as I was before and I can die eventually. ” (Urban poor female 
patient who interrupted treatment, Mchesi)
This shows that despite knowing the importance of adherence, there are sometimes factors 
affecting the patients that lead to interrupting treatment. The quantitative data also shows that 
the poor are more likely to die or to be lost from ART. Patients in the qualitative data also 
showed that patients stopped treatment due to a complex interplay of reasons such as poverty, 
travel, or lack of support.
6.4.1 Poverty and lack of a reliable income
Poverty and an unreliable source of income caused one single mother to stop her treatment.
Her husband had been the breadwinner in the household. After he passed away she was forced 
to do casual labour in order to earn an income to support her children and also support her 
treatment.
'7 started missing treatment in the month of January. I stay with many children and I am 
a single mother and we did not have food at home. I usually do ganyu (casual labour) 
such as washing clothes but I could not find any ganyu, as such I could not afford K200 
to use as transport to the hospital, so I went the whole month without getting my drugs. 
Money was so scarce in those months" (Urban poor female patient who interrupted 
treatment, Kauma)
6.4.2 Marital obligations and fear of divorce
One woman in Case Study 4, stopped treatment on account of the feeling that she was wasting 
her time taking drugs as she feels she is continually getting re-infected. (Despite being on 
treatment, she continues to engage in unprotected sex with her husband, who is in a 
polygamous marriage).
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Case Study 4: If I refuse to have sex with him, he will divorce me
A 26 year old female who is married had missed drugs for three months. She had missed the 
first month because she had been away from home for a month, however she continued 
missing her drugs the second and third month because she was afraid of how the health 
workers would react when she went back to the hospital. However, she also said that she felt 
that she was not being truthful with herself as her husband had refused to have an HIV test, 
saying her sickness was none of his business. He also refused to use a condom which usually 
affects her psychologically. However the wife was afraid that if she refused to have sex with her 
husband then he would divorce her as the husband will just go to his other wife.
“I was affected in the sense that because we are two wives, my husband and his other wife are 
not taking drugs, so it is only me who is on treatment. The problem is that I still sleep with my 
husband and because of that I feel that this disturbs the treatment because the instructions say 
that when you are taking ARVs, you are not supposed to be engaged in sexual activities. And 
that if you want to have sex, you should put on a condom and my husband does not use a 
condom. ” (Urban non poor female patient who interrupted treatment, Mchesi).
6.4.3 Travel
Travel outside Lilongwe over an extended period of time also caused some patients to stop or 
interrupt treatment. A male patient explained that he had missed his treatment appointment 
because he had been away working in another district and had not arranged to take adequate 
drugs for the time he would be away before hand (he did not know that he was going to stay 
away for that long).
7 have missed treatment appointments twice, at one time because I went to a funeral 
thinking that I will come back the next day, but [when] I got there something cropped up 
and I ended up staying longer than I had thought. I missed an appointment but I did not 
miss taking any tablets. This time I missed treatment because I had travelled to Mzimba 
because of work and stayed there for more than a month. I did not travel with my health 
passport or any note that I was on treatment from the hospital. Therefore I missed 
treatment. [Interviewer: Why did you not pick up enough drugs before going?] I had not 
thought about that because before I left for Mzimba the office had told me that I was
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going to be away for two weeks. So at the time I was leaving I thought that I had enough 
tablets. ” (Urban male poor patient traced after being lost to follow up)
A female patient explained that she had travelled to her home village in December 2009 which 
had caused her to miss a treatment appointment, but while the study team was still at the 
house, the husband returned and the attitude of the patient changed as explained below:
'We went to Golgotha in Area 23 to visit Chifatso Kafewa. When we asked her why she 
had missed her treatment for a month, she said that she went to her home village in 
December, and because she knew she would be away, she collected two bottles for two 
months which ended in February this year. When we asked why she was not going back 
to the health facility to collect drugs two months later from when she was supposed to 
collect her last supply, she was not answering or explaining the reasons why she didn't 
go to the clinic to collect her pills. She was also not answering some of the questions 
that we were asking and she looked wary, as if someone might hear her. Chifatso had 
an HIV test while pregnant for purposes of PMTCT. The husband, who had returned 
from where he had gone, was in the house and it made us feel as if he was listening to 
our conversation. We therefore felt as if Mercy had not disclosed to her husband and we 
asked her to come to the c//n/c." (Research Assistant)
6.4.4 Health workers' perceptions of why patients are lost to follow up
Health workers said that a major factor causing people to default was that most patients were 
living very far away from the hospitals. The quantitative data showed that patients take a 
median of about three hours to travel to and from a health provider.
“Our experience is showing the real reasons on what caused the people to default, is 
because some patients are coming from very far away places. ” (ART clerk, Mitundu)
“Some of the people default because of distance, they come from very far away from the 
hospital and they easily get tired of walking to this place, while others are encouraged to 
stop by other people just because they are looking very health/ (ART Nurse, Nkhoma)
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It was also common among health workers to feel that patients who are lost to follow up are 
those who do not accept their HIV positive status.
“There are a number of patients who default from treatment and it is a concern for us. 
Defaulters are usually those who have not accepted their status. During the group 
counselling we tell them everything that is going to happen for the rest of their lives and 
if they don't understand at this stage, it is very difficult for them to follow the ART 
treatment" (ART nurse, Nkhoma).
“The other issue is that there are some patients who did not accept their test results 
when they have been found positive; this also increases the number of defaulting 
patients” (ART clerk Kabudula).
Other reasons reported by the health workers included lack of disclosure, lack of support, and 
also the use of traditional healers and religious beliefs contribute to some patients stopping 
treatment.
“Here I think they balance but others default when they are better than before, some due 
to prayers because when they have prayed they think they will be fine and others 
because of herbs, they were told that they will be healed.” (ART Clinician, Kawale Health 
Centre)
“The other reason that make patients to default treatment is that they easily forget the 
date in which they are to collect their drugs so they need to have a very good guardian. 
So if the guardian is not a good care taker, they will just stay without drugs. ” (ART nurse, 
Likuni hospital)
6.4.5 Patient follow up programmes to reduce ART attrition and challenges in 
implementing such programmes
Health workers reported that patients who are identified as missing treatment appointments are 
supposed to be fallowed up in their homes. The coordination of following up patients is mainly 
done by the ART nurse and ART clerk together with HSAs who are community health workers.
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in some facilities, there were very good follow up programmes for patients who had missed 
treatment. For example at the Martin Preuss Centre, there were dedicated staff who on a 
regular basis monitored the patients who had missed appointments and therefore followed up 
through phone calls or by visiting the patients to their homes. They also have the support of 
Community Home Based Care groups who also visit the patients in their homes and encourage 
them to take their drugs. Similarly at Nkhoma hospital, the ART nurse reported that she was 
also the HBC coordinator and as such, she was linking the treatment follow programmes with 
the HBC groups. However, in the other ART centres, there were challenges in implementing 
proper follow up programmes for patients who are lost to follow up. Health workers reported the 
challenges below in Table 33 as the factors limiting effective patient follow up programmes.
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Table 32: Factors affecting follow up programmes
Issue Illustrative quote
Limited skills among health workers in follow up 
programmes - limited capacity and skills among the 
community health workers on following up patients 
due to lack of training on how they could approach 
patients without breaching patient confidentiality 
and observing ethical issues
"On paper it's just a matter of using health workers 
to be following up all defaulting patients in the 
villages, but on the ground it is not working 
because some of the healthy workers are not 
oriented on ART issues and how they can properly 
approach patients in the communities. So a person 
cannot just go and say 7 have been told that you 
are not going to the hospital to collect your ARVs 
for three months’ -it means that you have not 
respected the patient’s right So this means before 
involving the HSAs, at least they have to be 
oriented on how to reach the patients in the village 
and what are they going to do when they reach the 
patients’’(ART clinician, Kabudula).
Lack of transport for follow up programmes as 
facilities have large catchment areas particularly in 
the rural areas
"As of now 1 feel that the default rate is high 
because we are not able to follow up the patients 
due to lack of transport since we have only one 
vehicle for the whole facility which caters for 10 
health centres around this facility. So you may want 
to go to follow up and at the same time that same 
vehicle is also required to take patients to another 
facility -as a result we fail” (ART Clerk, Kabudula).
Frequent change of residential areas in urban 
areas making it difficult to trace patients
"We have a patient master card which captures the 
map of where the patient stays but the main 
challenge in town is that people move from one 
place to another. For example a patient may 
register that he/she stays in Kaliyeka, but if go 
there you will find out that he has moved to Kawale
2 or may be moved from Kawale to area 25, so it is 
very difficult to trace them up” (ART clinician, 
Kawale).
Patients not wanting to be followed up and 
providing wrong physical addresses
"Some of those people who plan to default, they 
have their means of running away from being 
followed up in the way that they cannot be traced 
but most of the patients give us proper contacts like 
their guardian's phone numbers and other contact 
details” (ART Clinician, Nkhoma)
Questioning of the effectiveness of patient follow up 
programmes as some patients do not return to start 
care even after follow up or return when they are 
very ill resulting in death
"When we follow them up some of a proportion of 
the defaulters comes back but when they refuse 
some of them come when the conditions are worse 
while they are very sick that even if they restart 
treatment they do not get well and within a short 
time they die” (ART clinician, Kawale)
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6.5 The majority of patients who initiate ART, continue on treatment
Most of the patients who were recruited in the study had successfully initiated and were 
continuing with their treatment. A total of 324 patients (71.7%) from the quantitative study were 
alive and on treatment, or had transferred out to another ART facility. It is assumed that patients 
who transfer out are continuing with treatment in the new ART sites. Only patients who were 
alive and on treatment and had not transferred out to other facilities were followed up for 
qualitative interviews to understand factors that made them continue with treatment.
Health workers believed that most of the ART patients were doing well on treatment, with only a 
few patients reporting side effects and a few others being switched to other ARV treatment 
regimens due to failure.
“I must proudly say that most patients are doing very fine and it is only very few who are 
experiencing drug side effects. There are also few who fail on treatment and we see this 
especially during the time checking CD4 count or when weighing them, the scale shows 
that this patient is gaining weight or losing weight. ” (ART clinician, Kawale)
Most of the patients had seen how they had benefited from treatment through improved health 
and reduction in illnesses experienced, which was highly motivating for continuing with 
treatment. Other patients had good support from their spouses, children, from the health 
workers and from the community volunteers.
“The reason that I am motivated to continue with my treatment is that I want to maintain 
my life in good health by making sure that I do not miss any treatment but follow it 
properly. If I miss treatment it means that I want to go back into the life of illness life 
again - a thing that I don't want to happen because I have an experience of a certain 
woman who missed treatment for one month and when she came here she was 
complaining of different illnesses because she stayed for a long time without taking the 
drug, something which we were already told during the group counseling that it is not 
good to miss any treatment at all and sickness is likely to be the result to follow if you 
miss any doses. ” (Rural poor female patient on ART, Mitundu).
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7 have never missed my drugs, sometimes I only miss the time to take the drugs by a 
few minutes. This is because I have very dedicated children who remind me whenever I 
am leaving the house. Even these women, my wives, also make sure that by the time I 
wash my face in the morning, they have put the drugs beside the water basin. I know 
that my spirit is in my children because they monitor me.” (Rural non poor male patient 
on ART, Theu)
Some patients who failed to go to the hospital on the appointment dates; they had shared drugs 
with other friends or relatives on ART in an attempt not to miss the treatment doses
“What happened was that I missed my appointment but I did not miss any doses 
because I have a friend who comes from the side of Dowa and both of us receive 
Triomune 30 here at the hospital. Because our village is just in the border of Lilongwe 
and Dowa, I went to him to borrow me some tablets which would last for the time I would 
not be able to go to the hospital. I returned the same number of tablets after I collected 
mine from the hospital.”(Rural poor male patient on ART, Chembe).
However, the qualitative data from patients who were successfully continuing with treatment 
showed that patients still faced a number of challenges which they had to overcome in order to 
be able to continue with their treatment. Poverty and long distances to the health facilities were 
the main challenges to sustaining treatment adherence. Other factors included forgetting to take 
doses and stigma and discrimination.
6.5.1 Loss of income and a struggle to earn a living
Financial challenges to support a family were the main challenge due to inability to work due to 
long illness, leading to loss of income. The quantitative data showed a median 30 days lost (1QR 
= 11.5 - 94.2) among 262 patients who reported losing days due to illness. The qualitative data 
showed that illness negatively affected patient’s abilities to continue in their income generating 
activities.
“Because of the problem I have, lack of money, l sometimes force myself to work, like to 
drive a car since I am a taxi driver, in order to find some money for daily use. Sometimes
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when I am home I do tailoring but the unfortunate part is that people are not bringing 
their clothes and materials as they used to do because they know that I am not 
physically in good condition” (Urban poor male patient on ART and cancer treatment, 
Chinsapo)
In the cases where women had lost their partners, they faced multiple challenges where first 
they had to cope with their illness and second, had to be able to support their families.
“My life now is different from the way I was at first as I have already said, my husband 
died and it is difficult for a woman to earn a living and support your children, more 
especially when you are keeping many children like I am doing, there is indeed a 
problem” (Urban poor female patient interrupted treatment, Kauma)
Despite having financial challenges, a number of patients were at least relieved that they had 
enough food, which meant that they had a good harvest and they had enough maize to last 
them until the next harvest. However, there were a few women did not have food.
"/ have problems with having adequate food because I am not able to buy fertiliser and 
therefore I reiy on the subsidised fertiliser provided by government, but when we have 
been left out from receiving the fertiliser coupons, we don’t harvest enough food "(Rural 
poor female patient on ART, Kabudula)
6.5.2 Long distances to health facilities
Most of the patients referred to challenges that they sometimes faced in adhering to treatment 
including those who were interviewed because they had successfully initiated and were 
continuing with their treatment. The challenges faced were due to poverty and distance to the 
health facilities and their problems were compounded because of their illness and the need to 
frequently visit the health facility.
“There are big challenges because from my village to this facility it is 20 kilometres 
cycling but if the bicycle gets broken then we walk all the way to this place. Because of 
the transport problem, there was a time that I failed to go to the hospital realising that the 
distance is very long and I could not manage to walk from home to this facility. I missed
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treatment for a period of one week then we came the following week when I had 
transport and when we arrived here the doctor shouted at us so much saying it should 
not happen aga/n.” (Rural poor male patient on ART, Chembe).
6.5.3 Forgetftilness
A few patients did not miss any hospital appointments to collect their drugs, but reported 
missing doses frequently due to forgetfulness.
“/ do not know how often I have missed drugs especially when I had just started 
treatment, I used to miss a lot, I used to forget a lot since I was just starting the 
treatment but now I do not forget as much.”(Urban poor male patient on ART, Kawale)
6.6 Challenges experienced by health workers in providing HIV treatment 
6.6.1 Shortage of health workers
Shortage of health workers and an increasing number of patients starting ART was the major 
challenge for most of the health facilities. Particularly as most of the staff were not only 
responsible for the ART clinic, but also worked in other hospital departments. This often 
explained why the ART clinic was only opened on specific days of the week in some of the 
facilities.
“The problem is that we have very few nurses and clinicians who are qualified in ART, 
yet they are the same nurses who are to attend in the wards as well as the maternity 
services and also those same clinicians attend to other general patients in other hospital 
departments like the OPD. Similarly, I am the ART clerk and I also work as an HSA 
which means I also to go to my catchment area to assist other people. Then wealso 
have outreach clinics, we have to be there as well. ” (HSA, Kabudula)
The rapidly increasing number of patients against a static number of health workers results in 
overcrowding at ART clinics and long waiting times for the patients. In one ART clinic, in order 
to be responsive to patient needs, the clinic would start as early as 5:00 am in the morning so 
that working patients would not have to miss going to work early.
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6.6.2 Shortage of resources
Shortage of drugs and stationery was reported in some facilities in the urban areas, which 
forced the health workers to ration the number of pills they could give to patients in an effort that 
patients should not miss drugs.
“Sometimes it happens that we are running out of drugs so it becomes very difficult for 
us to see patients returning without drugs yet we are the ones who explained to them 
that ffrey have to take their drugs every day. So sometimes I go to other facilities which 
have more supplies to share some drugs with us so that patients do not go back without 
any thing. Stationery is also becoming a problem now because in the early years we 
were given all the supplies but now you will see that there are no files for mastercards so 
it becoming very difficult to have an effective clinic. ” (ART clinician, Kawale Health 
Centre)
However, this resulted in patients making more frequent visits to the health facility. There were 
also no vehicles or motor cycles to assist with patient follow up. In some facilities, while other 
departments like the TB department had at least a motorcycle for following up patients, the ART 
clinic did not have such resources.
6.6.3 Non-stocking of some medications for critical OIs in some facilities 
The health workers also felt that, at times, for patients who had other problems such as Kaposi’s 
sarcoma or meningitis, there was limited medication. As such they had to refer patients to 
referral hospitals which were often far away. However, they did not understand why treatment 
for these conditions had to be centralised when they thought it was possible for them to be 
treating such conditions themselves.
“Some ART patients have got other disease that do not require ART treatment, or apart 
from ART, they require other drugs like Kaposi’s sarcoma, sore throat as well as 
meningitis. So here we as a facility, we don't have drugs for these diseases, we are able 
to make diagnosis but we cannot treat them as we do not stock such drugs. So we refer
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these patients to other facilities. We ask ourselves up to what time are we going to be 
referring these patients yet we are here and we can treat those conditions?" (ART 
clinician Kabudula).
Other challenges included privacy of where the ART services are located. In one facility, there 
was concern that closeness of the ART clinic to a main gate, therefore it might push away 
patients who wanted privacy and did not want to be seen at the clinic.
6.6.4 Limited motivation for pre-ART care among patients not yet on ART 
Among the patients who had been told they could not yet start treatment, I wanted to assess 
their understanding of what they had been told at the health facility and whether they were still 
in HIV care. Six patients out of the eight (who said they were told not to start treatment yet) 
mentioned they had been referred for CD4 cell count tests. One woman was on PMTCT drugs 
as she was expectant at the time that we visited her. The six patients who had been referred for 
CD4 cell count tests were in facilities that did not have CD4 count machines and in one clinic 
the machine had broken down. As such, they were referred for lab tests to the central hospital 
or to CHAM facilities which were running the tests. Only one female, out of all the patients had 
gone to the referral centre for the CD4 tests, but she also had not received her test results for a 
long time.
'7 went there twice but I did not find the CD4 count results, so I told them that if I go to 
Kabudula Hospital and explain verbally that I did not find the results, they would not 
believe me so if they could write somewhere in my health passport book, I will just 
show the note. As of now I don’t know anything about whether the CD4count results 
have come or nof.” (Rural poor female patient not started ART, Theu Village)
The other five patients who were also referred for CD4 count tests had not gone for the tests. All 
of them referred to the long distances to where they would be able to get a CD4 test. Going to 
the facilities where they could get a CD4 test meant that they had to use transport money as the 
facilities were much further than their ART sites.
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“I had been going to Mtenthera health centre for medical help for some time and I was 
told that I needed to start treatment but when I went to Nkhoma Hospital they kept 
saying that it was not time for me to start treatment for so long. At one time I was told to 
pay for the CD4 count test which I failed to do as I was not working. Three months ago I 
went back to Ntenthera due to sickness and was again referred to Nkhoma for ART, and 
this time I was told I could start treatment. ” (Rural non poor male patient, Mchiteni 
Village)
Most of these patients who had been referred for CD4 tests and had not started treatment had 
had an HIV test due to PMTCT. As such, they were not experiencing any serious sickness at 
the time of the interview, and since they had been told that they were not supposed to start 
treatment because they seemed well, the patients felt it was not necessary for them to seek the 
CD4 count tests. For others, it was clear that they did not know why they needed the CD4 count 
test. Most of the patients did not return to the facility for further HIV care, and some did not know 
that they needed to remain in care and access cotrimoxazole prophylaxis.
Case Study 5: We have not gone back to the ART clinic
When Mr and Mrs Mapata were expecting a baby and went to the antenatal clinic at Ukwe 
health centre. They were referred for HIV testing. They both went for HIV screening and both 
were HIV positive. The couple was therefore referred to an ART site. They went to the ART site 
and on the same day the wife was told to attend the ART group counseling session while the 
husband was told to wait until when he will also be told to start ARVs. After the group 
counseling they were told to return to the ART clinic on another day and they were also 
informed about taking bactrim. The couple did not go back on the appointment date but went 
back on another day. Unfortunately it was on a holiday and the ART Clinic was closed. 
Afterwards, they never went back to the ART clinic again. They said they did not have any 
health problems and they were both doing well.
Since they knew they were living with HIV, they had taken an initiative to take their baby for HIV 
testing when he was a year old and the baby was also HIV positive. However, they were asked 
to take the baby for another test later when he was 18 months old. (Constructed from an 
interview with a rural poor female patient and her husband who had not started treatment, 
Ukwe).
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Some patients who had been referred for CD4 tests and had not accessed the test, they feared 
going back to the ART sites as they had not followed instructions to go for the CD4 test and they 
felt this was a prerequisite for any further HIV care that they needed. Lack of proper information 
from the health workers left the patients uncertain of what they needed to do.
7 went into the class (group counseling session), from there my weight was measured 
and I was told that my weight is still high: that l cannot start treatment unless I go to 
Mtengo wanthenga or Namitete hospital to check my CD4 count. So at the time they 
were writing these things, there was no clear confirmation to whether / will start 
treatment or not... but as for my husband here, he just returned without being told 
anything." (Female patient, not started ART, Tsare Village)
The patients did not understand why they were being given or why they had been offered 
bactrim. Four of the female patients were in HIV care and receiving cotrimoxazole prophylaxis, 
and two of these were also accessing PMTCT services and therefore also receiving ARVs for 
PMTCT.
Health workers reported that they explain the different stages of illness to their patients so that 
patients understand the actions that the health workers take. However, lack of understanding 
about why they should have been in care might have caused patients not to consider being in 
HIV care as important.
Health workers agreed with patients about the difficulties of getting a CD4 cell count. In all the 
facilities, clinical staging was the primary way of assessing the eligibility of patients for ART. At 
the time of the study, only two of the health facilities in the study had CD4 machines. Therefore 
in the five other facilities, patients had to be referred to other health facilities for CD4 cells count. 
However in two of the facilities without CD4 cell count machines, the facilities collected samples 
among pregnant women which were then sent to a government referral hospital for CD4 cell 
counts. While in the rest of the facilities even pregnant women had to also use their own 
resources to have a CD4 cell count test.
“For pregnant women, we check their CD4 count, but we don’t do the tests here, we take 
the sample and these are sent to Bwaila/Kamuzu central hospitals and if the count
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reaches 350 or below that then they start the ARVs while if it is above 350, we just give 
the drugs we use for PMTCT. The results take two weeks to come, its either they bring 
them or our counsellors go and collect the results. But it sometimes takes as long as a 
month for the results to come due to other delays under certain circumstances. ” (ART 
nurse, Mission Hospital)
6.7 Conclusion
The results from the qualitative data, can be situated within the health belief model which states 
that care seeking is influenced by how patients perceive their susceptibility to illness, its 
severity, perceived barriers to accessing care and the perceived benefits from taking action. 
Some patients have reported the difficulties in making a decision to have an HIV test and in 
accepting the HIV test result. This could be a result of how they perceive their susceptibility to 
HIV and to illness. Where patients might not perceive their illness as severe, they may delay 
seeking care and accessing an HIV test or starting treatment. The study has shown that most 
patients seek an HIV test due to illness, often after shopping for care and perceiving their illness 
to be getting worse. Similarly, health workers are more likely to refer patients for HIV testing if 
they perceive the patients unresponsive to treatment or making repeated visits to seek care. 
Where patients perceived themselves to be well, or knew they had not reached the ART 
eligibility stage, there was less effort to seek HIV care. I found that a number of patients who 
had not started treatment were not yet eligible for treatment. These patients usually do not 
return to the health facility to be in pre-ART programmes.
However, where patients had perceived their illness to be severe and had positive perceptions 
of the benefits of ART, they started treatment and continued with treatment despite challenges 
that pose potential hindrance to treatment adherence. Patients who had interrupted treatment 
and those continuing with treatment mentioned that they face challenges to adhere to treatment. 
The challenges included long distance, psychosocial challenges, travel, challenges of disclosure 
and stigma. The barriers that patients face stem from the community which causes fear of 
stigma. At the household level, patients showed the challenges that they had in disclosing their 
HIV status for fear effacing marital problems and divorce, particularly among women. Poverty
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and lack of financial and social support were barriers faced by patients in accessing and 
adhering to treatment.
Among patients who were eligible for treatment but were not yet on ART, lack of support, long 
distance and lack of money for transport and travel in search of economic livelihoods were the 
reasons reported for not starting treatment.
Health workers also faced challenges in providing treatment due to shortage of health staff, 
drugs and supplies, with some clinics not stocking some essential drugs for managing 
opportunistic infections and following up patients who are lost to follow up.
In conclusion, the qualitative interviews showed that there are a multiplicity of issues that affect 
people’s access and adherence to ART. The data help to provide understanding of the 
quantitative findings through exploring the experiences of patients and health workers. The 
results demonstrate that a person’s decision not to initiate treatment, to have a late diagnosis or 
to disclose HIV status is not due to a single individual factor but an interrelation of multiple 
factors. These factors interplay at individual, community or health system levels to influence 
patients’ access and adherence to ART. This interrelation of factors is revealed more with the 
use of the case studies.
In the following chapter, I will discuss the qualitative and the quantitative findings and situate 
them within the literature in the sub-Saharan region and in Malawi and the conceptual 
framework described in section 3.4. I will then draw up recommendations emerging from the 
study.
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Chapter 7: Discussion 
7.0 Introduction
In this chapter, I will discuss the quantitative and qualitative findings in relation to the literature 
reviewed in Chapter 2 (sub-Saharan Africa) and Chapter 3 (Malawi). The overall organising of 
the discussion is the Tanahashi framework. I discuss how patients seeking care are affected by 
the three delays in the pathway to accessing HIV treatment and care. The pathway to care 
seeking is influenced by interactions at three levels - the community, the patients and their 
households and the health system. The different levels of coverage within the health system 
(availability, accessibility, acceptability and contact) interact to influence the level of effective 
coverage for ART.These key steps in the Tanahashi framework are interrogated by through the 
key themes in the conceptual framework discussed in section 3.3: gender, geography, poverty, 
residence, illness meaning and stigma. I then present recommendations for promoting provision 
and equitable access to ART.
7.1 Availability of HIV and AIDS services
Comparison of the respondents to national ART access
HIV infection prevalence in Malawi is higher among women (13%) than men (10%). HIV 
infection is highest among women from between the age of 15 to 29 but peaks amongst men 
aged 30-39; HIV prevalence is higher in rural areas than in urban areas (MDHS, 2010). 
Prevalence among men in urban areas is estimated at 16.3% and 8.8% for the rural men, while 
amongst urban women it is 18% and 12.5% for rural women (ibid.). Since ART became free of 
charge, consistently more women access ART than men. The gender balance among the 
patients recruited in this study was similar to those who started ART in the nationwide ART 
programme. In the first and second quarter of 2009 (the same period when respondents were 
being recruited to this study), 61% of the patients started on ART nationally were female while 
39% were male. In this study, I recruited 62.7% female patients and 37.3% were male patients.
Since 2002, Malawi, has been implementing an Essential Health Package which is intended to 
provide the minimum public health and clinical interventions at primary and secondary level care 
(MoHP, 2002). The EHP is used in the Sector Wide Approach (SWAp) to identify cost-effective 
interventions to address critical health problems (MoHP, 2002). The EHP in Malawi includes 
treatment of HIV and related opportunistic infections (ibid.). HIV treatment mainly relies on
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donor funding, particularly from the Global Fund. The availability of EHP services in each health 
facility, including at the primary level, is important in the health care seeking behaviour of 
patients. With EHP, patients can be easily be referred for HIV testing when presenting with HIV 
related illnesses or when suspected as HIV infected. In this study, health care seeking for ART 
was triggered by a number of different factors. Most patients seek care due to illness and are 
then referred for HIV testing or the patient him/herself opts for client initiated HTC. Some 
patients are routinely offered an HIV test, for example TB patients, while other patients are not ill 
but contact health services due to antenatal services and test due to PMTCT. For proper 
management of the people presenting to health services, it is therefore important that the health 
facilities are able to provide HIV related services, particularly HIV testing under the EHP. 
However, this is a challenge in Malawi as the health sector is heavily underfunded. According to 
the assessment of the EHP in a Sector Wide approach, the EHP has been underfunded and 
only 57% of the necessary costs were covered on average (Bowie and Mwase, 2011). Delivery 
of the EHP has also been hampered by shortages of both staff and drug supplies (Mueller et al., 
2011). Drug stock outs of basic antibiotics and HIV test kits is a major issue in Malawi and 
hinders referral for HIV testing (Lawson et al., 2008).
Section 5.4.1 shows that most of the health visits were made to the formal health facilities in 
government and CHAM facilities and self treatment was the third most commonly reported 
source of care seeking, in Malawi, the public sector provides over 60% of health care services, 
followed by CHAM facilities which provide about 37% of services. Therefore, where patients 
make contact with the formal health sector, the unavailability of proper services may cause 
patients to be improperly managed. This results in missed opportunities for HIV diagnosis and 
causes patients to seek alternative care in their search for health solutions.
Although the challenges faced in accessing health facilities might be expected to increase use 
of traditional care or self treatment, this study suggests that traditional healers were visited by 
only a small proportion of patients. Only 4% of the patients visited traditional healers on the first 
visit and this was even less common in subsequent care seeking visits. In Malawi, self treatment 
has previously been reported as the first step taken in care seeking by most patients (Hatchett 
et al., 2004; Simwaka et al., 2007; Salaniponi et al., 2000). The difference in my findings might
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be explained by the fact that I studied health care seeking behaviour from the point when the 
patients perceived their illness to be serious, and it is possible that at this stage, patients might 
have already explored self treatment options or traditional medicine. It is also possible that 
since the interviews took place in health facilities, patients might have under-reported use of self 
treatment and traditional healers. However, this study shows the importance of health facilities 
as a source of health care for people diagnosed with HIV and AIDS and as an opportunity to 
offer HIV testing as most of the patients had visited the health facilities due to illness.
The availability of health services is a challenge for rural communities particularly. Although 
85% of the Malawi population live within a 10km radius of a health centre, only 46% can access 
a health facility within a 5km radius (MoH, 2007). However, as most of the facilities cannot 
provide all the basic essential services, patients have to travel further to access such services. 
Only 20% of the population in Malawi are within reach of a tertiary or a secondary hospital within 
a 25km radius (MoH, GOM, 2007; MoH, 2001).
The number of ART sites nationally has rapidly grown, from 60 in 2005 to 417 ART clinics at the 
end of 2010 (217 static clinics and 122 outreach or mobile clinics) (MoH, 2010). The availability 
of ART sites is inequitable and favours the urban areas (Makwiza et al., 2005; WHO, 2010). In 
urban Lilongwe, ART is available at tertiary, secondary and in most primary level facilities, 
including in the private sector. However in rural Lilongwe, ART is mainly only available in 
secondary level facilities - community hospitals and CHAM hospitals. The limited availability of 
ART services has been compounded by the acute shortages of health workers (Me coy et al., 
2008; Muula et al., 2007). In addition, the limited number of health workers is inequitably 
distributed with half of the Malawi’s doctors and 25% of all the nurses working in the four central 
hospitals (McCoy et al., 2005). While the urban areas account for only 15% of the population, 
and most poor Malawians live in the rural areas, most medical assistants and nurses work in 
urban areas (DFID, 2010). I found that both patients and health workers reported that shortage 
of health workers was a challenge for providing services more effectively, resulting in some 
facilities only providing ART on specific days of the week. The northern region of Malawi, which 
has a less dense population, has more clinical officers, nurses and medical assistants than the 
south and central regions which are more populated (ibid.).
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While the Emergency Human Resource Rian has succeeded in increasing the number of nurses 
by 38% and doctors by 516%, the number of health workers is still not adequate to meet the 
health needs of the Malawian population (EHRP, 2010). Despite over $53 million being invested 
into increasing pre-service training capacity, the output of nurses from the training schools has 
only increased by 22% annually (MoH, 2011). Migration is one of the factors contributing to 
health worker shortages (EQUINE! SC, 2007). it is estimated that more than half of the 
registered nurses in Malawi left to work internationally over a four-year period in search of better 
working conditions (Roisin, 2004; Rowson 2004). There needs to be a continued emphasis on 
training and recruiting more health workers into the public health sector, and strengthening 
mechanisms for retaining and motivating them (Price and Binagwaho, 2010; Barnighhausen et 
al., 2007). As part of the EHRP, the Ministry of Health implemented a 52% salary top up for 
health workers in Malawi as a means of staff motivation and retention (Palmer, 2006). Most 
health workers (over 75%) are in favour of the top ups, however there is need for a long term 
plan to sustain this incentive and to equitably distribute the available health workers (MoH,
2011; Ebener et al., 2009). Task shifting should also be enhanced to allow decentralisation of 
services to the peripheral areas as this approach has enabled increase in the coverage and 
equity of ART services in Thyolo district, Malawi (Zachariah et al., 2009; Bemelmans et al.
2010).
7.2 Accessibility of services
For patients to utilise general health services and antiretroviral therapy services, services should 
be within reach of the people who are in need of a health service. A study by Malawi Equity 
Justice Network (MJEN) showed that people had to travel on average 10.2 km to reach the 
nearest government health centre and on average to reach a district hospital, people travelled a 
distance of 30km (MEJN, 2006).
Distance to ART remains a major challenge in accessing and adhering to ART in Malawi. The 
limited availability and accessibility of health services among the rural populations is also 
evidenced by relatively longer travel time to health providers. I found, that patients spent a 
median of 3 hours travel time for a return visit to a health provider and that this was longer for 
rural patients than for patients from urban areas (Section 5.6.3) Patients from rural areas spent 
about 3.6 hours travel time while urban populations had a median travel time of 2.5 hours.
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Among the patients who anticipated that they would face challenges in treatment adherence, 
about half mentioned distance to the health facility as an issue. The qualitative results also 
identified distance as a major challenge among patients who had not yet started treatment, and 
those both adhering to ART and those who had been lost to follow up. This is consistent with 
studies that have used spatial mapping using Geographical Information Systems and showed 
that patients on ART are not equally distributed among the HIV prevalence population, with 
greater proportions of patients being close to the ART sites receiving ART (Ebener et al.f 2009). 
An earlier study showed that the poorest 20% from the rural areas travelled 23.3 km to get to an 
ART site, compared with the poorest 20% from the urban areas who travelled on average 7.7 
km to an ART site (Chilipaine et al., 2009).
The problem of distance and transport to health providers and ART sites is not unique to Malawi 
and has been found elsewhere in the sub-Saharan region. Chileshe and Bond (2010) described 
how patients in rural Zambia walked long distances, sometimes as much as half a day’s 
distance to catch a bus to the hospital. In their study, patients often had to sell livestock or other 
household assets to use for transport money. A study in Rakai District, Uganda showed that half 
of the respondents reported long distance to ART centres as a major barrier to using ART 
(Kunihira et al., 2010). Accessibility of ART sites is more challenging. ART provision occurs 
mainly in the secondary level health facilities and a few primary level facilities. In Lilongwe, most 
of the rural primary level facilities do not provide ART. The findings in my study (section 5.6) 
show that transport costs accounted for 35% of all reported direct costs. This is similar to a 
study in South Africa which showed that transport cost accounted for 42% of health expenditure 
in ART access (Goudge et al., 2009). A study conducted in two districts in rural and urban 
Malawi which looked at travel costs for a single visit to an ART site found that, on average, the 
poorest patients from the rural areas spent $2.7 while the poorest from the urban areas spent 
$1.1 (Chilipaine et al., 2009). In a study in Zambia, patients spent between $3 and $7.50 for 
each trip to the ART site (Chileshe and Bond, 2010). In my study, (section 5.6.1), I found that 
transport costs tend to be high among patients in urban areas as they pay for a bus/minibus to 
travel to the ART site. Due to the high travel costs and because most poor people and rural 
populations may not have money, most people walk to access health services (Mann et al., 
2008). The majority of rural Malawians are involved in subsistence agriculture and have limited 
access to cash income so that most rural patients are forced to walk or use bicycles to travel to
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the health facilities (ibid). In section 5.7,1 found that more women (40%) than men (26.5%) 
reported that they would walk to the ART facility.
I have found in sections 5.5 and 5.6 that there are inequities in the patients’ health care seeking 
experiences. The poor and rural populations significantly spent more time travelling to seek 
care and spent more waiting time at the health provider than the non poor which reflects the 
limited availability and accessibility of services to poor and rural populations. A limitation of the 
findings from this study is that the participants who were recruited in the study represent those 
who had accessed services, and therefore the population who might be marginalised from ART 
access are not represented. Even so, I am of the opinion that the long and complex health care 
seeking experienced by the study respondents, means that some patients are very likely to drop 
out from the care seeking pathway. For ART services to be more equitable, it is important to 
improve the accessibility of services by making services more available and closer to the people 
who need them (Harries et al., 2010). ART needs to be further decentralised to the primary 
health facilities. Since the ART scale up is dependent on donor funding particularly from the 
Global Fund, decentralisation of services will depend on availability of resources. The Global 
Fund is the major HIV and AIDS funding agency in Malawi. So far, the Global Fund has 
approved funding amounting to approximately $375 million through the National AIDS 
Commission in Global Fund Rounds 1, 5 and 7 (Namakhoma et al., 2010). Currently, the 
sustainability of ART programmes and treatment expansion are under threat; Malawi’s last two 
proposals to the Global Fund were not approved: a Round 10 $560 million proposal to support 
the national response to HIV and AIDS for five years and a $375 million to support an extended 
national HIV and Aids Action Framework 2010-2012 (Global Fund website, 2011). These 
rejections have coincided with the Malawi adoption of the new ARV treatment guidelines 
recommended by WHO, which recommend starting treatment at earlier stages of HIV infection 
and switching to treatment regimens with fewer side effects (WHO, 2010; MoH, 2011). The 
implementation of the new treatment guidelines have led to an increase in the number of people 
in need of ART, leading to an even greater need for more resources for the ART programme.
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7.3 Acceptability of services
In Malawi, cost is a major consideration influencing the acceptability of health services. In the 
public health sector, services are provided free of charge at the point of delivery. However, the 
public sector effective delivery of health services is crippled by shortage of staff, drug stock outs 
and shortage of supplies making the services offered in most of the primary level facilities 
unacceptable (Lawson et al., 2008; Ratsma et al., 2005). In an attempt to increase access to 
essential services, the government of Malawi through the District Health Offices (DHOs) is 
encouraging Service Level Agreements (SLA) between DHOs and CHAM facilities. The SLAs 
are for the payment of fees from the DHO to a CHAM facility in exchange for the removal of the 
user fee in the CHAM facility. The service level agreements aim is to ensure free services at 
the point of delivery and improved capacity to deliver the Essential Health Package. These 
SLAs are important for increasing access in the rural areas as 85% of CHAM facilities are in the 
rural areas where the majority of the Malawi population lives. Agreements with the CHAM 
facilities have previously shown positive results with a 75% increase in live births in the facilities 
and a reduction in maternal and neonatal deaths (Mann, 2008). By early 2011, a total of 72 
SLAs had been signed, a few SLAs are for the provision of the full EHP, while most are for 
maternal and newborn health services (MoH, 2011).
In CHAM facilities, HIV and AIDS services are provided free of charge as these are supplied 
through the Ministry of Health. However, before HIV diagnosis, patients in CHAM facilities pay a 
consultation fee of K20 and may also often have to pay for drugs for opportunistic infections in 
case these drugs are not supplied by the Ministry of Health (Mann et al., 2008). Since in most 
CHAM facilities, the SLAs currently only cover Maternal Health and Child Health services, adult 
patients may still incur higher direct costs of health services. In my study, I found that patients 
who were recruited into this study from the CHAM facilities had incurred higher costs of health 
care compared to those in the public facilities.
As discussed in chapter 3, the removal of the cost for ART at the point of delivery made the 
ART services acceptable to most Malawians who were previously marginalised due to high 
costs of treatment (Makwiza et al., 2005; Weigel et al., 2009). Free services at the point of 
delivery have been shown to be more equitable (ibid). Free ART services are also promoted by
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the WHO in order to promote equity in access and improve adherence to ART (Souteyrand et 
al. 2008). The rapid ART scale up has greatly improved access to ART by poor populations, 
resulting in reduction of travel, accommodation costs, food and incidentals costs. Despite free 
ART services at the point of delivery, HIV patients still experience costs in accessing care, 
usually incurred to cover transport costs, attendance in private clinics or CHAM facilities where 
they have to pay minimal charges for consultation fees and for opportunistic infections.
However, generally it is felt that the household out of pocket expenditures for HIV care in Malawi 
are lower compared to other countries due to provision of free services at the point of need and 
heavily subsidised services in the CHAM and the private sector (MOH, GOM, 2007).
These costs, though minimal, have a great impact on the already poor households. In this study 
I found that the median economic burden of care seeking represented about 87.5% of patients’ 
monthly income, while among the poor, health care seeking costs represented 155% of the 
monthly income. The income spent on health expenditure is lower than reported among patients 
seeking a tuberculosis diagnosis as poor patients were reported to spend 248% of their monthly 
income (Simwaka et al., 2007). The lower costs for HIV care seeking might be attributed to 
decentralised treatment registration compared to TB services where treatment registration 
occurs only in a few centres. Therefore, all patients diagnosed with TB first have to go to the TB 
treatment registration site to collect their drugs and put them in a facility close to their area of 
residence.
In my study, I found that the common reasons for choosing the type of health provider were 
closeness of the health provider, low cost of services and perceived effectiveness of treatment 
provided (section 5.4.1). Referral as a reason for choice of the provider became more common 
from the third and subsequent visits. This could have been a result of a limited number of health 
facilities which offer services including assessment of ART eligibility. This necessitates referral 
to ART sites and patients seeking health care from providers further away than patients would 
normally have considered.
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My findings also showed that the poor experience higher indirect costs which are related to loss 
of income, particularly among the urban poor and women. This could be related to the urban 
poor being mainly involved in casual labour and therefore being more likely to lose income in 
case of illness or care seeking (Kemp et al. 2007). Studies among TB patients in Malawi show 
that the burden of illness and care seeking often affects girls who are stopped from going to 
school in order to care for their siblings or care for the home replacing their mother's roles 
(Simwaka et al 2008).
In this study, women reported losing fewer days than men due to illness and care seeking than 
men. This might be a result of the way in which the question was framed during data collection 
as I had asked respondents to report about the number of days that they had lost work. 
Respondents who were not involved in paid work may not have considered that they had lost 
work days as most women continue with their normal activities within the home even when they 
are ill.
The findings from the qualitative data in this study highlight the importance of information for 
patients in making services acceptable. Among the patients who were identified as not having 
started treatment because they were not yet eligible, lack of information about why they needed 
to stay in care and the importance of having a CD4 cell count test contributed to patients not 
being in pre-ART care. A study by Ntata et al., (2006) found that community members often 
questioned why some people with HIV infection are started on ART while others are not. Many 
have therefore recommended that ART programmes should be implemented alongside strong 
community literacy programmes and increased community participation (EQUINET SC, 2007). 
The treatment literacy programmes however need to provide adequate information on pre-ART 
care which has been identified as a missing link in ART treatment programmes in Malawi and 
other sub-Saharan African countries (Larson et al., 2010; Harries et al., 2010; Lawn et al., 
2008). Health workers are key in providing information on treatment (Obua et al., 2011). As 
people perceive themselves to be in good health, they might perceive that the costs of 
remaining in care are not acceptable. Perceptions of good health often lead to patients not 
accessing or stopping ART (Rosen 2011).
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Experienced or perceived stigma is reported as a major barrier to accessing HIV and AIDS 
services in Malawi (Namakhoma et al., 2010; Fergusson et al., 2010). The fear of stigma often 
causes people to avoid finding out their HIV status and delay accessing HIV treatment. This is 
due to people not wanting to be seen accessing HIV services, which implicitly implies disclosure 
of their HIV positive status (ICRW, 2006; Skinner and Mfecane 2004). The findings in this study 
show that stigma is still present despite wide availability of treatment and contributed to some 
patients not starting treatment or stopping treatment. Health workers often felt that people do 
not start treatment or stop treatment because they have not fully accepted their HIV positive 
status. In the qualitiative findings, (section 6.2.2), a male patient reported not starting treatment 
due to fear of HIV related stigma at his workplace. It is likely that people do not want to be 
associated with HIV due to stigma related to the judgemental discourse which labels HIV 
infection with immorality (Wight et al., 2006; Mfecane and Skinner, 2004). People living with 
HIV in Malawi often endure insults, gossip and are labelled with names (Chikaphupha et al., 
2008; Fergusson et al., 2010).
7.4 Contact coverage
People who make contact with health services are those who have actually utilised the service. 
Due to the design of the study, all the respondents had utilised a health service and had also 
made contact with ART services. In sections 5.5 and 6.1, I found that patients make multiple 
health care seeking visits before accessing an HIV test and ART services. This results in three 
stage delay in accessing ART services.
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Figure 18: Showing three delays to accessing ART
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7.4.1 First delay: Delay from HIV infection to an HIV test
The first delay is the period after a person contracts HIV to the time that they have an HIV test. 
The findings in this study showed that the majority of patients (56.5%) who were initiating ART 
did not seek an HIV test until they became unwell. From the time patients perceived their illness 
to be getting serious, 50% of the patients tested within two months and 75% had an HIV test 
within five months. This means that before they became aware of their HIV status, patients 
continued to shop for care signifying that delay before HIV testing is a major contributor to 
delayed HIV diagnosis.
The pathway to HIV testing is complex for most patients.There are different pathways to 
accessing HIV testing dependant on the reason for seeking an HIV test: an HIV test can be 
initiated through the client him or herself or the health provider. While HIV testing services are
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available within the health facilities, this study shows that there are missed opportunities for 
provider initiated HIV testing resulting in delay in referral for HIV testing. HIV testing is the 
crucial gateway to accessing ART services and in a country where HIV prevalence is high, it is 
expected that health workers would encourage HIV testing to clients who makes contact with 
health services. Therefore, the first stage delay can be tackled by strengthening routine provider 
initiative testing in health facilities. Studies in Uganda showed that about half of the patients 
offered provider initiated HIV testing already had advanced HIV infection (Wanyenze et al., 
2011). Creating more awareness of the importance of knowing one’s HIV status could promote 
acceptability of testing through Voluntary Counseling and Testing (VCT).
The importance of promoting HIV testing cannot be overemphasised as it plays a double role: 
first for promoting access to ART and secondly for prevention and behaviour change. Routine 
HIV testing is emphasised for pregnant women and for patients with tuberculosis. Studies that 
have documented the health care seeking pathway in Malawi show that TB patients also 
experience long health care seeking pathways before diagnosis; in most cases, these patients 
also experience a variety of symptoms as has also been shown in this study (Mann et ai. 2008, 
Kemp et al., 2007). While the patients who are eventually diagnosed with TB are offered a 
routine HIV test, it means that opportunities to offer an HIV test are missed for those who are 
not suspected or diagnosed with TB. This study shows that it might be beneficial to expand offer 
of HIV testing to any patient who contacts the health facilities with any illness so that they can 
access ART before they are in very advanced stages of HIV infection. This is an important step 
towards achieving universal ART access.
in Malawi, the Ministry of Health is promoting routinely offered provider initiated HIV testing in 
health facilities with an opt out option (MoH, 2006). The findings in my study in section 6.1.3 
show that this implementation guideline is not consistently followed by health providers. 
Similarly findings from a study in primary health clinics in Blantyre, Malawi found that only 
13.3% of over 18000 clinic attendances were offered HIV testing (2011). Health providers offer 
testing based on their perception that a patient might have HIV due to the illness being 
presented. Using this approach to promoting testing might be problematic as it is selective, 
making people referred fortesting fearful of stigma and will only identify people with advanced
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HIV disease. However, if it is known that everyone is routinely offered HIV testing, patients will 
not question why only certain individuals are targeted for HIV testing and might reduce stigma 
within the facility setting. In a country where HIV prevalence is high, it is important to offer HIV 
testing as widely as possible and ensure that all hospital departments mainstream HIV testing 
referral and routinely offer testing so that HIV treatment access and prevention are enhanced.
This would also require some strengthening of the health system. There have been frequent 
reports of shortages of HIV test kits leading to missed opportunities for offering an HIV test for 
people who make contact with the health services (MOH, 2010; MoH, 2007). The 
WHO/UNAIDS (2007) guidelines strongly guides on the need for offering a minmum package of 
HIV prevention, treatment and care for those who test. Referral to subsequent care is a human 
right and an ethical issue. Therefore it is important that ART services are made more available 
so that health workers are not faced with an ethical dilemma of not being able to provide further 
care (Gruskin et al., 2008). The infrastructure for an enabling environment for testing and 
counselling that promotes privacy and confidentiality is challenging particularly at health centre 
levels where space is limited. Additionally all health workers who make contact with patients 
need to be adequately trained in PITC and address the negative attitudes that they might have 
about PITC by providing them with an enabling environment and clear guidelines on the ethical 
and hu man rights dilemmas that affect PITC. Where possible testing should be offered within 
the OPD consultation room and not rely on referral to another on-site building (Bassett et al., 
2007).
Strengthening skills of health workers in PITC, so that they are able to provide adequate 
information to enable pregnant women to undergo true informed consent and a voluntary 
decision to undertake the test is important within PMTCT Option B+ that Malawi has adopted.. 
Gruskin et al. (2008) raises important issues concerning pregnant women and points out that 
fear of HIV testing due to negative effects can outweigh concerns related to perinatal 
transmission. Approaches that coerce women into accepting HIV testing could lead to the failure 
of Option B+ for a number of factors which include:
• If women lose trust of the health service they might not return for further care;
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• How they consent and providing a positive result be dealt with for women who test 
during labour or delivery as well the best time to initiate of ART drugs that would need to 
be taken for life - at what will ART be initiated among this group of women;
• How best to maintain privacy and confidentiality where ARV drugs are not provided 
within ANC but with other general ART services;
• As women will be on ART for life, how best will disclosure be handled and what 
measures will be in place to protect women who might experience physical violence due 
to disclosure.
At the community level, people report that they are not ready for an HIV test because they 
perceive themselves not to be at risk of HIV and therefore feel an HIV test is not necessary 
unless they are ill (Yoder and Matinga, 2004). These findings are supported by the finding in our 
study that most patients had accessed an HIV test due to illness. In contrast, it also argued that 
where people overestimate their risk of HIV, due to their own or their partner’s risky sexual 
behaviour, they are fearful of a positive result and may postpone the test until they are ill (Kaler 
et al., 2010; Anglewicz et al., 2009). Fear of an HIV test is caused by the fear of stigma and 
discrimination which is prevalent in most communities. In Malawi, the scale up of HTC is 
concentrated in health facilities which on one hand is advantageous as it promotes an 
integrated approach to management of patients. This has been shown in this study through 
patient referral by health workers for HIV testing. However, on the other hand, this approach 
results in limited availability, accessibility and affordability of testing services. Access to health 
facilities is limited, particularly in the rural areas, and the challenge of scaling up mainly 
integrated HIV testing services is that it attracts mainly those people who are able to make 
contact with the health system and may leave out poor people in the communities who do not 
have the resources to access health care. Though HIV testing is offered free of charge in these 
facilities, HIV testing might not be a priority to community members, especially if they have to 
spend financial resources in order to access the testing facilities. HTC scale up should therefore 
also promote voluntary HIV testing and counselling through delivery systems closer to 
communities. Studies show that where HIV testing is closer to the communities or provided 
through home testing, the likelihood of accepting an HIV test is higher (Sekandi et al.,2011; 
Matovu et al., 2007; Negin et al., 2009).
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The interplay of gender and HIV treatment is complex. On one hand gender, plays a promotive 
role in HIV testing and ART uptake and has shown positive benefits for uptake of testing among 
women. Women in the reproductive age group access HIV testing services more due to PMTCT 
programmes and under five services. On the other hand, gender presents a challenge to 
disclosure. In section 6.1.2 and 6.4.2,1 found that fear of disclosure by married women to their 
spouses is a challenge and can cause delay in care seeking. Women fear to disclose their HIV 
status to their partners or spouses and as a result, might hinder them from making choices 
about their reproductive health and decisions about whether to have children or not. In 
Tanzania, it was found that non disclosure of HIV status to partners led patients to resist being 
followed up in their homes (Mshana, 2006). Men have limited opportunities for HIV testing and 
may access HIV services more due to illness. There is some evidence that the socialisation of 
men in societies and masculinities which cause men to perceive themselves as not weak may 
lead to delay in accessing HIV services (Skovdal et a!., 2011; Conell et al., 2009).
7.4.2 Second Delay: From HIV test to Initiating care
The second delay in accessing HIV treatment is the delay from having an HIV test to the time 
that patients initiate HIV care (pre-ART care). The findings of this study show that there is a 
missing link from the time that a person realises that they are HIV positive to the time that they 
initiate treatment. Patients who had been referred for further screening of ART eligibility through 
CD4 count tests did not go for these tests as they did not understand their importance (section 
6.2). This is because most of the ART facilities do not have laboratory infrastructure and 
machines for CD4 count tests. According to the WHO recommendations and the Malawi 
treatment guidelines, lack of laboratory infrastructure should not hinder patients from accessing 
treatment (WHO 2009; MOH 2008; MoH, 2011). However, if patients do not meet treatment 
criteria on WHO Clinical staging, then CD4 count is essential before ART could be started if 
indicated. A study in Biantyre among patients and health workers found a number of bottlenects 
that prevented patients from timelt completion of the ART eligibility assessments leading to 
patients dropping out from the process (Macpherson et al., 2012). The study showed that health 
workers found the WHO clinical staging complex and there were time constraints to finalise the 
process in busy clinics (ibid.). A study in Durban, South Africa showed that among patients 
diagnosed with HIV, only 39% had initiated ART after 1 year (Bassett et al., 2010). Rosen and 
Fox (2011) in their review of retention in care in sub Saharan Africa found that less than a third
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of HIV positive patients and not yet eligible for ART are retained in care. In Malawi, patients 
who are not yet on ART are offered cotrimoxazole prophylaxis but very few access the 
prophylaxis. This calls for the importance of educating patients on the need for being in HIV 
care as well as strengthening the health system so that accessing pre-ART care is not costly for 
the patient.
7.4.3 Third Delay: From ART eligibility to initiating ART
The third delay in the HIV treatment pathway is the delay from the time one realises that they 
need ART to the time that they actually initiate treatment. The findings from this study showed 
that this was not a long delay for most of the patients. About half of the patients had initiated 
treatment within three weeks of being identified as eligible for ART. Malawi ART guidelines 
require that a person should understand about ART and practically, clinics require that a patient 
attend one or two group ART counselling session followed by individual counselling by a health 
worker. However, studies have shown that it is not uncommon for patients to be lost during this 
pre-ART preparation period. In Uganda, the median delay was longer as just over half of the 
patients started ART within three months of being recommended for treatment (Parkes-Ratanshi 
et al., 2010). In this study, delay was reported to be a result of the patients’ non-acceptance of 
their HIV positive result. This may be because most of the patients are recognised to be positive 
at very advanced stages of illness and therefore by the time that they are referred for ART, they 
have not yet had an opportunity to reflect on their condition and have not yet developed 
mechanisms to cope with their situation.
It is important that patients should understand about their treatment in order to maintain high 
standards of treatment adherence, however, new ways of providing ART literacy and 
counselling sessions need to be devised so that the health system waiting period before 
treatment initiation is minimised among stable patients. Usually, in the smaller clinics, ART 
counselling sessions take place on specific days of the week due to shortages of staff. 
Community health workers can play a positive role in offering education to patients and also 
offering adherence support at the community level (Ware et al., 2009; Torpey et al., 2008). In 
Zambia, there was no significant difference between treatment outcomes among patients who 
were counselled by nurses and those who were counselled by lay community persons (Torpey 
et al., 2008). However, a standardised training curriculum for community health workers or lay 
persons, support and monitoring all need to be available in order to support the quality of the
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information provided. Experienced patients on ART are also a critical resource which needs to 
be effectively tapped in supporting patients initiating ART, both within the health system and in 
the communities (Torpey et al. 2008; Hermann et al., 2009).
While the majority of the patients in this study initiated treatment within the study period, 10% of 
the patients were lost to follow up before initiating treatment. Studies in Kenya and South Africa 
have shown that pre-ART loss to follow up is a significant problem (Karcher et al., 2007; Bassett 
et al., 2009). However, these studies also show that some of the patients lost during the pre- 
ART period had actually died. In the Kenya study, 11% of 35 patients who had not started 
treatment had died. In my study, 8 of the 49 (16.3%) patients who had not started treatment had 
died. Most health facilities in Malawi do not track if patients, who are identified eligible for ART, 
proceed to attend the group counselling session and start treatment. This makes it difficult for 
health providers to recognise the extent of pre-ART deaths and whether it poses challenges and 
how the situation can be addressed.
The data from my study show that rural patients take longer than urban patients to start 
treatment after being identified as eligible for treatment, median 23 days and 16 days 
respectively. This may be attributed to longer distances to travel to the ART sites by the rural 
populations, therefore requiring adequate preparations for means of transport to the clinic. The 
study findings in section 5.8 show that transport costs are a contributing factor to whether 
patients start treatment or not, as patients who spent higher transport costs in care seeking 
were twice as likely not to initiate treatment as those who reported lower transport costs. In my 
study, (section 6.2.1), I found that transport costs were also reported as a barrier to not starting 
treatment by patients who were followed to find out why they had not started treatment. The 
data from the study, particularly from the health workers showed that some of the patients who 
opt not to start treatment will often return to the health facilities at more advanced stages of 
illness.
Minimising delays to HIV treatment is important for good treatment outcomes as late initiation of 
treatment often offset the maximum benefits that would have been gained from ART (Reed et 
al., 2009; Anglemyer et al., 2011). Poor treatment outcomes in the first few months of treatment 
and deaths in the ART patient preparation stages prior to starting ART are a result of delay in 
starting treatment (Lawn et al., 2010; Birbeck et al., 2009). The study findings show that to
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address the situation, HIV testing and ART services need to be more available close to where 
people reside, they have to be accessible and affordable and also there is a need for more 
integration of services to maximise the benefit from people who have made contact with the 
health services (Harries et al., 2010; Bartlett et al., 2009; Ojikutu et ai., 2007).
7.5 Effective coverage
In this study, effective coverage refers to people who have received a satisfactory service, are 
adherent and are retained within the programme. This study showed that 19.3% were no longer 
in care after an average follow up of 15 months; 9.4% had died and 9.9% had been lost to follow 
up. In a study conducted in the northern region of Malawi, it was found that about half of the 
patients who are reported to have been lost to follow up had actually died (Yu et al., 2007). 
Similarly, in this study, I found that 46% of the patients who had been traced to their homes 
because they had been lost to care had died.
ART programmes in sub-Saharan Africa have recorded a high risk of mortality in early months 
of treatment (Lawn et al., 2010; Braitsten et al., 2006). Data from the ART programme in Malawi 
show that the proportion of patients dying in the first three months of treatment is decreasing. In 
2005, about 15% of patients died within three months of treatment, however among patients 
who initiated treatment in 2009, only 5% of the patients had died within the first three months of 
treatment (MoH, 2010). The decrease in early mortality is attributed to decentralisation of ART 
services. The data in my study showed that about 4.5% had died within the first three months of 
initiating treatment. The early deaths represented about 47% of all patients who had died during 
the study period. This finding was supported by the health workers who mentioned that most 
deaths of patients take place within the first three or four months of treatment. Early deaths 
among patients initiating ART might cause fear and negativity among communities of taking 
ART as people might associate these deaths with ART.
In my study, I found that 80.2% of the patients were retained on treatment. However, this 
assumes that patients who had transferred out from the ART site where they had initiated 
treatment were still on treatment. A study in Malawi showed that most of the patients who
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transfer out end up in the clinic where they had transferred out to (Yu et al., 2007). The retention 
rate is within the range that has been reported by the Ministry of Health. When compared with 
national retention rates among a cohort of patients who started treatment in quarter 4 of 2008, 
retention at 12 months was 78%. However, for the cohort of patients who started treatment in 
2010, retention at 12 months was estimated at 80% (MoH, 2010). The attrition from care does 
not vary much from the findings in a study in South Africa by Rosen and Fox (2010) who found 
that about 22% of patients are no longer in care one year after treatment initiation.
The data in this study show that sex and poverty are factors contributing to deaths and loss to 
follow up from treatment. Male patients were 1.97 times at risk of death and loss to follow up 
than women while the poor were 1.7 times more at risk of death and loss to follow up than the 
non poor. Other studies in Malawi and the sub-Saharan region have also found sex to be a 
significant factor determining retention. A study by Chen et al. (2008) in Malawi found that 
females had higher survival rate whilst on ART than males. The study found that poor survival 
rates among men were due to men initiating treatment at more advanced stages of treatment. 
Other studies have shown men to have a 25% greater risk of dying than women: men also had 
a higher default rate than women (Chilipaine-Banda et al., 2010). How the data are collected 
may influence findings. In South Western Uganda, passively collected data suggested that 
males were at a higher risk of death on ART but when deaths known through patient tracking 
are included, male sex was no longer a predictor of death (Geng et al., 2010) although male sex 
was still a predictor of loss from care. Earlier access to ART among females is attributed to a 
greater number of opportunities for accessing ART information, including their reproductive and 
caring role (Fergusson et al., 2010; Chikaphupha et al., 2006). The perceived reason for 
accessing an HIV test is also gendered. In Malawi, female health workers mainly reported 
accessing an HIV test because of their partner’s sexual behaviour, partner’s illness or death, 
whereas men mainly reported accessing an HIV test due to their own sexual behaviour 
(Namakhoma et al., 2010). Women therefore tend to blame their partners for their HIV infection 
and might experience less stigma in accessing HIV services (Somma et al., 2008). Delay in HIV 
care seeking amongst men is also believed to be a result of men’s beliefs of dominance and 
power, which lead them to interpret illness as a sign of weakness (Higgins et al., 2010).
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This study suggested that the poor were 1.7 times more likely to die or be lost from follow up 
than the non poor. The qualitative data showed that poverty was one of the factors that caused 
patients to stop treatment. HIV and AIDS puts vulnerable households at risk of being plunged 
into more poverty and incurring catastrophic health expenditures (Masanjala et al., 2007, Riot et 
al., 2007). Due to poverty, patients were also unable to meet transport costs leading to either 
stopping treatment or not starting treatment at all for some patients. Even among patients who 
were adhering to treatment, poverty resulted in patients struggling to meet transport costs to 
travel to the ART facility and food insecurity was also noted by some of the patients. These 
findings are similar to other studies in Malawi which found that poverty played a significant role 
to treatment interruption (Chibambo et al., 2010; Chikaphupha et al., 2008; Nyirenda et al., 
2007). Studies in sub-Saharan region have found that patients make difficult choices and resort 
to begging, borrowing and selling of assets in order to cope with costs of illness (Russell, 2004; 
Russell, 2005). My study showed that only two thirds of the patients could pay for their health 
costs themselves while the rest needed support from others, sold assets, or borrowed. A few 
patients had to wait to find money before they could seek care.
Other studies have also shown that patients sacrifice important investments resulting in 
reduction in other critical expenditures such as education for their children (Chuma et al., 2007; 
Kemp et al., 2007). Because of the challenges that the poor face, it is likely that it causes delay 
in seeking care and also in accessing ART services. As discussed above, the economic burden 
of care seeking is very high among the poor populations. The poor made more visits to the 
health care providers before they were referred for HIV testing and ART counselling. The poor 
may delay, due to lack of financial resources, and only travel to the health facilities when they 
are too ill. The poor might seek care from inappropriate providers because they are cheaper 
(Falkingham, 2004; Onwukekwe and Uzochukwu, 2005). It is also common that though the poor 
experience more illness, they are less likely to seek care which might lead to seeking care at 
advanced stages of illness (Chuma et al., 2007; Hortsberg and Mwikisa, 2002). Studies in 
Malawi have shown that the repeated need for money to cover transport costs was a concern 
for many of the patients and that the poorest 20% wealth quintile incurred higher costs for a visit 
to the ART clinic than the richest 20% (Chilipaine-Banda et al., 2010; Chikaphupha et al., 2008). 
Transport costs remain a major challenge for poor patients to adhere to treatment (Zachariah et 
al., 2006; Zachariah et al., 2009).
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In my study, the majority of patients who participated in the qualitiative interviews had disclosed 
their HIV status to their spouses and were getting support from them. A study in Zambia showed 
that disclosure to a partner or spouse was associated with less stigma than disclosing to 
workmates and friends and therefore need to be encouraged (Pearson et al., 2009). In my 
study, I found that disclosure to a spouse was a problem for a minority of patients. Female 
patients faced particular challenges in disclosing to their partners. The data from this study 
showed that women may opt to stop treatment rather than disclosing their HIV status to their 
partners if they feel, the treatment might interfere with their marital life. This finding is consistent 
with findings from other studies which have shown that fear of negative consequences such as 
divorce and rejection causes a challenge of disclosure particularly among women (Murray et al., 
2009; Obermeyer et al., 2011). Non-disclosure to partners is a common dilemma among women 
who test through PMTCT programmes (Bobrow et al., 2008; Njunga and Blystad 2010). 
However, though non-disclosure to partners might affect only a minority of patients, the studies 
show that it is a problem that keeps recurring in different settings and therefore needs to be 
addressed in order to promote treatment access and retention.
As previously discussed, patient loss to follow up in Malawi is a challenge with an estimated 
15% of those ever starting treatment in Malawi being lost to follow up (MoH, 2010). This study 
showed that health workers from the peripheral facilities are not able to conduct programmes 
that promote adherence. Only the secondary facilities had programmes that traced patients who 
had been lost to follow up or were able to work with community Home Based Care Groups 
(CHBC). This was mainly due to limited human and financial resources, as well as lack of 
transport for follow up programmes. This suggests that ART adherence is not accorded the level 
of attention that it needs to prevent the development of drug resistant HIV strains. However 
tracking patients who are lost to follow up is expensive and the success of such programmes 
has been questioned in some settings as not all patients who may be traced may return into 
care (Rosen and Ketlhapile, 2010; Tweya et al. 2010; Ekouevi et al., 2010). Patients may also 
provide false addresses so that they cannot be traced and programmes may spend a lot of 
money to travel long distances to trace patients who cannot be found at their homes. Self 
transfers have also been reported by other studies though this was not evident in this study
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(Rosen and Ketlhapile, 2010). Due to large and increasing number of patients, it would seem 
impossible that all patients who need to be followed up could be reached in the current system. 
In most cases, the whole facility relied on one vehicle or a few motor bikes which are not only 
used by the ART programme but also by other departments within the health facility.
Evidence shows that community health workers or volunteers play critical roles with supporting 
treatment adherence as they provide the important link between health facilities and 
communities (Torpey et a!., 2008; Ware et aL, 2009). However health workers in peripheral 
facilities stated that community health workers have not been equipped with adequate skills to 
follow up patients and it is usually the clinic staff who follow up patients when they are not 
running ART clinics. It is widely agreed that community health workers improve access, 
coverage and health outcomes of basic health services (Hermann et a!., 2009; Phiri et al., 
2006). The involvement of community health workers or lay support workers such as ‘expert’ 
patients to increase engagement with patients is effective in improving treatment retention. In 
Uganda, there were reduced rates of patients lost to follow up through increased engagement 
with community health workers at the community level (Arem et al., 2011). In Zambia, 
adherence support workers succeeded in drastically reducing the rates of patients lost to follow 
up from ART programmes (Torpey et al,, 2008).
In Malawi, a common problem limiting involvement ofexpert patients or lay persons has been a 
one way referral approach of patients to health facilities, with no feedback provided back to the 
communities (Chibwana et al., 2011, Chikaphupha et al., 2010). A model which involves a 
functional back referral mechanism has been shown to be more effective in supporting retention 
(ibid.). The Lighthouse ‘Back to Care’ project which focuses on tracing patients who have 
defaulted from treatment is a good model. However, to make it affordable for the wider health 
system, it needs to be adapted so that the follow up programmes would be implemented by 
trained lay persons or expert patients with supervision from well trained Health Surveillance 
Assistants (HSAs). In Malawi HSAs, are employed by the government, receive a salary of 
between $42 and $52 per month and a basic training in public health. The HSA are based within 
their catchment area of service and are supposed to serve a catchment population of between 
1000-2000 people. The number of HSAs with funding from Global Fund has tripled from a
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population of 4000 to over 11,000 nationally. HSAs’ work is focused on a wide range of health 
interventions including immunisations, management of child hood illnesses, sanitation, health 
and nutrition and follow up of TB patients among other activities. It would be difficult for them to 
concentrate on only HIV treatment activities but they are in a unique position to improve such 
services. As they are the available cadre of community health workers who have established 
remunerated positions within the Ministry of Health, their linkage with other non established 
community health workers would promote interaction between the communities and health 
facilities.
In Malawi, apart from the HSAs, most of the community health workers are volunteers. As is 
often the case with programmes which rely on volunteers, turn over tends to be high and this 
constantly presents challenges to the effectiveness and sustainability of programmes relying on 
volunteer community health workers (Hermann et al., 2009; Lehman and Sanders, 2007). In 
resource poor countries, it would be difficult to remunerate all CHWs but alternative means of 
incentivising the community health workers are essential as volunteers in settings like Malawi 
are often poor and require an income. The incentives can be non monetary such as asdequate 
provision of materials necessary for their work, trainings, supervision and provision of means of 
transport such as bicycles to enable timely referral. For community health worker programmes 
to work better, there needs to be appropriate selection which involves the community; 
continuing education and training; guidelines and standardised protocols for initial training 
involvement and re-orientation of health service staff; relationship with the formal health service 
and improvement in supervision and support (Lehman and Sanders 2007; Hermann et al.,
2009) . Thyolo district, a single district in Malawi has successfully achieved universal ART 
coverage through meaningful involvement of community health workers (Bemelmans et al.,
2010) . Apart from imparting them with skills on how to engage communities, CHWs also need to 
be equipped with basic counselling skills to be able to deal with marital or psychosocial issues. 
This is important as in my study, I found that a few of patients who had stopped treatment or 
had not started treatment had been because of a lack of support from spouses or a fear of 
stigma.
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7.6 The household/individual and community factors affecting HIV treatment 
access and adherence
As shown in the literature reviewed in section 2.3, illness is a social experience and the 
interpretations attached to illness are socially determined and influenced by the society in which 
people live. Therefore illness health seeking behaviour is a factor of socio-cultural 
understanding of the illness, its perceived threat to a person’s health and the perceived benefit 
that care seeking will relieve or prevent illness (Wringe et al., 2009). Patients' beliefs about their 
illness determine the kind of provider that they will make contact with while at the same time, 
patients will consider the perceived benefits and barriers of contacting a particular provider. In 
this decision making process patients might also consider the issues of availability, accessibility 
and acceptability of the provider of their choice. While in certain cases, for example, patients 
might want contact with a formal provider, in Malawi due to long distances to facilities, high 
transport costs and difficulties travelling to health facilities, patients tend to seek care from 
traditional healers and private health care facilities (Woolf et al., 2006). According to the 
conceptual framework in Section 3.3, Figure 7, the decision making process will be influenced 
by the interrelation between the individual/household or community and the health system 
factors.
In this study, patients interpreted their illness according to the symptoms that they were 
experiencing. Most common symptoms that patients experienced were fever, cough, diarrhoea, 
and body weakness and patients usually interpreted their illness to be malaria, tuberculosis, 
diarrhoea with some suspecting HiV/AIDS. Those who mentioned HIV/AIDS were likely to have 
already been aware of their HIV status for a longer period of time and were just becoming 
eligible for ART at the time of the study. Malaria is an endemic communicable disease in 
Malawi, with about six million cases annually (NMCP, 2010). When a person has a fever, the 
perception of having malaria is likely to be high. The study findings showed that 37.1% of the 
patients perceived themselves as having malaria. Patients with a cough were also likely to 
consider themselves as suffering from tuberculosis.
Chapter 2 shows how patients and communities define and understand their illness and its 
severity, may determine their health care seeking behaviour (Kigozi et al., 2011; Bignami-Van
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Assche et al., 2007; Wringe et al., 2009). In section 5.4.1, use of formal health providers was 
commonly reported, but patients also reported self treatment, use of traditional healers and 
religious leaders. I found that 2.5% of the provider visits were to traditional healers because of 
the patients' beliefs about the cause of their illness. In Malawi, use of traditional medicine is 
common (Hatchett et al., 2004; Chikaphupha et al., 2008). Hatchett et al. (2004) found that 
patients have a three step process in care seeking. Initial use of local herbs or other treatments 
found around the home is common, care is then sought from traditional healers and finally, 
patients will seek care from formal providers as a last resort, often in more critical conditions. As 
explained in section 7.1.1, self treatment or use of traditional medicine might have been 
underreported in this study as the study focused on the health seeking steps made after 
patients perceived their illness to be getting serious.
According to the Health Belief Model (HBM), people are likely to assess their perceived 
susceptibility to HIV infection before considering an HIV test (Kigozi et al. 2011;
Rosenstockl 974). The study findings from the quantitative and qualitative data showed that 
most patients access an HIV test due to illness. Frequent illnesses or lack of improvement after 
visiting different health providers leads the patient to consider that they might be HIV infected. 
Health workers are also likely to consider suggesting HIV testing in patients who are not 
responding to previous treatments (section 6.1.3). Wringe et al. (2009) in rural Tanzania found 
that among HIV infected patients, physical symptoms were more associated with care seeking 
from a health facility. Patients weigh up the severity of the illness against the perceived benefits 
likely to be acquired from care seeking. At the point of accepting an HIV test, patients are likely 
to consider their illness to be severe and recognise that it could be beneficial to make contact 
with HIV services. The qualitative data also showed that if patients were not yet eligible for ART, 
they did not follow up their pre-ART care as they did not perceive their illness to be severe. 
Health workers felt that patients who know that they are eligible to start ART immediately, and 
do not start treatment and usually return to the ART site when they are more ill.
Overall, although ART access might be recognised as beneficial, the study has showed there 
are often complex challenges that patients perceive as potential barriers to accessing or 
adhering to treatment. The fear of stigma, fear of divorce, loss of income, lack of transport and
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long distance to the health facilities were highlighted as keeping patients from initiating or 
adhering to treatment. The study findings suggest that for patients to make contact with the 
health services, they need to have overcome or be prepared to mitigate the perceived barriers 
that they conceive.
Based on Roger’s theory on diffusion of innovation (Rodger, 1971) described in section 2.3.2, 
the knowledge that people have about HIV treatment services and the extent to which the 
community perceive them to be of advantage are important for the utilisation of services. In this 
study most patients were initiated on ART within a month of accessing an HIV test. After HIV 
testing, HTC providers provide information about ART as part of a patient’s counselling. With 
the expanding availability and utilisation of HIV services, there is increasing experience among 
communities of the positive impact of ART in the lives of PLWHIV. In Zambia, a study among 
Christian men found that there is increasing enthusiasm about ART and the ‘miraculous’ return 
to health experienced due to ART access. Similarly, in Malawi, ART has brought hope as HIV 
infection is no longer a death sentence among communities (Makwiza et al., 2009). The 
involvement of community based organisations in treatment literacy and providing social and 
psychological support is important in promoting accepting attitudes towards HIV services in the 
communities (Zachariah et al., 2007).
For health systems to achieve effective coverage, patients have to perceive ongoing benefits 
from treatment, to help them tackle or overcome barriers that might hinder adherence and 
patient’s belief in their self worth and confidence. In Section 6.4,1 found that patients who are 
not able to overcome challenges that they faced such as lack of transport and lack of social 
support from spouse and they interrupted treatment despite appreciating the benefits 
experienced from ART. Improved health and feeling of independence motivated most patients to 
overcome barriers that they faced so that they could continue with treatment. Ware et al. (2009) 
similarly found that improvement in health and ability to participate in normal activities motivated 
adherence among patients on ART.
7.7 What is the impact of adopting new treatment guidelines on equity?
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Malawi has adopted new HIV treatment guidelines which require patients to start treatment at 
less advanced stages of HIV infection (with CD4 cell counts of 350 rather than 200), have all 
pregnant HIV positive women on treatment, and provide universal access to symptomatic 
children bom to HIV positive mothers who are less than two years old (MoH, 2011). This poses 
major challenges. Firstly, while these treatment guidelines are important for HIV prevention and 
universal ART coverage, implementation is taking place at a time when HIV financial resources 
from donors are dwindling and there are no mechanisms for raising resources locally. The data 
in this study from the health workers showed that in some facilities, ART rationing was being 
implemented so that all patients could at least receive some drugs when they visit the ART 
facility. However, this increases the burden of costs upon patients and compromises adherence 
as they need to make more visits to get their ARV refills. A study in two districts of Malawi, 
Rumphi and Lilongwe showed that each a single visit for ARV refill to the ART site cost patients 
in the poorest 20% quintile $2.4, while it cost the richest 20% $2, demonstrating the burden of 
such an approach on the poor (Chilipaine-Banda et al., 2009).
Secondly, health systems are already overburdened with the task of providing ART services to 
those currently on treatment. Due to health worker shortages, limited physical infrastructure and 
limited laboratory capacity, ART scale up has been limited resulting in only reaching about half 
of all those who need treatment. It is clear that with the new guidelines, health systems might 
not be able to cope with the burden of ART clients. Reaching all HIV positive pregnant women 
with ART and patients with less advanced HIV might result in ART programmes putting more 
focus on the already existing and more established ART sites and hinder further 
decentralisation of ART services. In my study, there were complaints of health worker shortages 
both from health workers themselves and patients, resulting in treatment only being provided on 
specific days of the week and long waiting times for patients. To achieve the new 
recommendations, existing ART sites will need to be strengthened first to allow them to cope 
with a higher load of patients and additional resources will be required to train health workers in 
the current ART sites on the new guidelines.
Thirdly, along with the new guidelines, it is important that deliberate mechanisms to strengthen 
treatment adherence and reduce loss to follow up are put in place. Ways for handling non
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disclosure to spouses, which might affect adherence, (particularly among women from PMTCT 
programmes) need to be considered. More involvement of community health workers, 
promotion of treatment literacy programmes and mass public education will be important.
Fourthly, the use of laboratory monitoring will need to be strengthened. Financial and human 
resources have been a challenge for using laboratory based monitoring and it has been 
considered that this should not hinder ART access in resource poor countries (DART Trial,
2010; NAG, 2005). As patients start treatment earlier, children start treatment only based on 
their symptomatic condition and their mothers’ positive status and pregnant women start 
treatment for the rest of their lives, it would be unethical to maintain that laboratory monitoring is 
unaffordable while programmes can afford the ARV drugs.
Lastly, there is a need to revise the policy on equity to ART access which was written when ART 
scale up had only just started (NAG, 2005). The policy stipulated that in the case of drug 
shortages, certain population groups such as the police, teachers, health workers, defence 
force, sex workers and children would be given priority. These policy principles will need to be 
considered in light of the new treatment guidelines which are further increasing the number of 
people in need of ART. The ART policy principle which stipulates provision of subsidised drugs 
to the private sector need to be revisited in light of the declining ART resources, as private 
sector facilities tend to occur in urban areas where ART services are already available. People 
who visit private facilities for ART might also be those who have more capacity to pay potentially 
providing an opportunity for cost recovery and raise local resources for ART.
Another potential way for ART programmes to reduce the cost of ART provision is to strengthen 
workplace HIV programmes that cover costs of ART through the private health sector so as to 
reduce the number of patients relying on government subsidised ART programmes.
7.8 Recommendations
The goal for provision of antiretroviral therapy is to reach universal access, which is defined as 
80% coverage of those who need ART. Malawi has only reached 50% coverage and efforts are
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on the way to reach universal access. The study findings and discussion suggest that to reach 
universal access, improvements and changes will have to be made in policy and practice at the 
health system level and also at the community and household level.
7.8.1 Health systems
Health systems have the potential to address equity issues by facilitating effective coverage of 
ART services. This can be achieved by tackling the challenges that hinder availability, 
accessibility and acceptability of services. It is important to prioritise training and retention of 
trained health workers through the Emergency Human Resource Programme which has 
resulted in increasing staffing levels and retention of health workers. The current numbers are 
still inadequate compared to the required need. However, ART decentralisation has been 
possible through task shifting to non-physician cadres particularly ciinincal officers, medical 
assistants and nurses. Expansion of health providers should also be concentrated on these 
cadres so that they can work in peripheral health facilities, particularly in rural areas.
Health services particularly in the rural areas need to be strengthened and also innovatively 
deliver services in a way that does not burden the rural poor population or households with high 
service costs. ART services should continue to be decentralised to health centre levels so that 
patients do not pay high costs for transport. This might also help in reducing the long periods 
spent shopping for care that patient’s experience. In the areas where patients travel long 
distances to access services, the use of mobile services to health facilities that do not offer 
ART, could make services easier to access. Access to health services is a human right and 
government and providers should strive to provide services to those who need them.
Pre-ART care for patients living with HIV seems to be failing in the current health systems. 
Patients seem not to recognise the need for being in care before ART. However, ensuring that 
most patients with HIV infection are in care would mean increasing burden for the health system 
and calls for more strengthening of HIV service provision. With the change in policy to starting 
ART at an earfier stage of HfV infection, the PMTCT B+ programme and symptomatic children 
bom to HIV positive mothers, a good proportion of the HIV infected population who would have
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to be on pre-ART care wil! now be on treatment. It will therefore be important to critically monitor 
how the health systems will cope with these new guidelines and for policy makers to be quick, 
aggressive and flexible in responding to challenges that might arise. Monitoring of the ART 
programmes will need to focus on the impact of this approach on the provision of other critical 
health services. Adoption of these new guidelines will have impact on reducing further HIV 
transmission. However these efforts should be supported with other new strategies which have 
proven effective for preventing transmission such as male circumcision.
Lack of follow up of patients is a common problem. Health providers could work with community 
health workers, including volunteers and HSAs who are commonly available in most 
communities, to follow up patients in their communities. This would require investing in training 
CHWs to enable them to provide psychosocial support, basic HIV and ART literacy and ethical 
issues concerned with following up patients.
Most of the patients visit formal health providers during care seeking, and therefore routine 
offers of HTC for outpatients as well as inpatients would promote early access to HTC. HTC 
should also be expanded beyond the health facilities to the communities through increased 
voluntary counselling and testing sites and also through door to door testing. Men need to be 
particularly targeted with HIV testing services through creating awareness of the importance of 
HIV testing in places where men are found, such as through HIV at work place programmes, 
agricultural clubs, trading places.
With the increasing number of patients, the infrastructure for providing services is limited and 
management of patient information is paper based in most facilities. Improving the data 
management system will reduce the load of health staff and improve management of patients. 
There are currently efforts to address this and recently, Center for Disease Control (CDC) has 
announced grants which aim to improve quality of care and health impact through innovative 
system technologies in Malawi which, once implemented, would enable HIV data from different 
programmes such as HIV testing, PMTCT, ART to be harmonised and be centrally available at 
the district and national level.
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7.8.2 Community based system
Strengthened community based systems have the potential to bring services to the poor 
communities. This could involve training more CHWs, HSAs and lay counsellors, in HIV testing 
and involving them in door to door testing or in point of care testing for households who have 
HIV related symptoms. CHW have the advantage of understanding patients and household's 
situations and environment as they also reside or work within the communities they serve. They 
have the opportunity to interact with the patient at the individual and household levels and to 
persuade them about the importance of HIV testing where the patient will not require travelling 
long distances to access the test, hence increasing the uptake of these HIV services.
Home based care groups or patient support groups are effective in patient referral and providing 
basic care among chronically ill patients. These promote adherence among patients in the 
communities but often lack proper linkage and support from health facilities to know who to 
follow up and how to provide feedback to the facilities. Community based organisations should 
also create more awareness about HIV and addressing HIV related stigma in communities 
which hinder people from accessing and adhering to ART.
However, for the community systems to work, referral systems need to be functional and should 
have mechanisms for providing feedback. Referral systems are often less effective where 
patients are poor and have to travel long distances or money for transport is required. They are 
also hampered and challenged by poor condition and impassable roads.
Self treatment usually through drugs bought from grocers is common and often these are the 
first point of care. Involvement of informal private providers such as grocery store owners, 
traditional healers for referral and providing advice could help in cutting the long pathway for 
care seeking. Integration of other private providers who operate in rural and urban areas for HIV 
testing and referral would reduce number of health visits that patients make before HIV 
diagnosis. While there is a public/private partnership where ART is heavily subsidised within the 
private sector; these are often registered private facilities more commonly found in urban areas 
than in rural areas. However, in the rural and peri-urban areas, other non-form a I ised private
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providers might be recruited and working with them to promote early referral for health care to 
ART sites.
7.8.3 Resource mobilisation strategies for ART and HIV
The Malawian health system is heavily underfunded and provision of free care at the point of 
delivery limits the possibility of cost sharing. As most Malawians are poor, free care remains the 
best option for equitable access to care for the poor. The government might however need to 
deliberately introduce mechanisms such as introducing health insurance programmes for middle 
class and upper class. Micro-health insurance programmes might also motivate people to 
access care from the private sector.
Through revision of ART policy concerning the private health centres, MoH should consider 
increasing patients’ contribution towards ARV drugs and encourage employers, particularly from 
the private sector, to provide health services to their employees.
Some of the necessary responses for sustainable and equitable treatment and support goes 
beyond the health sector. Addressing poverty, gender issues, nutrition needs of patients or good 
road networks goes beyond the health sector and inter and multi-sectoral action is needed. For 
example, the government of Malawi has been providing subsidised fertiliser and seeds to the 
poor. This has improved food security in the country despite requiring siginificant resources and 
the sustainability of the programme cannot be guaranteed. A cash transfer programme has 
been piloted where cash is provided to poor households and promotes children from poor 
households to be in school. However, these approaches will need to ensure that they target the 
poor and do not marginalise people living with HIV and AIDS as a means of addressing the 
patients’ multiple needs and challenges.
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Chapter 8: Conclusion
In this chapter, I will draw my conclusions from the thesis on the key questions that I sought to 
address in the beginning in Chapter 1, drawing from the conceptual framework which was 
based on existing published and grey literature in Chapters 2 and 3 and using a mixed methods 
approach from qualitative and quantitative approaches.
With so many people infected by HIV in Malawi and the negative impact that has so far been 
experienced by different sectors of the economy, there has been great enthusiasm in the 
expansion of ART provision in Malawi. Patient access and adherence to treatment is critical for 
successful treatment outcomes. This thesis aimed to explore the experiences of men and 
women in urban and rural Lilongwe in accessing and continuing with treatment. To understand 
the issue, I focused on responding to four key questions using a predominantly quantitative 
approach and a follow up qualitative approach.
• What is the health care seeking behaviour of patients leading to the time they are eligible 
for ART and begin the antiretroviral drug initiation process?
• What are the associated direct and indirect costs of care seeking and are there 
inequalities in how the costs impact on different social economic groups?
• Are there patients who do not initiate treatment despite knowing that they are eligible for 
treatment and why do these patients not start treatment?
• Among the patients who are lost to follow up or die whilst on ART, what are the factors 
that contribute to attrition?
In this thesis, I have shown that there are inequities in provision of ART services which 
negatively affects the experiences of poor and rural patients in accessing care. I found that 
patients seek care for symptoms when they perceive as common illnesses such as malaria, 
usually because of fever. Only a few mostly who have had a prior HIV diagnosis suspect they 
have AIDS. The health care seeking is influenced by socio-economic factors. Patients’ health 
care seeking behavior was characterized by multiple visits to health providers leading to delay in 
HIV diagnosis and ART access. Most of the patients sought an HIV test due to illness and there 
was usually not a long delay from the time of HIV testing to the process of ART initiation. There 
are health system and patient related factors that contribute to delays in HIV testing. Patients
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and health providers consider HIV testing when they feel the illness is not responding to various 
treatments they have received or prescribed. As such, the study showed that most patients 
initiate treatment at advanced stages of illness. There is also limited availability coverage of 
ART services due to shortages of health workers and infrastructure constraints. The limited 
availability of ART services in most rural health facilities lead to challenges in accessibility and 
acceptability. Patients often present themselves for HIV care at advanced stages of illness as 
their actions to seek care might be shaped by their perceived severity of their illness and 
through a lack of willingness to overcome barriers such as long distances, high transport costs, 
and stigma.
The direct and indirect costs of care seeking were high with about half of the patients requiring 
close to one month’s income on care seeking. The direct costs of care seeking are influenced 
by whether a patient is initiating treatment in a public or a CHAM facility. While overall direct 
costs do not vary by rural and urban residence, the study has shown that the kind of direct costs 
vary by geography. Transport costs for urban populations tend to be high while rural residents 
spend more on consultation, drugs and treatment and food and incidental costs. Rural residents 
also have high opportunity costs of care seeking.
The study showed that some patients choose not to initiate treatment despite their knowledge of 
the need to start treatment. Patients initiating treatment at secondary level facilities were likely 
not to start treatment and high direct costs of care seeking related to transport costs had an 
influence on patients not initiating treatment. Patients who perceive themselves to be well stop 
seeking further care from the health facility. Most health facilities are not able to monitor the 
drop out of patients before they start ART as they lack a system for monitoring such data. 
Patients who had not started treatment were reluctant to stay in care as they felt they were not 
sick.
I found that attrition from care due to documented death and loss to follow up was close to 20%. 
A high number of patients classified by the facility records as lost to follow up, had actually died. 
Socio-economic factors such as gender and poverty were the main factors contributing to 
deaths and loss to follow up from treatment. Men tended to have higher deaths and loss to 
follow up than women. Poverty, travel and lack of support from spouses contributed to patients 
dropping out from treatment. Programmes that promote adherence and reduce loss to follow up
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are mainly available in the larger secondary health facilities but are lacking at the peripheral 
facilities.
Conceptually and analytically, I have found that the Tanahashi model, is an effective model in 
evaluating the health system and the different stages from which patients can drop out from the 
antiretroviral therapy path. The model follows the patient pathway in seeking care and therefore 
problems at any point in that pathway can potentially lead to the patient dropping out from care 
seeking. Availability, accessibility, acceptability (including affordability) of the services are all 
important elements affecting whether patients make contact with services and adhere to 
treatment. For chronic illnesses such as HIV, it is clear that the different dimensions and factors 
that affect HIV care and treatment, interplay of these factors at different stages through the life 
of the patient to determine whether they access or remain in treatment. Therefore while services 
might be available, accessible, acceptable and utilised at a certain point, there will be variation 
depending on the influence of factors affecting the health system, the household or the 
community. The advantage of using this model was that I was able to track attrition at the 
different stages and it gave me an opportunity to explore the patient journey in seeking care and 
retention in ART. One of the limitations to understanding the patterns of health care seeking in 
my research has been that I recruited patients at the point where they were initiating ART and at 
a stage where patients had already made initial contact with the ART services. It would be 
important to assess the contact coverage prior to contacting ART services to have an in-depth 
understanding of issues preventing patients from HIV services.
The thesis has demonstrated that care seeking is not only influenced by health systems issues 
but is also highly dependent on the patients' construction of how, where and when they seek 
care which is influenced by their beliefs and expectations from care seeking. The social 
dynamics, beliefs and perceptions underpin how patients seek and remain in care.
Methodologically, I have found the mixed methods approach very useful in bringing a holistic 
understanding of the factors that influence health care seeking. The quantitative approach 
quantified the different elements of the study objectives such as patterns of care seeking, the 
costs and the numbers dropping out from care. In contrast the qualitative approach brought 
meaning to how cost affected patients care seeking. The qualitative approach also showed the 
complexity of the factors and how they interplay with one another to influence patients’ 
decisions.
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This thesis shows the dynamism around ART roll out through time in a quest to reach universal 
coverage. This enthusiasm in the unfolding system needs to continue in a way that takes equity 
in the forefront.
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Appendices
Appendix 1: Policy principles for promoting equity in access to ART
1. Government will progressively provide access to affordable, high quality ART and prophylaxis to 
prevent opportunistic infections, to adults and children who have tested HIV-positive, 
understand implications of ARV therapy and are medically deemed to be in need of this drug 
therapy
2. ART will be provided to the private sector at the subsidized rate of 20% of cost
3. To receive ART at subsidized rates private sector providers will be trained, will understand the 
implications of ART and will participate in national monitoring activities.
4. ART will be provided simultaneously in at least one public sector site in all districts.
5. ART will be free-of-charge at the point of delivery in the public health sector (including CHAM).
6. At the point of delivery in the public sector, ART enrollment will be on an open ‘first-come, first- 
served’ basis.
7. Targeted gender-sensitive health promotion of ART will be made to groups of people 
considered to be in ‘strategic’ or in vulnerable situations.
a. Situations of moral obligation to treat (e.g. to prevent mother to child HIV transmission)
b. Essential human resources in key front-line services (e.g. health workers, teachers)
c. Maximum multiplier effect for society, whereby treating a strategic group may 
encourage more people to speak openly of HIV/AIDS, seek HIV testing and early 
access to care (e.g. people living positively with HIV/AIDS)
d. Principles of non-discrimination and pro-poor measures (e.g. orphans, remote rural 
dwellers, sex workers, prisoners)
8. Cost-effectiveness maximization in existing public health interventions
9. Implementers will be encouraged to overcome specific geographical barriers to access for 
remote populations.
10. In the unexpected event that demand for ART outstrips supply priority considerations be given 
to people already on ART, pregnant women and young children.
11. ART provision will support the provision of essential health services, particularly within the 
public health sector.
12. Equity monitoring (including disaggregation by sex and age) will be conducted as part of the 
ART scale-up.
Source: NAC, 2005
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Appendix 2: Quantitative study tool
GENERAL INFORMATION
Interview ID Number:
Interviewer Code
Type of health facility 1. Government Hospital
2. Government health centre
3. Government Community hospital
4. Mission hospital
5. Mission health centre
6. Private not for profit facility
Name of health facility ----------------------------------------------
Date of the interview
288
Any Comments on interview
Time interview start and finish
289
First I would like to ask you a few questions about your background information.
101 Patient ART Registration Number ART REG
102 Sex 1. Female
2. Male
SEX
103 Age in years. Muli ndi zaka zingati? Exclude if <16
years
AGE
104 Current marital status
Kodi muli pa banja?
1. Single never married
2. Married/non formal union
3. Divorced/separated
4. Widowed
99. Not Known
MARITAL
105 Normal area of Residence.
Mumakhala kuti?
Exclude if outside
Lilongwe
--
RESIDE
106 Level of education 1. Lower Primary
3. Upper Primary
4. Secondary
5. Tertiary
EDUC
I will ask you questions regarding your illness, how it started, the symptoms you have experienced 
and about HIV
testing. Tsopano ndikufunsani mafunso okhudzana ndi kudwala kwanu, zizindikiro zomwe 
mwaziona
mthupi mwanu komanso zokhudzana ndi mmene inu munadziwira kuti muli ndi HIV.
290
Mungandifotokozereko mmene matenda anu anayambira, anayamba liti, komanso 
zizindikiro zimene inu mwakomana nazo, kodi mwkakhala mukuvutika/mukudwala kwa 
nthawi yaitali bwanji?
291
201 When did you first have symptoms
Mudayamba kuona zizindikiro zakuti
mukudwala liti?
Date
MM YY
WHENSYP
202 What symptoms did you have at the 
beginning of your illness? Kodi ndi 
zizindikiro ziti zomwe munkaziona pa
kuyamba kwa matenda anu?
Circle a
maximum of 3
1. Cough
2. Fever/Malaria
3. Pneumonia
4. Night sweats
5. Body weakness
6. Vomiting
7. Loss of body weight
8. Diarrhoea
9. Skin rashes/other skin
conditions
10. Wounds/sores on body
11. Throat infections
12. Mouth sores
13. Heartbum/indigestion
14. Chest pains
15. Other
sp
99. Not known
SYMPTOM1
SYMPTOM2
SYMPTOM3
203 What did you think you were suffering
from?
Kodi munkaganiza kuti mukudwala
chiyani?
Indicate one
major illness
1. TB
2. Asthma
3. Malaria/Malungo
4. Bewitchment
5. Cancer
6. Diarrhoea
7. Pneumonia
8. Anaemia
9. General body
weakness
10. General body pains
ILLNESS
292
11.
12.
13.
14.
15.
16.
99.
Chest pains
HIV/AIDS
Mouth sores
Throat infections
Breathlessness
Other sp
Not known
204 When did you feel your sickness was ILSERIOUS
getting more serious and needed
attention? Kodi munayamba kudwala
mowirikiza kapena kuona kuti matenda MM YY
anu akukula liti? —
205 Which major sign or illness prompted you Circle one 1. Cough MAJORSY
to seek care? Nanga ndi chizindikiro major sign or 2. Fever/Malaria
chiti chomwe chidakupangitsani inu illness 3. Pneumonia
kuti muyambe kufuna chithandizo? 4. Night sweats
5. Body weakness
6. Vomiting
7. Loss of body weight
8. Diarrhoea
9. Skin rashes/other skin
conditions
10. Wounds/sores on body
11. Throat infections
12. Mouth sores
13. Heartburn/indigestion
14. Headache
15. Other
sp
99. Not known
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206 What conditions or symptoms did you have 
which you think led your clinician to 
recommend you for ART? Kodi ndi 
zizindikiro ziti zomwe inu mukuganiza 
kuit zidapangitsa dokotola wanu kuti 
akuyambitseni mankhwala a ARV?
Circle a 
maximum of 3
1.
2.
3.
4.
5.
6.
7.
8.
9.
10. 
11. 
12.
13.
14.
15.
16.
207 When did these conditions start? Kodi 
zizindikiro zimenezi zidayamba liti?
Date
MM
208 (IF HAD A CD4 Count) Did you choose to 
have a CD4 count yourself or did your 
clinician/some one else recommend one?
Kodi mudasankha nokha kukayezetsa 
CD4 kapena adokotala ndi amene 
adakupemphani kuti muyezetse CD4?
If no CD4 test, 
go to 210
209 When did you have a CD4 count test?
Mudayezetsa liti chitetezo chanu cha 
CD4 komaliza? MM
17.
18. 
99.
CUN SYP2
CLINSYP3
Swollen or hot parts of ICLINSYP1 
body
Skin rashes/other skin 
conditions 
Shingles 
Cough 
Diarrhoea 
Fever/Malaria 
TB
Cancer
Meningitis
Asthma
Mouth sores
Wounds/sores on body
Body weakness
Weight loss
Pneumonia
Heartbum/Frequent
indigestion
Low CD4 count
Other (sp)
Not Known
WHENCLIN
1.
2.
3.
YY
Self CDREF
Clinician
Other
(specify).
CDDATE
YY
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210 Did you already know you were HIV+?
Kodi munkudziwa kale zoti mull ndi HIV
mthupi mwanu?
1. Yes
2. No
3. Don’t know
KNOWHIV
211 When did you find out your HIV+ status?
Mudayezetsa lit! magazi anu kuti
mudziwe ngati mull ndi HIV? MM YY
HIVTEST
212 What prompted you to have an HIV test?
Chidakupangitsani kuti mukayezetse
magazi ndi chayani?
Choose one 1. Partner - partner’s past
sexual behaviour
2. Partner - partner told
you to get tested
3. Partner/child-
partner/child ill or died
4. Exposure - your own
past sexual behaviour
5. Exposure - blood
transfusion
6. Exposure - taking care
of people with
HIV/AIDS
7. Exposure -
contaminated
instrument
8. Giving blood
9. Symptoms/ ill health
10. Future plans-
marriage/having
children/planning for
the future
11. Referral by health
worker
12. PMTCT
13. Want to know sero-
status
14. Other (Sp)
HIVPROMPT
295
99. Not known
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40
1
Date first attended formal health care for
these symptoms?
DATEFORM DD....MM.....YY.....
40
2
Date had first HIV test?
40
3
Date first referred for ART? DD....MM.....YY.....
40
4
Date of CD4 count (just before starting 
ART, Date sample was taken)? Tsiku 
lomwe mudayezedwa chitetezo cha
mthupi (CD4)?
If no CD4
indicate N/A
DD.....MM....YY....
40
5
When did you go to the clinic for ARV
counselling? Tsiku lomwe mudakalandira
uphungu wa makhwala a ARV?
If no
counselling
indicate N/A
DD....MM....YY....
40
6
Date started ART treatment? {If patient has
started ARV treatment) Tsiku lomwe
mudayamba kulandira ma ARV?
If not yet on
ART indicate
N/A
DD....MM....YY....
40
7
Name of the facility patient is receiving 
ART or will be receiving ART (if not at the
current facility)
Chipatala/malo amene wodwala
akulandilako ma ARV kapena komwe
azikalandililako ma ARV?
Name of the
facility
40
8
Is there another facility close to your home 
where you would also be able to get your 
ARV treatment from? Kodi pafupi ndi 
komwe mumakhala kuli chipatala china
chomwe munakatha kumakalandira
1. Yes
2. No
3. Don’t know
308
makhwala a ARV?
40
9
*
Why have you chosen this facility for your 
ARVs? Chifukwa chiyani mudasankha
kumadzalandira makhwala anu a ARV
ku chipatala chino?
Referring to
facility in 405
Circle only
one major
factor
ICost low or free treatment
2. Quick service
3. Treatment effective for
ailment
4. Beliefs
5. Close to
home/workplace/short
distance
6. Referral
7. Recommended (others or
media)
8. No particular reason
9. Confidentiality
10. Good quality services
11. Other
sp:
41
0
*
How would you travel to this facility for your 
ARVs? Mayendedwe anu amakhala 
otani podzatenga ma ARV?
1. Walk
2. Bus/minibus
S.Matola
4. Bicycle
5. Own vehicle
6. Hired car/taxi
7. other (specify)-----------------
309
41 How long does it take you to travel to this TPTARV
1 facility? Mumatenga nthawi yayitali 
bwanji kuti mudzafike ku chipatala
kuno?
.....................HRS
41 How much would you pay for transport to If no TPTARVCT
2 be coming to this facility for each visit (to transport
and from the facility)Mumalipira ndalama costs, go to
zingati pa mayendedwe anu pobwera ku
chipatala ndi kubwerera kunyumba?
414 K.......
41 How do you plan to find the money to 1. Own money FINDMON
3 cover for the expenses mentioned above?
Ndalama zoyendera mumazipeza 2. From spouse
bwanji? 3. From children/parents
4. From friends/relatives
5. Borrowed (without interest)
6. Borrowed (with interest)
7. Begging
8. Sell asset
9. Other
sp......
41 Do feel you will be able to continue taking 1. Yes DRUGCON
4 the drugs as per the clinician's 2. No T
instructions? Mukuwona kuti 3. Not sure
mudzakwanilitsa kulandira mankhwala
motsatira malangizo adokotala wanu?
41 Are there any challenges you feel you 1. None DRUGCHA
5 might encounter which could cause you to 2. Distance to the facility L
stop taking the drugs? Kodi mukowona 3. Stigma
kuti pali zovuta zomwe zingapangitse 4. Financial challenges
310
tkuti inuyo musiye kumwa mankhwala? 5. Lack of food
6. Don’t want to take
drugs all life
7. Will be cured through
prayer
8. Will be cured through
herbs
9. Side effects
10. Other (sp)
11. Don’t know
Now I would like to ask questions about the effect that your illness or health care seeking has 
had on your livelihood.
501
*
*
many days have you lost work 
due to illness or care seeking before 
starting ART in the past year?
Kodi ndi masiku angati omwe 
simunagwire ntchito chifukwa 
chodwala komanso kupeza 
chithandizo musadayambe ma 
ARV muchaka chapitachi?
Enter days 
in figures. 
Need to 
probe
whether not 
working 
because of 
sick or 
because of 
lack of 
employment 
(household 
or paid) - 
only use 
time due to 
being sick
502 If not working for more than 6
months, how are you meeting your 
food and financial needs?
If not
applicable 
go to
1.
2.
3.
4.
Ngati mwakhala musakugwira 503
Living with relatives 
Selling assets 
Receiving remittances 
Other
(sp)_____________
LOSTDAYS
311
1
ntchito kwa miyezi 6 chakudya ndi
zina zotelo mumazipeza bwanji?
503 If farmer , what time of agricultural If not 1. Preparing field AGRICAL
calendar did you lose these days? farmer, go 2. Planting
Ndi nyengo iti ya ulimi yomwe to 506 3. Fertiliser application
idatayika? 4. Harvesting
5. Other (Sp)
't
504 Did this affect your output? Kodi 1. Yes AFFECT
zimenezi zinachepetsa zokolola 2. No
zanu? 3. Don’t know
505 If yes, by how many bags? 1. 1-5 bags BAGS
Ngati ndi choncho, zokolola zanu
zachepa ndi matumba angati?
2. 6-10 bags
3. More than 10 bags
4. Don’t know
506 When you go for care seeking, who 1. No one REPLACE i
replaces your normal activities? 2. Spouse
Mukapita kokafuna chithandizo 3. Male child
amakugwirirani ntchito zanu ndi 4. Female child
ndani? 5. Male Friend/relative/parent
6. Female Friend/relative/parent
7. Employee
8. Workmate
507 Has your household income reduced I.Yes HHINCOM
because of your illness?
2.No
Kodi chuma chanu chomwe
mumachipeza chatsika chifukwa
chamatendawa?
3.Do not know j
508 Total number dependent children in DEPCHILD
household
Ana amene mumawayang’anira
alipo angati pakhomo panu?
312
!509
N
Total number of household
members.
Nanga mnyumba mwanu
mumakhala anthu angati?
TOTHHOLD
510
1
Relationship to household head
Mutu wa pabanja lanu ndi ndani
wanu?
If self, go to
514
I.Self
2.Spouse
3. Parent
4.Son/daughter
5.0ther(Specify)
RELHEAD
511 Sex of head of household?
Kodi mtsogoleri wa banjalanu ndi
ndani?
1. Male
2. Female
SEXHEAD
512
►
Level of education of household
head?
Sukulu adalekezera pati?
1. Never
2. STD 1-5
3. STD 6-8
4. JCE
5. MSCE
6. Tertiary
7.Other (specify)
EDUCHEAD
513 Occupation of household head
Kodi mtsogoleri wa banja lanu
If household
head self,
1. Salaried: Professional, technical,
administrative or managerial
2. Salaried: Clerical
OCCHEAD
313
!amagwira ntchito yanji? go to 516 3. Salaried: Skilled employment
4. Salaried: Unskilled employment
5. Not salaried: Own business - medium-large
(more than 5 employees)
6. Not salaried: Own business - micro-small
(0-5 employees)
7. Not salaried: skilled worker
8. Cash crop farming
9. Subsistence Farming
10. Casual Labourer (ganyu)
11. Retired (on pension)
12. None
13. Other soecifv
514 What is your main occupation?
Nanga inuyu mumagwira ntchito
yanji?
1. Homeworkers (mother etc)
2. Student
3. Farmer
4. Own business
5. Employed
6. Other
OCCRES
<
515 What is the main activity you do to
earn cash?
Nanga inu mumagwira ntchito
yanji kuti mupeze ndalama
This is the
occupation
of the
respondent
1. Salaried: Professional, technical,
administrative or managerial
2. Salaried: Clerical
3. Salaried: Skilled employment
4. Salaried: Unskilled employment
5. Not salaried: Own business - medium-large
(more than 5 employees)
6. Not salaried: Own business - micro-small
(0-5 employees)
7. Not salaried: skilled worker
8. Cash crop farming
9. Subsistence Farming
10. Casual Labourer (ganyu)
11. Retired (on pension)
12. None
314
!Other soecifv
516 Did you change your occupation
while sick?
Kodi munasintha ntchito yanu pa
nthawi yomwe mumadwala?
1. Yes
2. No
3. Don’t know
*517 If yes, what to?
Ngati munasintha, mumagwira
ntchito yotani?
Note new
occupation
518 How many household members earn
a salary?
Ndi anthu angati mnyumba
mwanu omwe all pa ntchito
yolandira pa mwezi?
f19 What is the condition of the walls of
your house?
Kodi khoma la nyumba yanu 
ndilomangidwa ndi chiyani?
1. Poles and mud walls
2. Compacted earth walls
3.Sun-dried brick walls
4. Burnt brick walls
WALLS
520
►
What is the condition of the floor of
your house?
Nanga pans! pa nyumba yanu ndi
popangidwa ndi chiyani?
1. Cement Floor
2. Mud floor
3. Other (specify)
FLOOR
521 What is the condition of the roof of
your house?
Kodi denga ya nyumba yanu
ndilomangidwa ndi chiyani?
1. Grass-thatched roof
2. Tiled roof
3. Iron Sheet roof
4. Cement Sheet roof
5. Other specify........................................
ROOF
315
What is the condition of the windows
of your house?
Kodi mazenera a nyumba yanu 
ndi wopangidwa ndi chiyani?
1. Wooden Windows
2. Glass windows
3. No windows
Other(specify).......................................
WINDOW
What kind of toilet facility does your
household?
Nanga chimbudzi chanu ndi
chotani?
1. Flush toilet
2. VIP latrine
3. Latrine with san plat
4. Traditional latrine
5.0ther(Specify)
TOILET
Where do you draw water for 
drinking? Madzi akumwa
mumatunga kuti?
1. River/lake
2. Protected well
3. Unprotected well
4. Borehole
5. Piped supply
6.0ther(specify).............................
DRINKWAT
i
Household’s major source of water
for other domestic use?
Kodi madzi wogwiritsa ntchito 
zina ndi zina za pakhomo panu
mumatunga kuti?
1. River/lake
2. Protected well
3. Unprotected well
4. Borehole
5. Piped supply
6.0ther(specify).............................
DOMWATER
i
What is the major source of energy 
for lighting in your household?
Kodi mumaunikira chiyani?
1. Paraffin
2. Candle lighting
LIGHT
316
3. Electricity
4.Gas
5.Other (sp).....................................
What is the major source of energy
for cooking
Kodi mumaphikira chiyani?
1. Purchased firewood
2. Collected firewood
3. Charcoal
4. Paraffin
5. Gas
6. Electricity
Other(sp)..................................
COOKING
How much farming land do you
cultivate? Kodi muli ndi munda
waukulu bwanji?
1. Less than 0.25 Acres
2. 0.25 to 0.5 Acres
3. 0.5 to 0.99 Acres
4. 1 to 2.99 Acres
5. 3 to 9.99 Acres
6. More than 10 Acres
LAND
Do you grow hybrid maize? Kodi
mumalima chimanga cha mbeu 
yamakono/hybrid? 1. Yes
2. No
What other crops do you grow? Kodi
pali mbeu zina zomwe
mumadzala?
1. Cassava
2. Rice
3. Potatoes
4. Vegetables
5. Other for consumption
6. Tobacco
7. Cotton
8. Coffee
9. Other for cash
o you grow crops to sell? Kodi
mumalima mbeu zakuti
mudzigulitsa?
1. Yes, mostly for sale
2. Yes, part for sale, part for consumption
3. Yes, but mostly for consumption
317
4. No
Do you employ ganyu labour? Kodi
mumalemba anthu a ganyu pa
ntchitoyi?
1. Yes
2. No
3. Don’t know
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3.
533 How many cattle do you have? Kodi
muli ndi ng’ombe?
If none put
0
534 Have you bought sugar in the last 
two weeks? Kodi munagulako
sugar mu masabaa awiri apitawa? 1. Yes
2. No
535 Do you have a bicycle?
Kodi mult ndi njinga?
1. Yes
2. No
BICYCLE
536 Do you have a motor cycle or a car?
Kodi muli ndi galimoto?
1. Yes
2. No
CAR
537 Do you have a television set?
Nanga muli ndi wailesi
yakanema?
1. Yes
2. No
TV
538 Do you have a radio?
Kodi muli ndi wailesi?
1. Yes
2. No
RADIO
539 Do you have a fridge?
Kodi muli ndi firiji?
1. Yes
2. No
REFRIG
i
540 Do you have a bed?
Kodi mult ndi bedi? 1. Yes
2. No
4
541 How many times do you eat per 
day? Mumadya kangati pa tsiku?
1. Once
2. Twice
3. Three times
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542 Do you spend some days without If no go to
1. Yeseating? Zimachitika masiku ena 545
kukhala osadya/kugona ndi njala? 2. No
3. Don’t know
543 Why? Chifukwa chani? 1. Did not have food/money
2. Illness
3. Fasting
4. Other so:
99. Not applicable
545 How many months of a year do you 
have enough food (maize, cassava, 
or rice)? Ndi miyezi ingati pachaka
yomwe mumakhala ndi
chakudya?
§46 Which month of the year do you
receive more income? Ndi mwezi
uti womwe mumapeza ndalama
zochuluka?
►
Any other comments? Pali zoonjezera kapena mafunso? 
THANK YOU SO MUCH FOR YOUR COOPERATION!!!!
ZIKOMO KWAMBIRI CHIFUKWA CHAKUZIPEREKA KWANU!!!!
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Appendix 3: Qualitative Interview Guide for patients
1. Generally tell me how you are feeling now?
2. Briefly explain what happened for you to seek ART care?
a. When did you start the health care seeking behavior?
b. How many places were visited to seek care? (Why was the health care seeking 
pathway long or short?)
3. Did you attend the HIV counselling session?
a. What information was provided during this session?
b. Do you still have questions which you would have liked to be addressed during 
the counselling session
4. When did you start taking ARV?
a. If on ARVS, how long after the counselling session did you start treatment?
5. Are you also on any other medication apart from ARVS?
6. Are there any challenges that you have met that have caused problems for you to 
access treatment? Probe for stigma and discrimination, social support, food, transport 
costs etc
7. Have you ever interrupted treatment, missed treatment doses or missed appointments
a. If yes, how many times?
b. For how long did you interrupt treatment?
c. What happened for you to interrupt treatment?
d. Did you restart treatment (If yes, after how long, If not why not?)
8. How have you benefitted from the treatment?
9. If not on ARVS , why did you not start?
a. What do you think has been the effect of not starting treatment
b. Do you have plans to start treatment?
c. When do you plan to start treatment?
d. What effect do you think not starting treatment will have? (probe: on your health, 
social life etc)
10. Any other comments?
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Appendix 4: Health Worker Interview Guide
1. Tell me about your qualifications and post in this facility?
2. What does your work involve?
3. How many patients are registered for ART in this facility?
4. How many days per week are ART services offered?
a. Why are services only offered on these days?
b. ART initiation and counselling services
c. How many days are patients identified eligible for treatment are supposed to 
come before they start Actual ART
5. How would you describe the health care seeking pathway that most patients follow to 
access ART?
a. Do you feel there are challenges that they face to access treatment?
6. Who are accessing ART services more in this facility - Women, men , boys, girls, 
children?
a. Do you feel there is any group which is not accessing as it should? Why?
7. How do you assess the treatment outcomes of patients in this facility? (Survival 
rates/default/stopped)
a. Is there routine review of treatment outcomes? How many times in a 
month/year?
b. Are there mechanisms for following up on patients who default treatment?
c. Who follows up?
d. What are the major reasons for defaulting treatment?
e. What are the contributing factors to the patients who die after starting ART?
i. During which period are deaths common - soon after starting ART or 
among those who have been on ART for some time?
ii. What are the common causes for this?
f. Are there patients who register/initiate treatment and never start treatment/ what 
are the causes of not starting treatment? Are there mechanisms to follow up on 
these patients?
8. How are patients monitored while they are on treatment? Are these records kept in 
patient records
9. What are the major challenges that you face as a provider in providing ART services?
a. Too many patients
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b. Patient attitudes
c. Support from the facility?
d. Training?
10. Any recommendations to make ART provision better? From patient and provider 
initiative
11. Is there a mechanism for getting patient feedback on the way services are provided in 
this facility?
i. Have there been any changes made in the way the services are 
provided?
ii. How do patients feel about he set up of the ART clinic? Is it appropriate 
do they feel it offers them privacy etc?
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Appendix 5: Welfare Model (Payongayong et al. 2002)
Urban Malawi proxy means test model
Variable Co-efficient t-statistic
HH owns a fridge 0.518 (6.25)***
Household size -0.306 (8.96)***
Household size squared 0.016 (5.26)***
Age of head of household 0.005 (2.22)**
Education level of household head 0.151 (7.04)***
No. of salaried HH members 0.061 (1.87)*
HH owns a car or motor cycle 0.704 (6.30)***
HH get lighting from electricity or gas 0.280 (5.00)***
HH owns a bed 0.247 (4.11)***
Blantyre City -0.037 -0.42
Constant 2.347 (16.84)***
Rural Malawi proxy means test model
HH cooks over collected firewood -0.174 (3.58)***
Household size -0.283 (19.12)***
Household size squared 0.015 (11.93)***
Education level of household head 0.078 (6.65)***
No. of salaried HH members 0.098 (4.11)***
HH owns a bicycle 0.153 (6.93)***
HH owns a car or motor cycle 0.693 (8.16)***
HH owns a fridge 0.591 (5.69)***
Total acreage cultivated 0.029 (6.70)***
HH grows tobacco 0.105 (4.03)***
HH owns a bed 0.263 (11.85)***
No. cattle owned 0.013 (3.10)***
HH grows hybrid maize 0.076 (3.28)***
Blantyre Rural 0.208 -1.53
Constant 2.826 (18.81)***
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Appendix 6: ART Patient Consent Form 
Introductory statement
I am {name} working on a research project supported by Research For Equity and Community 
Health (REACH) Trust. We are conducting a study on health care seeking behaviour among 
patients initiating ART. The study tries to understand the experience of people’s illness and how 
they sought care and how much it has costed you economically and socially to the point that 
you started treatment (or dropped out from initiating treatment). It also tries to understand the 
effect that health care seeking and the associated costs has had on their lives. By listening to 
people with these experiences, we hope to leam what has motivated you to go through the 
process (what cause you to drop from initiating treatment) and what has been a challenge for 
you and what could be done to improve the situation.
You have been selected to represent people from this clinic (in this area) and we would very 
much like to hear about your opinions and experiences. Before we get started, I would like to 
explain to you how the interview works. Your participation in the interview and in every aspect 
of the study is completely voluntary and you may withdraw at any time during the study and this 
will not affect the health care and support that you receive from this health facility.
If some questions are difficult or make you uncomfortable, we can skip them. You may also ask 
me to clarify any questions if you don’t understand them or decide to stop the interview at any 
time. Finally, all of the information that you provide for the study will be kept completely 
confidential. Your responses to our questions are identified only by number, never by name. If 
you have questions or concerns, after we are finished, you may contact {contact a health worker 
at the health facility) who may be able to contact us or you may contact Ms Ireen Namakhoma 
on this number (01753260).
Although there are no direct benefits to you from participating in this survey, we hope that the 
survey will help to improve health services and support for people living with HIV/AIDS. The 
survey will take about 45 minutes. Do you have any questions about the survey/in-depth 
interview? Would you be willing to participate in our study?
I would also like to let you know that all the patients who consent to participate in the study will 
have their records checked and followed for a minimum period of one year and therefore we
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would like to seek consent where we feel it is important, we could talk to you again in the next 
year.
2. Yes 2. No
(For in-depth interviews) I would also like to seek consent to record the interview so that I do not 
miss any thing that you tell me.
1. Yes 2. No
CERTIFICATE
I have read the foregoing information [or it has been read to me]. I have had the opportunity to 
ask questions about it and my questions have been answered to my satisfaction. I consent 
voluntarily to participate in this study and I understand that I have the right to withdraw at any 
time, without it in any way affecting my future medical care.
Participant
Name__________________________
Date___________________________
Signature ___________
or thumbprint if appropriate
Investigator
Name____
Date_____
Signature_
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Appendix 7: Research Assistants Training Topics
Introduction to Research What is research?
Quantitative research methods
Maintaining quality in data collection
ART in Malawi: The steps for initating ART
Eligibility for ART
Ethical issues in research Where to conduct interview
Approaching respondents and
introducing the study
Informed Consent and how to handle
respondents who refuse to participate
Study participants Inclusion and exclusion criteria
Introduction to the study tool How to ask questions/clarity
Filling out thequestionnaire
Checking with the supervisor
Piloting the tools and
process
Feedback from piloting
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Appendix 8; Qualitative Data Analysis framework
Health system
HW initiatives to improve services
Roles and responsibilities
experience providing ART
Delays to diagnosis
Challenges to providing care
Systems for assessing treatment outcomes
Costs
Patients not starting treatment 
Patient views
Waiting times 
Information provision 
Health worker attitudes 
Patient follow up programmes 
How they work 
Availability
Reason for not starting ART 
HW perspectives
vailability/non availability of CD4 machines 
Patient factors for not starting treatment 
Distance and transport 
Fear of returning to facilities after delay 
Family issues 
Stigma 
Support
Disclosure of HIV status 
Why 
To who
Effect of disclosure 
ART knowledge
Eligibility criteria 
Attended counselling session 
How ART works 
PMTCT
Illness experience 
HIV testing
Delay to testing 
Reason for HIV testing 
Effect of illness on hhold 
Adherence
Barriers
Motivators
Missed doses/ appoiments and why 
General challenges 
Effect of non-adherence 
Perceived benefits of ART 
Perceived effect of non adherence 
Recommendations for improving ART services
Appendix 9: National Health Sciences Research Committee Approval Letter
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In reply please quote No,Telephone: + 265 789 400 
Facsimile: + 205 70S 431
All Communications should be 
addressed to:
The Secretary for Health and Population
MINISTRY OF HEALTH AND POPULATION
P.O. BOX 30377 
LILONGWE 3 
MALAWI
13th August, 2008
IREEN NAMAKHOMA 
REACH TRUST 
Dear Madam,
Protocol t 556: A Study to Document the Health Care Seeking Behaviour 
among HIV and AIDS Patient in Lilongwe, Malawi
Thank you for the above titled proposal that you submitted to the National Health Sciences Research Committee 
(NHSRC) for review. Please be advised that foe NHSRC has reviewed and approved your application to conduct 
the above titled study,
• APPROVAL NUMBER 554
• The above details dwold be used on all conespondencea, consent forms and documents as appropriate.
• APPROVAL DATE :13* Attfust, 2008
• EXPIRATION DATE
This approval expires on 12th Asgast, 2009. After this date, this project may only continue upon renewal. 
For purposes of renewal, a progress report on a standard form obtainable from the NHSRC Secretariat 
should be submitted one month before the expiration date for continuing review.
• SERIOUS ADVERSE EVENT REPORTING: All serious problems having to do with subject safety 
must be reported to the NHSRC within 10 working days using standard forms obtainable from the NHSRC 
Secretinat.
• MODIFICATIONS: Prior NHSRC approval using forms obtainable from the NHSRC Secretariat is 
required before implcinentiiig any changes in the protocol (including changes in the consent documents). 
You may not uae any other consent documents besides those approved by the NHSRC.
• TERMINATION OF STUDY: On termination of a study, a report has to be submitted to the NHSRC 
using standard forms obtainable from the NHSRC Secretariat.
■ QUESTIONS: Pleaae contact the NHSRC on telephone number +265 I 789 400/32lot by email on
■ OTHER: Pleaae be reminded to rend in copies of your final research results for our records (Health 
Research Database).
Kind regards from the NHSRC Secretariat
For. IN. NATIONAL HEALTH SCIENCES RESEARCH COMMITTEE
J Promoting Ethical Conduct of Research'
Executive Committee: Dr C. Ktwmsombo (Chairperson), Prof. £ Motyneux (Vice-Chairperson)
Registered with the USA Office for Human Research Protectioes (OHRP) as an International IRB 
IRB Number IRB0000390S FWA00005976
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